
<html lang="en"     class="pb-page"  data-request-id="6fc505bc-5c20-4466-8196-590fc7379338"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00937;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition" /></meta><meta name="dc.Creator" content="Rim  Malek" /></meta><meta name="dc.Creator" content="Raquel L.  Arribas" /></meta><meta name="dc.Creator" content="Alejandra  Palomino-Antolin" /></meta><meta name="dc.Creator" content="Perle  Totoson" /></meta><meta name="dc.Creator" content="Celine  Demougeot" /></meta><meta name="dc.Creator" content="Tereza  Kobrlova" /></meta><meta name="dc.Creator" content="Ondrej  Soukup" /></meta><meta name="dc.Creator" content="Isabel  Iriepa" /></meta><meta name="dc.Creator" content="Ignacio  Moraleda" /></meta><meta name="dc.Creator" content="Daniel  Diez-Iriepa" /></meta><meta name="dc.Creator" content="Justyna  Godyń" /></meta><meta name="dc.Creator" content="Dawid  Panek" /></meta><meta name="dc.Creator" content="Barbara  Malawska" /></meta><meta name="dc.Creator" content="Monika  Głuch-Lutwin" /></meta><meta name="dc.Creator" content="Barbara  Mordyl" /></meta><meta name="dc.Creator" content="Agata  Siwek" /></meta><meta name="dc.Creator" content="Fakher  Chabchoub" /></meta><meta name="dc.Creator" content="José  Marco-Contelles" /></meta><meta name="dc.Creator" content="Katarzyna  Kiec-Kononowicz" /></meta><meta name="dc.Creator" content="Javier  Egea" /></meta><meta name="dc.Creator" content="Cristóbal  de los Ríos" /></meta><meta name="dc.Creator" content="Lhassane  Ismaili" /></meta><meta name="dc.Description" content="New tritarget small molecules combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis. Compound 3p has been identified as a very promi..." /></meta><meta name="Description" content="New tritarget small molecules combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis. Compound 3p has been identified as a very promi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2019" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00937" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00937" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00937" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00937" /></link>
        
    
    

<title>New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00937" /></meta><meta property="og:title" content="New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0008.jpeg" /></meta><meta property="og:description" content="New tritarget small molecules combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis. Compound 3p has been identified as a very promising lead, showing good Ca2+ channels blockade activity (IC50 = 21 ± 1 μM), potent affinity against hH3R (Ki = 565 ± 62 nM), a moderate but selective hBuChE inhibition (IC50 = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by lipopolysaccharide." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00937"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00937">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00937&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00937&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00937&amp;href=/doi/10.1021/acs.jmedchem.9b00937" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11416-11422</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01767" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.9b01207" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H<sub>3</sub> Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Rim Malek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rim Malek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neurosciences Intégratives et Cliniques EA 481, Pôle de Chimie Organique et Thérapeutique, Université Bourgogne Franche-Comté, UFR Santé, 19, Rue Ambroise Paré, F-25000 Besançon, France</div><div class="loa-info-affiliations-info">Laboratory of Applied Chemistry: Heterocycles, Lipids and Polymers, University of Sfax, B. P 802, 3000 Sfax, Tunisia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rim++Malek">Rim Malek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raquel L. Arribas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raquel L. Arribas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raquel+L.++Arribas">Raquel L. Arribas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alejandra Palomino-Antolin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alejandra Palomino-Antolin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Neuroinflammation and Neuronal Plasticity Laboratory, Research Unit, Hospital Universitario Santa Cristina, 28009 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alejandra++Palomino-Antolin">Alejandra Palomino-Antolin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Perle Totoson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Perle Totoson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EA4267 PEPITE, Université Bourgogne Franche-Comté, F-25030, Besançon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Perle++Totoson">Perle Totoson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Celine Demougeot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Celine Demougeot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EA4267 PEPITE, Université Bourgogne Franche-Comté, F-25030, Besançon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Celine++Demougeot">Celine Demougeot</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tereza Kobrlova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tereza Kobrlova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, CZ-500 01 Hradec Kralove, Czech Republic</div><div class="loa-info-affiliations-info">Biomedical Research Center, University Hospital CZ-500 05 Hradec Kralove, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tereza++Kobrlova">Tereza Kobrlova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ondrej Soukup</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ondrej Soukup</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, CZ-500 01 Hradec Kralove, Czech Republic</div><div class="loa-info-affiliations-info">Biomedical Research Center, University Hospital CZ-500 05 Hradec Kralove, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ondrej++Soukup">Ondrej Soukup</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabel Iriepa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel Iriepa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry and Inorganic Chemistry,  Institute of Chemical Research Andrés M. del Río, Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Iriepa">Isabel Iriepa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ignacio Moraleda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ignacio Moraleda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry and Inorganic Chemistry, Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ignacio++Moraleda">Ignacio Moraleda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Diez-Iriepa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Diez-Iriepa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry and Inorganic Chemistry,  Institute of Chemical Research Andrés M. del Río, Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</div><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, IQOG, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Diez-Iriepa">Daniel Diez-Iriepa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Justyna Godyń</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Justyna Godyń</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Justyna++Gody%C5%84">Justyna Godyń</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dawid Panek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dawid Panek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dawid++Panek">Dawid Panek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Malawska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Malawska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Malawska">Barbara Malawska</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4637-5820" title="Orcid link">http://orcid.org/0000-0003-4637-5820</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monika Głuch-Lutwin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monika Głuch-Lutwin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monika++G%C5%82uch-Lutwin">Monika Głuch-Lutwin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Mordyl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Mordyl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Mordyl">Barbara Mordyl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Agata Siwek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agata Siwek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agata++Siwek">Agata Siwek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fakher Chabchoub</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fakher Chabchoub</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Applied Chemistry: Heterocycles, Lipids and Polymers, University of Sfax, B. P 802, 3000 Sfax, Tunisia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fakher++Chabchoub">Fakher Chabchoub</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">José Marco-Contelles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">José Marco-Contelles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, IQOG, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Marco-Contelles">José Marco-Contelles</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0690-0328" title="Orcid link">http://orcid.org/0000-0003-0690-0328</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katarzyna Kiec-Kononowicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katarzyna Kiec-Kononowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katarzyna++Kiec-Kononowicz">Katarzyna Kiec-Kononowicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javier Egea</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javier Egea</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Neuroinflammation and Neuronal Plasticity Laboratory, Research Unit, Hospital Universitario Santa Cristina, 28009 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Egea">Javier Egea</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristóbal de los Ríos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristóbal de los Ríos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain</div><div class="loa-info-affiliations-info">Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Crist%C3%B3bal++de+los+R%C3%ADos">Cristóbal de los Ríos</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6456-7589" title="Orcid link">http://orcid.org/0000-0002-6456-7589</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lhassane Ismaili</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lhassane Ismaili</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neurosciences Intégratives et Cliniques EA 481, Pôle de Chimie Organique et Thérapeutique, Université Bourgogne Franche-Comté, UFR Santé, 19, Rue Ambroise Paré, F-25000 Besançon, France</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +33381665543. E-mail: <a href="/cdn-cgi/l/email-protection#7b17131a08081a151e551208161a1217123b0e15120d561d1814160f1e551d09"><span class="__cf_email__" data-cfemail="b8d4d0d9cbcbd9d6dd96d1cbd5d9d1d4d1f8cdd6d1ce95dedbd7d5ccdd96deca">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lhassane++Ismaili">Lhassane Ismaili</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6013-3150" title="Orcid link">http://orcid.org/0000-0002-6013-3150</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00937&amp;href=/doi/10.1021%2Facs.jmedchem.9b00937" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11416–11422</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 June 2019</li><li><span class="item_label"><b>Published</b> online</span>14 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00937" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00937</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11416%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRim%2BMalek%252C%2BRaquel%2BL.%2BArribas%252C%2BAlejandra%2BPalomino-Antolin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D24%26contentID%3Dacs.jmedchem.9b00937%26title%3DNew%2BDual%2BSmall%2BMolecules%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%2BTherapy%2BCombining%2BHistamine%2BH3%2BReceptor%2B%2528H3R%2529%2BAntagonism%2Band%2BCalcium%2BChannels%2BBlockade%2Bwith%2BAdditional%2BCholinesterase%2BInhibition%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11422%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00937"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1135</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00937" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rim&quot;,&quot;last_name&quot;:&quot;Malek&quot;},{&quot;first_name&quot;:&quot;Raquel&quot;,&quot;last_name&quot;:&quot;L. Arribas&quot;},{&quot;first_name&quot;:&quot;Alejandra&quot;,&quot;last_name&quot;:&quot;Palomino-Antolin&quot;},{&quot;first_name&quot;:&quot;Perle&quot;,&quot;last_name&quot;:&quot;Totoson&quot;},{&quot;first_name&quot;:&quot;Celine&quot;,&quot;last_name&quot;:&quot;Demougeot&quot;},{&quot;first_name&quot;:&quot;Tereza&quot;,&quot;last_name&quot;:&quot;Kobrlova&quot;},{&quot;first_name&quot;:&quot;Ondrej&quot;,&quot;last_name&quot;:&quot;Soukup&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Iriepa&quot;},{&quot;first_name&quot;:&quot;Ignacio&quot;,&quot;last_name&quot;:&quot;Moraleda&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Diez-Iriepa&quot;},{&quot;first_name&quot;:&quot;Justyna&quot;,&quot;last_name&quot;:&quot;Godyń&quot;},{&quot;first_name&quot;:&quot;Dawid&quot;,&quot;last_name&quot;:&quot;Panek&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Malawska&quot;},{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Głuch-Lutwin&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Mordyl&quot;},{&quot;first_name&quot;:&quot;Agata&quot;,&quot;last_name&quot;:&quot;Siwek&quot;},{&quot;first_name&quot;:&quot;Fakher&quot;,&quot;last_name&quot;:&quot;Chabchoub&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Marco-Contelles&quot;},{&quot;first_name&quot;:&quot;Katarzyna&quot;,&quot;last_name&quot;:&quot;Kiec-Kononowicz&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;Egea&quot;},{&quot;first_name&quot;:&quot;Cristóbal&quot;,&quot;last_name&quot;:&quot;de los Ríos&quot;},{&quot;first_name&quot;:&quot;Lhassane&quot;,&quot;last_name&quot;:&quot;Ismaili&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;11416-11422&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00937&quot;},&quot;abstract&quot;:&quot;New tritarget small molecules combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis. Compound 3p has been identified as a very promising lead, showing good Ca2+ channels blockade activity (IC50 = 21 ± 1 μM), potent affinity against hH3R (Ki = 565 ± 62 nM), a moderate but selective hBuChE inhibition (IC50 = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by lipopolysaccharide.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00937&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00937" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00937&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00937" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00937&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00937" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00937&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00937&amp;href=/doi/10.1021/acs.jmedchem.9b00937" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00937" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00937" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00937%26sid%3Dliteratum%253Aachs%26pmid%3D31724859%26genre%3Darticle%26aulast%3DMalek%26date%3D2019%26atitle%3DNew%2BDual%2BSmall%2BMolecules%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%2BTherapy%2BCombining%2BHistamine%2BH3%2BReceptor%2B%2528H3R%2529%2BAntagonism%2Band%2BCalcium%2BChannels%2BBlockade%2Bwith%2BAdditional%2BCholinesterase%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D24%26spage%3D11416%26epage%3D11422%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292582" title="Calcium">Calcium</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/jmcmar.2019.62.issue-24/20191226/jmcmar.2019.62.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">New tritarget small molecules combining Ca<sup>2+</sup> channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis. Compound <b>3p</b> has been identified as a very promising lead, showing good Ca<sup>2+</sup> channels blockade activity (IC<sub>50</sub> = 21 ± 1 μM), potent affinity against hH3R (<i>K</i><sub>i</sub> = 565 ± 62 nM), a moderate but selective hBuChE inhibition (IC<sub>50</sub> = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by lipopolysaccharide.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), one of the most serious medical problems in modern society, remains the main cause of memory impairment and dementia in elderly people.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD exhibits highly interconnected physiopathological signs, where the accumulation of abnormal extracellular deposits of amyloid-β (Aβ) peptide, intracellular neurofibrillary tangles (NFT), along with dramatic neuronal death and decreased levels of choline acetyltransferase are the typical hallmarks.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The increased oxidative stress (OS) and imbalances in the homeostasis of biometals such as Cu, Fe, or Zn <a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> constitute also other prominent features of AD.</div><div class="NLM_p">Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) are the catabolic enzymes responsible for acetylcholine (ACh) hydrolysis, and it is known that BuChE has a compensatory role in the hydrolysis of ACh in brains. Moreover, the levels of AChE decrease while those of BuChE increase, in aged AD patients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Accordingly, three acetylcholinesterase inhibitors (AChEIs) donepezil, rivastigmine, galantamine<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> are used for AD therapy but with limited therapeutic success. However, combined therapy of memantine a <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and AChEI may be associated with better benefits.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">In view of this situation, new strategies have been promoted based on the multitarget-directed ligand (MTDL) approach<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> for the development of new drugs able to bind simultaneously at diverse enzymatic systems or receptors involved in AD pathology.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> Following this paradigm, we have developed a number of new MTDL using multicomponent reactions (MCRs)<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> as the method of choice for introducing rapidly and efficiently chemical diversity in the search for new MTDL.</div><div class="NLM_p">Continuing with our contributions in this area, we report here the design, synthesis, and biological evaluation of diethyl 2,6-dimethyl-4-(4-(2-(amine-1-yl)alkoxy)phenyl)-1,4-dihydropyridine-3,5-dicarboxylates (<b>3a</b>–<b>p</b>) as new MTDLs resulting from the incorporation of a typical histamine 3 receptor (H3R) antagonist motif, such as the cycloalkylamine, present in pitolisant and contilisant, into a 1,4-dihydropyridine (1,4-DHP) <b>I</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) through a convenient linker. Pitolisant is a H3R antagonist currently under investigation for diverse cognition impairments,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> while contilisant is a recently developed MTDL by some of us, showing H3R antagonism, and a very attractive new lead-compound for AD therapy.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> H3R is commonly recognized as a useful pharmacological tool in the treatment of neurodegenerative diseases, involved in the central regulation of histamine levels by feedback inhibition of histamine release<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the release of other neurotransmitters, such as acetylcholine, serotonin, dopamine, and norepinephrine.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, we have to keep in mind that high affinity H3R inverse agonists may produce side effects as highly potent H3R ligands developed were rejected in preclinical studies because of unwanted effects<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> like phospholipidosis, high plasma protein binding, or poor blood–brain penetration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of 1,4-DHPs <b>3a</b>–<b>p</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">1,4-DHPs are privileged scaffolds in medicinal chemistry and the core fragment of well-known calcium channel antagonists such as nilvadipine, which is undergoing a European multicenter, double-blind, placebo-controlled, phase III trial targeted to mild-to-moderate AD.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It is well-known that increased cytosolic calcium levels, involved in the pathogenesis of AD, facilitate formation of Aβ peptides through calcium-mediated β-secretase activity<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31">(27−31)</a> and also regulate glycogen synthase kinase, protein kinase C, and other kinases that hyperphosphorylate tau and potentiate NFT formation.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Moreover, calcium entry through voltage-gated L-type Ca<sup>2+</sup> channels (Ca<sub>v</sub> 1.1–1.4) causes calcium overload and mitochondrial disruption,<named-content content-type="anchor" rid="sch1" type="simple"></named-content> which leads to the activation of the apoptotic cascade and cell death.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Thus, the calcium channel blockers (CCBs) of the type of DHP can prevent the formation of Aβ peptides, NFT formation providing neuroprotective effect, a fact that suggests that DHPs may prevent or slow the rate of progression of AD.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Thus, the new 1,4-DHPs <b>3a</b>–<b>p</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were investigated for their calcium channels and their affinity toward H3R receptor and for their ChE inhibition and antioxidant power. From these studies, we have identified 1,4-DHP <b>3p</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) as a new and very promising hit-agent for the potential AD therapy combining activities against three biological targets, as <b>3p</b> is a good Ca<sup>2+</sup> channel blocker with potent H3R affinity and selective hBuChEI, showing in addition strong antioxidant properties.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) Br-(CH<sub>2</sub>)<sub><i>n</i></sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 24 h; (2) corresponding cycloalkylamine, KI, reflux, 24 h; (ii) ethyl 3-oxobutanoate, ammonium carbonate, EtOH–H<sub>2</sub>O (1:1), MWI, 120 °C, 4 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Calcium Channel Blockade, H3R Affinity, ORAC Analysis, and BBB Prediction of 1,4-DHPs <b>3a</b>–<b>p</b> and Standard Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0007.gif" alt="" id="GRAPHIC-d7e779-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">% calcium channels blockade</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM), calcium channels blockade</th><th class="colsep0 rowsep0" align="center">H3R, <i>K</i><sub>i</sub> ± SEM (nM)</th><th class="colsep0 rowsep0" align="center">ORAC</th><th class="colsep0 rowsep0" align="center">BBB prediction (PAMPA)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">17 ± 3.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.0</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">41 ± 6.2</td><td class="colsep0 rowsep0" align="left">26 ± 6.1</td><td class="colsep0 rowsep0" align="left"><05%</td><td class="colsep0 rowsep0" align="left">3.9 ± 0.3</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">92 ± 3.2</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.6</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.0</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">96 ± 2.0</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.9</td><td class="colsep0 rowsep0" align="left">17%</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="left">95 ± 1.0</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">3.0 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="left">88 ± 8.3</td><td class="colsep0 rowsep0" align="left">4.0 ± 4.0</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="left">19 ± 16</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">83 ± 9.2</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="left">16 ± 14</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">46 ± 4.1</td><td class="colsep0 rowsep0" align="left">16 ± 9.2</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3j</b></td><td class="colsep0 rowsep0" align="left">28 ± 5.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">40 ± 3.1</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3k</b></td><td class="colsep0 rowsep0" align="left">20 ± 5.3</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3l</b></td><td class="colsep0 rowsep0" align="left">42 ± 10</td><td class="colsep0 rowsep0" align="left">24.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">1619 ± 114.0</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.3</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3m</b></td><td class="colsep0 rowsep0" align="left">37 ± 4.1</td><td class="colsep0 rowsep0" align="left">25 ± 7.0</td><td class="colsep0 rowsep0" align="left">60 ± 3.1</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3n</b></td><td class="colsep0 rowsep0" align="left">37 ± 5.0</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">49%</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3o</b></td><td class="colsep0 rowsep0" align="left">49 ± 3.1</td><td class="colsep0 rowsep0" align="left">15 ± 1.1</td><td class="colsep0 rowsep0" align="left">425 ± 27.1</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">10 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="left">42 ± 3.0</td><td class="colsep0 rowsep0" align="left">21 ± 1.0</td><td class="colsep0 rowsep0" align="left">565 ± 62.1</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">8.6 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nifedipine</td><td class="colsep0 rowsep0" align="left">39 ± 4.2</td><td class="colsep0 rowsep0" align="left">22 ± 1.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">methylhistamine</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">melatonin</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.1</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ferulic acid</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.7 ± 0.2</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Each IC<sub>50</sub> value is the mean ± SEM of quadruplicate of at least three different experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Not evaluated.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">PAMPA method (<i>P</i><sub>e</sub> ± SEM (×10<sup>–6</sup> cm·s<sup>–1</sup>). CNS + (high BBB permeation predicted): <i>P</i><sub>e</sub> ± SEM (×10<sup>–6</sup> cm·s<sup>–1</sup>) > 4.0.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the target 1,4-DHPs <b>3a</b>–<b>p</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) has been carried out by a straightforward two-step synthesis with good overall yields, as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The reaction of commercial 4-hydroxybenzaldehydes <b>1a</b>–<b>e</b> with the appropriate 1-bromo-<i>n</i>-chloroalkane in the presence of potassium carbonate in refluxing acetonitrile for 24 h followed by the reaction with the selected cycloalkylamines and potassium iodide afforded the (aminoalkoxy)benzaldehydes <b>2a</b>–<b>p</b>. Next, the one-pot Hantzsch MCR of <b>2a</b>–<b>p</b>, ethyl acetoacetate, and ammonium carbonate in ethanol–water under microwave irradiation (MWI) at 120 °C for 4 h gave the expected diethyl 2,6-dimethyl-4-(4-(2-(amine-1-yl)alkoxy)aryl)-1,4-dihydropyridine-3,5-dicarboxylates <b>3a</b>–<b>p</b>. All new compounds showed analytical and spectral data in full agreement with their proposed structures (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">To verify the effectiveness of the rational design, first of all, we investigated the blocking effect of the depolarization-induced Ca<sup>2+</sup> uptake in SH-SY5Y neuroblastoma cells stimulated with an extracellular concentration of K<sup>+</sup> 70 mM, which induces the cell Ca<sup>2+</sup> levels elevation by opening voltage-gated Ca<sup>2+</sup> channels (VGCC), monitored with the Ca<sup>2+</sup>-sensitive fluorescent dye Fluo-4. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, among the 16 tested compounds, nine displayed a Ca<sup>2+</sup> channel blockade at 10 μM better than nifedipine used, as positive standard. These VGCC blockers were further assayed at different concentrations to assess their concentration-dependent blocking profile, and five of them showed IC<sub>50</sub> data ranging from 1.5 to 15 μM and were therefore more potent than nifedipine (IC<sub>50</sub> = 22 μM) in a significant manner. Not surprisingly, the most active compounds, having IC<sub>50</sub> below 5 μM, were 1,4-DHPs <b>3c</b>–<b>f</b> derivatives that bear halogen atoms at the phenyl ring, as one can find in amlodipine<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(35)</a> or felodipine,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> two well-known VGCC antagonists, largely used drugs in the clinics.</div><div class="NLM_p">The binding affinities for <b>3a</b>–<b>p</b> on hH3R were evaluated taking methylhistamine as radioligand. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>3g</b>, <b>3j</b>, <b>3l</b>–<b>m</b>, and <b>3o</b>,<b>p</b> showed interesting affinities with <i>K</i><sub>i</sub> ranging from 40 nM for <b>3j</b> and 1619 nM for <b>3l</b>. The most active compounds, with <i>K</i><sub>i</sub> in the nanomolar range, were <b>3j</b> and <b>3m</b>. It is worth noting that among the active compounds, <b>3l</b>,<b>m</b> and <b>3o</b>,<b>p</b> were simultaneously good VGCC blockers (see above), with IC<sub>50</sub> values comparable to that of nifedipine. Compound <b>3m</b> still remains the most balanced compound, with an IC<sub>50</sub> of 25 μM as VGCC blocker, showing an affinity for H3R with <i>K</i><sub>i</sub> = 60 nM. Regarding the structure–activity relationships (SARs), no activity was observed for <b>3a</b>–<b>f</b> that bear a length in the linker of <i>n</i> = 2, irrespective of the nature of amine and the substituent on the aromatic ring. Nevertheless, when <i>n</i> = 3 and except compound <b>3l</b>, which showed the less active and modest affinity, the activities were always observed for compounds without substituent on the aromatic ring. Finally and except hybrid <b>3n</b>, the same trend was observed for <b>3m</b> and <b>3o</b>,<b>p</b> with the length of the linker <i>n</i> = 4 and 5.</div><div class="NLM_p">Next and to complete the multitarget biological analysis, we evaluated the hChE inhibition capacity of <b>3a</b>–<b>p</b> following Ellman’s protocol;<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a> see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Table S1 (Supporting Information)</a>. No significant activity was observed toward hAChE. However and very interestingly, 1,4-DHPs <b>3n</b>–<b>p</b> (<i>n</i> = 4 and <i>n</i> = 5) showed good hBuChE inhibition power in the micromolar range, with IC<sub>50</sub> values equal to 7.22, 6.07, and 7.83 μM, respectively. Thus, <b>3o</b>,<b>p</b> were identified as three-target direct ligand for AD combining VGCC blockade, H3R affinity with hBuChE inhibition. These two compounds were chosen to evaluate their selectivity against the other histamine receptor subtypes (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Tables S2–S4, Supporting Information</a>). No activity was observed against H1. For H4, the structurally most homologous G-protein-coupled receptor, <b>3p</b> showed a very low antagonist activity (IC<sub>50</sub> = 1400 nM) compared to the value observed for thioperamide (IC<sub>50</sub>= 19 nM), while <b>3o</b> showed a very weak antagonist activity. This moderate H3R affinity against H4 was previously observed in other compounds related to <b>3o</b> and <b>3p</b> bearing a pentyloxy linker connected to cyclic amine moiety.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><named-content content-type="anchor" rid="tbl2" type="simple"></named-content></div><div class="NLM_p">Neuroprotective activity was then performed for <b>3o</b>,<b>p</b>. First, we tested the neuroprotective profile of these two compounds at different concentrations (0.1, 0.3, 1, and 3 μM) against two toxic stimuli related to neurodegeneration: (a) a model of oxidative stress and ROS generation, such as a cocktail of the mitochondrial respiratory chain blockers rotenone and oligomycin A (R/O), and (b) hyperphosphorylation of tau protein using okadaic acid (OA), a well-known protein Ser/Thr phosphatase inhibitor. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the two compounds showed an interesting profile against R/O. At 0.3 and 1 μM, <b>3o</b> produced a significant increase in cell viability against R/O (48.9% and 52.8%, respectively). Similarly, <b>3p</b> at 1 and 3 μM showed a potent increase in cell viability (64.8% and 49.9%). However, only <b>3p</b> showed a significant increase in cell viability against OA at the same concentrations of 1 and 3 μM (41.8% and 20.9%).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Quantitative Data of the Protective Effect of Compounds on SH-SY5Y Cell Death Induced by Rotenone 30 μM and Oligomycin A 10 μM (R/O) and OA (20 nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">R/O</th><th class="colsep0 rowsep0" align="center">OA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3o</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">35.5 ± 13.9<sup>ns</sup></td><td class="colsep0 rowsep0" align="left">7.21 ± 10.2ns</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">48.9 ± 7.51*</td><td class="colsep0 rowsep0" align="left">8.81 ± 13.1<sup>ns</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">52.8 ± 13.6**</td><td class="colsep0 rowsep0" align="left">18.5 ± 25.3<sup>ns</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">35.4 ± 9.52<sup>ns</sup></td><td class="colsep0 rowsep0" align="left">16.0 ± 13.6<sup>ns</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">17.0 ± 26.2<sup>ns</sup></td><td class="colsep0 rowsep0" align="left">not protective</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">35.1 ± 4.51<sup>ns</sup></td><td class="colsep0 rowsep0" align="left">not protective</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">64.8 ± 14.5**</td><td class="colsep0 rowsep0" align="left">41.8 ± 19.2**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">49.9 ± 13.6*</td><td class="colsep0 rowsep0" align="left">20.9 ± 11.7*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">melatonin</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">58.2 ± 5.90***</td><td class="colsep0 rowsep0" align="left">76.0 ± 11.0***</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data are expressed as % neuroprotection ± SEM of triplicate of at least five different cultures. Compounds were assayed at 0.1, 0.3, 1, and 3 μM, and melatonin was assayed at 0.01 μM. ***<i>p</i> < 0.001, **<i>p</i> ≤ 0.01, *<i>p</i> ≤ 0.05, <sup>ns</sup>not significant, with respect to control.</p></div></div></div><div class="NLM_p">Next, we explored the potential effect of <b>3o</b> and <b>3p</b> on memory behavior improvements in vivo, using the novel object recognition test (NOR) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Treatment of mice (250 μg/kg) with lipopolysaccharide (LPS) for 24 h resulted in a significant decrease of the discrimination index compared to control group, suggesting that LPS treatment significantly impaired memory behavior. Mice treated with 10 mg/kg of <b>3p</b> after LPS showed significantly improved discrimination index, while at the same dose, <b>3o</b> was not able to restore the cognitive impairment. These results show that recognition memory deficits caused by LPS (250 μg/kg) injection are restored at an enhanced level by <b>3p</b> at 10 mg/kg, an effect that compares very favorably with the one provided by donepezil at 1 mg/kg</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of ip compounds <b>3o</b>,<b>p</b> and donepezil on LPS (250 μg/kg) induced memory impairment in the novel recognition test in mice: ***<i>p</i> ≤ 0.001 with respect to control; <sup>##</sup><i>p</i> ≤ 0.01 with respect to LPS-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To potentiate the therapeutic power of 1,4-DHPs <b>3a</b>–<b>p</b>, the antioxidant activity was tested by the ORAC-FL method.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(38,39)</a> Results are expressed in Trolox equivalents (TE) unit, melatonin and ferulic acid being used as positive controls with ORAC values equal to 2.5 <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and 3.7,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> respectively. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, all 1,4-DHPs presented strong radical scavenging properties with TE values ranging from 2.2 (<b>3c</b>) to 3.9 (<b>3b</b>). Compound <b>3b</b> was a better antioxidant than ferulic acid, while seven of the remaining compounds were more active than melatonin. Regarding the SAR, no evident and clear trends could be observed. However, it should be noted that the two most balanced ligands <b>3o</b>,<b>p</b> showed a strong antioxidant power with ORAC values equal to 2.8 and 3.6, respectively.</div><div class="NLM_p">Prediction of the blood–brain barrier (BBB) penetration of <b>3o</b>,<b>p</b> has been addressed using the PAMPA method.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a> showing high probability for <b>3o</b>,<b>p</b> to cross the BBB via passive diffusion; see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Table S4 in Supporting Information</a>.</div><div class="NLM_p">A few 1,4-DHPs reported in the literature show good selectivity between the brain and cardiovascular calcium channels<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(41,42)</a> otherwise constituting a major drawback. Thus, the vasodilation effect of <b>3p</b> was evaluated compared to nifedipine. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and as expected,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(43)</a> nifedipine induced a robust dose-dependent vasorelaxant effect, with percentages of relaxation reaching 12, 37, and 81 at 0.1, 1, and 10 nM, respectively. By contrast, <b>3p</b> did not vasodilate aortic rings except at 10 nM at which a small relaxant effect was observed (5%), significantly lower than nifedipine (<i>p</i> < 0.01).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the vasorelaxant effects of <b>3p</b> and nifedipine. The vasorelaxant responses of <b>3p</b> and nifedipine at 0.1, 1, and 10 nM were assessed on endothelium-denuded aortic rings preconstricted with 100 mM KCl. Data are expressed as the mean ± SEM (<i>n</i> = 6 aortic rings): **<i>p</i> < 0.01; n.s., not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To obtain structural clues for selectivity against hH3R, we performed docking studies of <b>3o</b> and <b>3p</b> into the active sites of the X-ray crystal structure of the hH1R (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>) of the homology-modeled hH3R and of the hH4R homology model. The modeling of the receptors 3D structures was performed using the automated homology-modeling program SWISS-MODEL,<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(44,45)</a> and the program AutoDock Vina was used to perform the blind docking. The predicted docking poses for <b>3o</b> and <b>3p</b> in the hH3R were characterized by relatively high docking scores of −8.5 and −8.0 kcal/mol, respectively. Protein–ligand interactions include a salt bridge between the protonated amine of the pyrrolidine or piperidine groups and Asp114 (N···O distance, 3.71 and 5.44 Å) and a π–cation interaction with Phe398 (<b>3o</b>) or Tyr115 (<b>3p</b>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">5S (Supporting Information)</a>).<named-content content-type="anchor" rid="fig5" type="simple"></named-content> The first interaction is considered to be critical for receptor activation. The aliphatic linker is surrounding by Pro184, Ala190, Leu111, and Tyr374. Additionally, the oxygen ether was found to involve hydrogen bonding with the hydroxyl group of Tyr394 (O···O distance, 3.25 Å for <b>3o</b>; 2.91 Å for <b>3p</b>). Moreover, π–π stacking interaction could be observed between the phenyl ring and Tyr189.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3p</b> in the binding site of hH3R homology built 3D-model based on human M1 muscarinic acetylcholine receptor (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CXV">5CXV</a>). Compound <b>3p</b> is rendered as balls and sticks and illustrated in orange. The side chain conformations of the mobile residues are illustrated in blue sticks. Asp114 is colored in yellow. Hydrogen bond is represented as green dashed line, and π–cation and salt bridge interactions are represented as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a, <b>3o</b> and <b>3p</b> are located on the top of TM5, TM6, TM7 interacting with the extracellular loop 2 (ECL2) of hH1R. Both compounds are far from the crucial amino acids in the ligand-binding site; hence, no interaction between <b>3o</b>, <b>3p</b> and the binding site residues could be observed. The predicted binding modes in H1R are in agreement with the no activity observed in vitro.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Binding of <b>3o</b> (blue) and <b>3p</b> (yellow) in the hH1R (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>). (b) Binding of <b>3o</b> (yellow) and <b>3p</b> (pink) in the homology model of hH4R based on hH1R (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>). The key binding site amino acids are shown in orange sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the hH4R, both compounds are positioned at the same site, as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b. The ligand-binding site is buried in an interior cavity, and it is located between TM3, TM5, TM6 and TM7. Compounds <b>3o</b> and <b>3p</b> are located at the entrance, blocking the access to the binding pocket by interaction with TM4, TM3, and ECL2. The weak inhibitory activities of these compounds support this interaction model</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The development of new drug candidates for an effective treatment of AD is a challenging task for medicinal chemists and a research area with potential huge impact in society. In the search for new MTDL able to bind simultaneously at diverse enzymatic systems or receptors involved in AD, 16 compounds were now designed, synthesized via Hantzsch MCR, and evaluated for their activities to modulate calcium dyshomeostasis, binding affinities of H3R, ChEs inhibition, and antioxidant power. From these results, we have identified diethyl 2,6-dimethyl-4-(4-((5-(piperidin-1-yl)pentyl)oxy)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (<b>3p</b>) as a suitable MTDL for further development. 1,4-DHP <b>3p</b> showed good Ca<sup>2+</sup> channels blockade activity (IC<sub>50</sub> = 21 ± 1 μM), potent good affinities against H3R (<i>K</i><sub>i</sub> = 565 ± 62 nM), moderate and selective hBuChE (IC<sub>50</sub> = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by LPS. In addition, <b>3p</b> did not show a significant vasorelaxing effect. It can therefore be hypothesized that, in vivo, unlike nifedipine <b>3p</b> exerts its effects independently of vasodilatation. Work is now in progress in our laboratory to develop new analogues of the identified compounds, looking for a lead 1,4-DHP for AD therapy, and the results will be reported elsewhere in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> PAINS Analysis</h3><div class="NLM_p">Being aware that nitro bearing 1,4-DHP dihydropyridines, such as nifedipine or nicardipine, have been recognized as putative pan assay interference compounds (PAINS)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(46)</a> or might also have the potential to form aggregates and cause misleading results,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(47)</a> we did not use the nitro group in our design. Consequently, we are confident that our hit-compounds <b>3o</b> and <b>3p</b> are very reliable and the starting point of new family of neuroprotective agents.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(48)</a> However, and in spite of this, we have analyzed these compounds for their potential PAINS.</div><div class="NLM_p">First, the analysis conducted by using swissadme.ch proved that these compounds are not PAINS (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Supporting Information</a>), a reasonable expectation for these compounds, since PAINS with dihydropyridine structure, reported in literature, have another chemical structure than our compounds (with a many conjugated double bonds, especially with double bond at C4 carbon atom of dihydropyridine). Besides this, we based our compounds on dihydropyridine drugs, which are not identified as PAINS.</div><div class="NLM_p">Our hit-compounds <b>3o</b> and <b>3p</b> were not recognized also as PAINS according to the Free ADME-Tox filtering tool (FAFDrugs4) program (<a href="http://fafdrugs4.mti.univ-paris-diderot.fr/" class="extLink">http://fafdrugs4.mti.univ-paris-diderot.fr/</a>) and to the “False Positive Remover” software (<a href="http://www.cbligand.org/PAINS/" class="extLink">http://www.cbligand.org/PAINS/</a>).</div><div class="NLM_p">Regarding the cholinesterase inhibition, no interference was expected with the assay, as the compounds were only active against BuChE but not against AChE.</div><div class="NLM_p">The compounds showed an absorbance (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Supporting Information</a>) at 343 nm, whose excitation at this wavelength gave a tiny emission at 421 nm, and therefore no possible interference was observed with the cytosolic Ca<sup>2+</sup>-sensitive fluorescent dye Fluo-4M in SH-SY5Y, shown at 485 nm (excitation wavelength) and 520 nm (emission wavelength).</div><div class="NLM_p last">Finally, <b>3o</b> and <b>3p</b> were not recognized as aggregators according to the software “Aggregator Advisor” (<a href="http://advisor.bkslab.org/" class="extLink">http://advisor.bkslab.org/</a>). However, and since the aggregators are nonspecific inhibitors, <b>3o</b> and <b>3p</b> were tested against an unrelated enzyme, such as MAO A, showing no inhibition.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> General Chemistry</h3><div class="NLM_p last">All reagents were purchased from Sigma-Aldrich or TCI. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker spectrometer, operating at <sup>1</sup>H NMR at 400 MHz, <sup>13</sup>C NMR at 100 MHz, in solution in dimethylsulfoxide (DMSO-<i>d</i><sub>6</sub>) at 20 °C; chemical shift values are given in δ (ppm) relatively to TMS as internal reference. Coupling constants are given in Hz. The following abbreviations were used: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Elemental analyses were obtained by a Carlo Erba EA 1108 analyzer, and the analytical results were within ±0.2% of the theoretical values for all compounds. The purity of the new compounds was checked by elemental analyses, conducted on a Carlo Erba EA 1108 apparatus, and confirmed to be ≥95%. In addition, new compounds were found to be ≥95% pure by HPLC analysis (see chromatogram of <b>3p</b> in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">Supporting Information</a>) using a Hitachi Lachrom Elite series instrument equipped with a L2400 Lachrom Elite DAD detector and a Waters Atlantis R3 column (4.6 mm × 100 mm, ⌀ = 5 μm). Peaks were detected at 230 nm, and the system was operated at 25 °C with a flow rate of 1.5 mL/min. The mobile phase was an isocratic mixture of acetonitrile and aqueous ammonium acetate (2 g/L) (40:60, v/v).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Procedure for the Synthesis of Diethyl 2,6-Dimethyl-4-(4-(2-(amine-1-yl)alkoxy)aryl)-1,4-dihydropyridine-3,5-dicarboxylates (<b>3a</b>–<b>p</b>)</h3><div class="NLM_p last">In a 10 mL microwave glass tube equipped with a septum cap, the appropriate aldehyde <b>2a</b>–<b>p</b> (1 equiv), ammonium carbonate (2 equiv), and ethyl acetoacetate (3 equiv) were dissolved in a mixture EtOH/H<sub>2</sub>O (1:1, 1.5 mL). The mixture was then exposed to microwave irradiation at 120 °C during 4 h. After reaction was complete (monitored by TLC), the mixture was evaporated and the residue was dissolved in dichloromethane, washed with water, brine, dried over anhydrous sodium sulfate, and concentrated. The solid residue was purified by flash column chromatography, using mixtures (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>3</sub> 90:9.9:0.1) to afford the desired compounds <b>3a</b>–<b>p</b>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00937" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b00937?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00937</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures covering the synthesis, spectral characterization of compounds <b>2a</b>–<b>p</b> and hybrids <b>3a</b>–<b>p</b>, pharmacological methods, and docking studies (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">PDB files (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_002.zip" class="ext-link">ZIP</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf">jm9b00937_si_001.pdf (3.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_002.zip">jm9b00937_si_002.zip (822.74 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_003.csv">jm9b00937_si_003.csv (2.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00937" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lhassane Ismaili</span> - <span class="hlFld-Affiliation affiliation">Neurosciences
Intégratives et Cliniques EA 481, Pôle de Chimie Organique
et Thérapeutique, Université
Bourgogne Franche-Comté, UFR Santé, 19, Rue Ambroise Paré, F-25000 Besançon, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6013-3150" title="Orcid link">http://orcid.org/0000-0002-6013-3150</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b0dcd8d1c3c3d1ded59ed9c3ddd1d9dcd9f0c5ded9c69dd6d3dfddc4d59ed6c2"><span class="__cf_email__" data-cfemail="87ebefe6f4f4e6e9e2a9eef4eae6eeebeec7f2e9eef1aae1e4e8eaf3e2a9e1f5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rim Malek</span> - <span class="hlFld-Affiliation affiliation">Neurosciences
Intégratives et Cliniques EA 481, Pôle de Chimie Organique
et Thérapeutique, Université
Bourgogne Franche-Comté, UFR Santé, 19, Rue Ambroise Paré, F-25000 Besançon, France</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Applied Chemistry: Heterocycles, Lipids and Polymers, University of Sfax, B. P 802, 3000 Sfax, Tunisia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raquel L. Arribas</span> - <span class="hlFld-Affiliation affiliation">Servicio
de Farmacología Clínica, Instituto de Investigación
Sanitaria, Hospital Universitario de la
Princesa, C/Diego de
León, 62, 28006 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto Teofilo
Hernando, Universidad
Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alejandra Palomino-Antolin</span> - <span class="hlFld-Affiliation affiliation">Molecular
Neuroinflammation and Neuronal Plasticity Laboratory, Research Unit, Hospital Universitario Santa Cristina, 28009 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto
de Investigación Sanitaria, Hospital
Universitario de la Princesa, 28006 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto Teofilo
Hernando, Universidad
Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Perle Totoson</span> - <span class="hlFld-Affiliation affiliation">EA4267
PEPITE, Université Bourgogne Franche-Comté, F-25030, Besançon, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celine Demougeot</span> - <span class="hlFld-Affiliation affiliation">EA4267
PEPITE, Université Bourgogne Franche-Comté, F-25030, Besançon, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tereza Kobrlova</span> - <span class="hlFld-Affiliation affiliation">Department
of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, CZ-500 01 Hradec Kralove, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Biomedical
Research Center, University Hospital CZ-500 05 Hradec
Kralove, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ondrej Soukup</span> - <span class="hlFld-Affiliation affiliation">Department
of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, CZ-500 01 Hradec Kralove, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Biomedical
Research Center, University Hospital CZ-500 05 Hradec
Kralove, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Iriepa</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry and Inorganic Chemistry, 
    Institute of Chemical
Research Andrés M. del Río, 
     and , Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ignacio Moraleda</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry and Inorganic Chemistry and , Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Diez-Iriepa</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry and Inorganic Chemistry, 
    Institute of Chemical
Research Andrés M. del Río, 
     and , Alcalá University, 28805 Alcalá de Henares, Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, IQOG, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justyna Godyń</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawid Panek</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Malawska</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4637-5820" title="Orcid link">http://orcid.org/0000-0003-4637-5820</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Głuch-Lutwin</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Mordyl</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agata Siwek</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fakher Chabchoub</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Applied Chemistry: Heterocycles, Lipids and Polymers, University of Sfax, B. P 802, 3000 Sfax, Tunisia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Marco-Contelles</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, IQOG, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0690-0328" title="Orcid link">http://orcid.org/0000-0003-0690-0328</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarzyna Kiec-Kononowicz</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Jagiellonian University Medical
College, Medyczna 9, 30-688 Kraków, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier Egea</span> - <span class="hlFld-Affiliation affiliation">Molecular
Neuroinflammation and Neuronal Plasticity Laboratory, Research Unit, Hospital Universitario Santa Cristina, 28009 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto
de Investigación Sanitaria, Hospital
Universitario de la Princesa, 28006 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto Teofilo
Hernando, Universidad
Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristóbal de los Ríos</span> - <span class="hlFld-Affiliation affiliation">Servicio
de Farmacología Clínica, Instituto de Investigación
Sanitaria, Hospital Universitario de la
Princesa, C/Diego de
León, 62, 28006 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto Teofilo
Hernando, Universidad
Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6456-7589" title="Orcid link">http://orcid.org/0000-0002-6456-7589</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.M. carried out the chemistry. R.L.A. and C.d.l.R. did the calcium channel assays. A.P.-A. and J.E. did the in vitro and in vivo experiments. M.G.-L., B.Mo., A.S., and K.K.-K. performed H1, H3R, and H4 assays and corrected the manuscript. B.M. and J.G. did ChEs inhibition. T.K. and O.S. performed the PAMPA assay. I.I., I.M., I.D.-I., and J.M.-C. did the molecular docking and corrected the manuscript. P.T. and C.D. did the vasodilatation effect, and L.I. contributed to the chemistry, ORAC-FL assays, wrote the manuscript, and conceived the project.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">L.I. thanks the Regional Council of Franche-Comté (Grants 2016YC-04540 and 04560) for financial support, M.-J. Henriot (PHV Pharma) for support in the HPLC analyses, Dr. Eva M. Garcia-Frutos from CSIC Spain for her support for fluorescence study, and Rudolf Andrys and Kamil Musilek for testing MAO inhibition. C.D. thanks Proyectos de Investigación en Salud (Grant PI16/01041, IS Carlos III, Spain, to C.D; cofunded by EU FEDER funds). J.E. thanks Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) (Programa Miguel Servet, Grants CP14/00008 and PI16/00735; cofunded by EU FEDER funds) and Fundación Mutua Madrileña. Financial support by the Jagiellonian University Medical College Poland Grant K/ZDS/007121 (H3, H1,4R affinity estimation) is gratefully acknowledged. The contribution of B.M. was supported by the European Cooperation in Science and Technology COST Action CA15135.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">ChE</td><td class="NLM_def"><p class="first last">cholinesterase</p></td></tr><tr><td class="NLM_term">ChEI</td><td class="NLM_def"><p class="first last">cholinesterase inhibitor</p></td></tr><tr><td class="NLM_term">1,4-DHPs</td><td class="NLM_def"><p class="first last">1,4-dihydropyridines</p></td></tr><tr><td class="NLM_term">H3R</td><td class="NLM_def"><p class="first last">histamine 3 receptor</p></td></tr><tr><td class="NLM_term">MCR</td><td class="NLM_def"><p class="first last">multicomponent reaction</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligand</p></td></tr><tr><td class="NLM_term">OS</td><td class="NLM_def"><p class="first last">oxidative stress</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Querfurth, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFerla, F. M.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>362</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1056/NEJMra0909142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&issue=4&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease&doi=10.1056%2FNEJMra0909142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lgfFxq8N45o1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26issue%3D4%26spage%3D329%26epage%3D344%26doi%3D10.1056%2FNEJMra0909142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frölich, L.</span></span> <span> </span><span class="NLM_article-title">The Cholinergic Pathology in Alzheimer’s Disease--Discrepancies between Clinical Experience and Pathophysiological Findings</span>. <i>J. Neural Transm. Vienna Austria 1996</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1007/s007020200083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1007%2Fs007020200083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD38zms1yisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1003-1013&issue=7%E2%80%938&author=L.+Fr%C3%B6lich&title=The+Cholinergic+Pathology+in+Alzheimer%E2%80%99s+Disease%2D%2DDiscrepancies+between+Clinical+Experience+and+Pathophysiological+Findings&doi=10.1007%2Fs007020200083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings</span></div><div class="casAuthors">Frolich L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1003-13</span>
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    </div><div class="casAbstract">The cholinergic hypothesis of Alzheimer's disease (AD) states 1. that cholinergic neurons in the basal forebrain are severely affected in the course of disease, detectable both histopathologically by a loss of neurons and neurochemically, by a loss of marker enzymes for acetylcholine synthesis and degradation, and 2. that the resulting cerebral cholinergic deficit leads to memory loss and other cognitive and non-cognitive symptoms, which are characteristic for the illness.  This hypothesis was mainly based on studies, which had been conducted on brains of patients with advanced dementia.  Nevertheless, it has served as the rationale for the development of drugs, i.e. acetylcholine-esterase inhibitors (AChE-I), which have shown consistent, but modest clinical efficacy against cognitive decline and behavioural symptoms of dementia for a limited period of time.  These drugs are presently regarded the standard treatment of dementia in Alzheimer's disease.  Now, due to a more sensitive and reliable clinical diagnosis, neurobiological investigations can be performed on early stages of disease, when the changes detected presumably are more relevant for the pathogenesis.  New studies on the pathophysiology of the cholinergic system in AD suggest 1. that the cholinergic deficit occurs only late in the disease, 2. that at the earliest stages there even is an upregulation of cholinergic activity in the brain, and 3. that an increased activity of AChE may develop under therapy with AChE-I's.  These data show that there is a plasticity of the central cholinergic system in AD and that the positive clinical effects of AChE-I are to be weighted against possible detrimental effects on a pathophysiological level.  These data challenge the cholinergic hypothesis in its present form, e.g. should stimulate studies on the underlying process, which leads the cholinergic system to increase its activity in patients in the early stage of AD and may have clinical consequences regarding cholinergic drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2xbVApEVCbVf1XRtfYM0dfW6udTcc2eaYkpoxotcqkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zms1yisw%253D%253D&md5=93c09f085d14268752bf80ef16264145</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs007020200083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs007020200083%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6lich%26aufirst%3DL.%26atitle%3DThe%2520Cholinergic%2520Pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease--Discrepancies%2520between%2520Clinical%2520Experience%2520and%2520Pathophysiological%2520Findings%26jtitle%3DJ.%2520Neural%2520Transm.%2520Vienna%2520Austria%25201996%26date%3D2002%26volume%3D109%26issue%3D7%25E2%2580%25938%26spage%3D1003%26epage%3D1013%26doi%3D10.1007%2Fs007020200083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Tacrine Derivatives and Alzheimer’s Disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1838</span>, <span class="refDoi"> DOI: 10.2174/092986710791111206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F092986710791111206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20345341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1825-1838&issue=17&author=V.+Tumiattiauthor=A.+Minariniauthor=M.+L.+Bolognesiauthor=A.+Milelliauthor=M.+Rosiniauthor=C.+Melchiorre&title=Tacrine+Derivatives+and+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F092986710791111206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine derivatives and Alzheimer's disease</span></div><div class="casAuthors">Tumiatti, V.; Minarini, A.; Bolognesi, M. L.; Milelli, A.; Rosini, M.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) inhibitors (AChEIs) and, more recently, an N-methyl-D-aspartate receptor (NMDAR) antagonist.  AD is a multifactorial syndrome with several target proteins contributing to its etiol.  "Multi-target-directed ligands" (MTDLs) have great potential for treating complex diseases such as AD because they can interact with multiple targets.  The design of compds. that can hit more than one specific AD target thus represents an innovative strategy for AD treatment.  Tacrine was the first AChEI introduced in therapy.  Recent studies have demonstrated its ability to interact with different AD targets.  Furthermore, numerous tacrine homo- and heterodimers were developed with the aim of improving and enlarging its biol. profile beyond its ability to act as an AChEI.  Several tacrine hybrid derivs. were designed and synthesized with the same goal.  This review will focus on and summarize the last 2 years of research into the development of tacrine derivs. able to hit AD targets beyond simple AChE inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAUhZIxP33LVg90H21EOLACvtfcHk0lgJuNUPEObJCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D&md5=0506197d9fdaa47d5a76bdf2099cf483</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986710791111206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791111206%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DTacrine%2520Derivatives%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26issue%3D17%26spage%3D1825%26epage%3D1838%26doi%3D10.2174%2F092986710791111206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&issue=7&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+Stress+in+Alzheimer%E2%80%99s+Disease%3A+Are+We+Connecting+the+Dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0livKVpvbEiCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520Stress%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Are%2520We%2520Connecting%2520the%2520Dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D7%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Drug Development Based on the Metals Hypothesis of Alzheimer’s Disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.3233/JAD-2008-15208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-2008-15208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=18953111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cmtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=223-240&issue=2&author=A.+I.+Bush&title=Drug+Development+Based+on+the+Metals+Hypothesis+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2008-15208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Development Based on the Metals Hypothesis of Alzheimer's Disease</span></div><div class="casAuthors">Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-240</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The recent report of pos. results from a Phase IIa clin. trial of PBT2, a novel drug that targets amyloid-β-metal interactions, underscores the value of abnormal transition metal metab. as a potential therapeutic target in Alzheimer's disease.  The Metals Hypothesis of Alzheimer's disease is based upon observations of the pptn. of amyloid-β by zinc and its radicalization by copper.  Both metals are markedly enriched in plaques.  The Hypothesis involves the perturbance of these endogenous brain metals, and it does not consider toxicol. exposure part of pathogenesis.  Recent descriptions of the release of ionic zinc and copper in the cortical glutamatergic synapse, modulating the response of the NMDA receptor, may explain the vulnerability of amyloid-β to abnormal interaction with these metal ions in the synaptic region leading to aggregation and fostering toxicity.  Increasingly sophisticated medicinal chem. approaches are being tested which correct the abnormalities without causing systemic disturbance of these essential minerals.  PBT2, clioquinol and related compds. are ionophores rather than chelators.  PBT2 is a once per day, orally bioavailable, second generation 8-OH quinoline deriv. of clioquinol.  It has performed very satisfactorily in toxicol. and Phase I clin. trials and is advancing as a disease-modifying candidate drug for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhLYKZxz7C7Vg90H21EOLACvtfcHk0livKVpvbEiCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cmtr3J&md5=e69992b89e2c5294552ada499b3afa1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3233%2FJAD-2008-15208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2008-15208%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DDrug%2520Development%2520Based%2520on%2520the%2520Metals%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2008%26volume%3D15%26issue%3D2%26spage%3D223%26epage%3D240%26doi%3D10.3233%2FJAD-2008-15208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilukuri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase and the Cholinergic System</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2012.12.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.neuroscience.2012.12.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=23305761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2013&pages=53-68&author=G.+A.+Reidauthor=N.+Chilukuriauthor=S.+Darvesh&title=Butyrylcholinesterase+and+the+Cholinergic+System&doi=10.1016%2Fj.neuroscience.2012.12.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase and the cholinergic system</span></div><div class="casAuthors">Reid, G. A.; Chilukuri, N.; Darvesh, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-68</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cholinergic system plays important roles in neurotransmission in both the peripheral and central nervous systems.  The cholinergic neurotransmitter acetylcholine is synthesized by choline acetyltransferase (ChAT) and its action terminated by acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).  The predominance of AChE has focused much attention on understanding the relationship of this enzyme to ChAT-pos. cholinergic neurons.  However, there is ample evidence that BuChE also plays an important role in cholinergic regulation.  To elucidate the relationship of BuChE to neural elements that are producing acetylcholine, the distribution of this enzyme was compared to that of ChAT in the mouse CNS.  Brain tissues from 129S1/SvImJ mice were stained for BuChE and ChAT using histochem., immunohistochem. and immunofluorescent techniques.  Both BuChE and ChAT were found in neural elements throughout the CNS.  BuChE staining with histochem. and immunohistochem. produced the same distribution of labeling throughout the brain and spinal cord.  Immunofluorescent double labeling demonstrated that many nuclei in the medulla oblongata, as well as regions of the spinal cord, had neurons that contained both BuChE and ChAT.  BuChE-pos. neurons without ChAT were found in close proximity with ChAT-pos. neuropil in areas such as the thalamus and amygdala.  BuChE-pos. neuropil was also found closely assocd. with ChAT-pos. neurons, particularly in tegmental nuclei of the pons.  These observations provide further neuroanatomical evidence of a role for BuChE in the regulation of acetylcholine levels in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryfLt0nfCszLVg90H21EOLACvtfcHk0livKVpvbEiCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWgtL4%253D&md5=0e70a02526df9cb9f925e1367b610681</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2012.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2012.12.054%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DG.%2BA.%26aulast%3DChilukuri%26aufirst%3DN.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DButyrylcholinesterase%2520and%2520the%2520Cholinergic%2520System%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D234%26spage%3D53%26epage%3D68%26doi%3D10.1016%2Fj.neuroscience.2012.12.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bond, M.</span>; <span class="NLM_string-name">Rogers, G.</span>; <span class="NLM_string-name">Peters, J.</span>; <span class="NLM_string-name">Anderson, R.</span>; <span class="NLM_string-name">Hoyle, M.</span>; <span class="NLM_string-name">Miners, A.</span>; <span class="NLM_string-name">Moxham, T.</span>; <span class="NLM_string-name">Davis, S.</span>; <span class="NLM_string-name">Thokala, P.</span>; <span class="NLM_string-name">Wailoo, A.</span>; <span class="NLM_string-name">Jeffreys, M.</span>; <span class="NLM_string-name">Hyde, C.</span></span> <span> </span><span class="NLM_article-title">The Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Review of Technology Appraisal No. 111): A Systematic Review and Economic Model</span>.  <i>Health Technol. Assess.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume">16</span> (<span class="NLM_issue">21</span>), <span class="refDoi"> DOI: 10.3310/hta16210</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3310%2Fhta16210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=22541366" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&issue=21&author=M.+Bond&author=G.+Rogers&author=J.+Peters&author=R.+Anderson&author=M.+Hoyle&author=A.+Miners&author=T.+Moxham&author=S.+Davis&author=P.+Thokala&author=A.+Wailoo&author=M.+Jeffreys&author=C.+Hyde&title=The+Effectiveness+and+Cost-Effectiveness+of+Donepezil%2C+Galantamine%2C+Rivastigmine+and+Memantine+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease+%28Review+of+Technology+Appraisal+No.+111%29%3A+A+Systematic+Review+and+Economic+Model&doi=10.3310%2Fhta16210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3310%2Fhta16210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3310%252Fhta16210%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DM.%26atitle%3DThe%2520Effectiveness%2520and%2520Cost-Effectiveness%2520of%2520Donepezil%252C%2520Galantamine%252C%2520Rivastigmine%2520and%2520Memantine%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520%2528Review%2520of%2520Technology%2520Appraisal%2520No.%2520111%2529%253A%2520A%2520Systematic%2520Review%2520and%2520Economic%2520Model%26jtitle%3DHealth%2520Technol.%2520Assess.%26date%3D2012%26volume%3D16%26issue%3D21%26doi%3D10.3310%2Fhta16210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, C.</span></span> <span> </span><span class="NLM_article-title">Memantine in Patients with Moderate to Severe Alzheimer’s Disease: Meta-Analyses Using Realistic Definitions of Response</span>. <i>Dementia Geriatr. Cognit. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1159/000353801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1159%2F000353801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24107324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVCls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=71-85&issue=1%E2%80%932&author=D.+Wilkinsonauthor=Y.+Wirthauthor=C.+Goebel&title=Memantine+in+Patients+with+Moderate+to+Severe+Alzheimer%E2%80%99s+Disease%3A+Meta-Analyses+Using+Realistic+Definitions+of+Response&doi=10.1159%2F000353801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in Patients with Moderate to Severe Alzheimer's Disease: Meta-Analyses Using Realistic Definitions of Response</span></div><div class="casAuthors">Wilkinson, David; Wirth, Yvonne; Goebel, Claus</div><div class="citationInfo"><span class="NLM_cas:title">Dementia and Geriatric Cognitive Disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">DGCDFX</span>;
        ISSN:<span class="NLM_cas:issn">1420-8008</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: We aimed to develop realistic definitions of clin. worsening in advanced Alzheimer's disease (AD) and to use them in a post hoc responder anal. of memantine.  Methods: 2,340 patients with moderate to severe AD (Mini-Mental State Examn. <20) were included from 9 multicentre, 16- to 28-wk, randomized, double-blind, placebo-controlled studies of memantine 20 mg/day vs. placebo.  Responder meta-analyses were performed, with definitions of response based on minimally important differences (MIDs) on cognitive, functional, and global assessment scales.  Validated or established MIDs were used where available; otherwise, MIDs were estd. by a data-driven approach, using data from our moderate to severe AD population.  Results: Patients with moderate to severe AD treated with memantine had a lower incidence of worsening from baseline to endpoint than patients treated with placebo, in cognition [24.4 vs. 35.0%; odds ratio (OR) = 0.60; p < 0.001], function (38.1 vs. 43.4%; OR = 0.81; p = 0.01), global status (39.8 vs. 48.6%; OR = 0.70; p < 0.001), and in a combined 'triple' worsening measure (9.4 vs. 16.1%; OR = 0.54; p < 0.001).  Conclusions: New definitions of clin. worsening based on MIDs represent a more realistic functional decline in advanced stages of AD.  Results of this new anal. show that memantine reduces the incidence of clin. worsening in key symptomatic domains in moderate to severe AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU9KiS3U7Bm7Vg90H21EOLACvtfcHk0ljRx6KThOwZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVCls7s%253D&md5=37b5803823d4cacc3fba5a8d12805a34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1159%2F000353801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353801%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DWirth%26aufirst%3DY.%26aulast%3DGoebel%26aufirst%3DC.%26atitle%3DMemantine%2520in%2520Patients%2520with%2520Moderate%2520to%2520Severe%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Meta-Analyses%2520Using%2520Realistic%2520Definitions%2520of%2520Response%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2014%26volume%3D37%26issue%3D1%25E2%2580%25932%26spage%3D71%26epage%3D85%26doi%3D10.1159%2F000353801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gareri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putignano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotroneo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Palo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacummo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurlo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putignano, S.</span></span> <span> </span><span class="NLM_article-title">Retrospective Study on the Benefits of Combined Memantine and CholinEsterase Inhibitor TreatMent in AGEd Patients Affected with Alzheimer’s Disease: The MEMAGE Study</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.3233/JAD-132735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-132735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24643135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKhsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=633-640&issue=2&author=P.+Gareriauthor=D.+Putignanoauthor=A.+Castagnaauthor=A.+M.+Cotroneoauthor=G.+De+Paloauthor=A.+Fabboauthor=L.+Forgioneauthor=A.+Giacummoauthor=R.+Lacavaauthor=S.+Marinoauthor=M.+Simoneauthor=A.+Zurloauthor=S.+Putignano&title=Retrospective+Study+on+the+Benefits+of+Combined+Memantine+and+CholinEsterase+Inhibitor+TreatMent+in+AGEd+Patients+Affected+with+Alzheimer%E2%80%99s+Disease%3A+The+MEMAGE+Study&doi=10.3233%2FJAD-132735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study</span></div><div class="casAuthors">Gareri, Pietro; Putignano, Daria; Castagna, Alberto; Cotroneo, Antonino Maria; De Palo, Grazia; Fabbo, Andrea; Forgione, Luigi; Giacummo, Attilio; Lacava, Roberto; Marino, Saverio; Simone, Maurizio; Zurlo, Amedeo; Putignano, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Combined therapy of memantine and acetylcholinesterase inhibitors (AChEIs) in patients with Alzheimer's disease (AD) may be assocd. with higher benefits than either monotherapy.  This retrospective multicentric study conducted in 7 Italian Ambulatory Centers for Dementia assessed the efficacy and safety of memantine 20 mg/day administered for 6 mo in addn. to an AChEI in AD patients with worsened cognitive functions and behavioral disorders.  A total no. of 240 patients (61.7% of women, 38.3% men, mean age 77.9 years old) who had started treatment with the combination therapy were recruited.  At baseline (T0), Month 3 (T1), and Month 6 (T2), cognitive functions were assessed by Mini-Mental State Examn. (MMSE), functional dependence by activities of daily living (ADL) and instrumental ADL, behavioral disturbances by the Neuropsychiatric Inventory (NPI), and comorbidities by Cumulative Illness Rating Scale.  Adverse events were reported during the study.  MMSE total score significantly increased at Month 6 and IADL total score significantly decreased from baseline to endpoint.  There were no significant changes from baseline in mean ADL, despite significant improvements in NPI total score.  The mean MMSE total score significantly increased with the combination donepezil + memantine compared to rivastigmine + memantine.  The adverse events profile was in line with the expected range of the drugs studied and concomitant therapies.  Overall, 17 patients discontinued treatment in the observation time.  Combined treatment with memantine and AChEIs was effective in patients with AD, particularly in slowing cognitive impairment and preventing the onset of agitation and aggression in elderly AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGX2p5bzUUmLVg90H21EOLACvtfcHk0ljRx6KThOwZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKhsrbF&md5=4f4d9a1efcdb0e02ba95f4f5ba256fc2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3233%2FJAD-132735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-132735%26sid%3Dliteratum%253Aachs%26aulast%3DGareri%26aufirst%3DP.%26aulast%3DPutignano%26aufirst%3DD.%26aulast%3DCastagna%26aufirst%3DA.%26aulast%3DCotroneo%26aufirst%3DA.%2BM.%26aulast%3DDe%2BPalo%26aufirst%3DG.%26aulast%3DFabbo%26aufirst%3DA.%26aulast%3DForgione%26aufirst%3DL.%26aulast%3DGiacummo%26aufirst%3DA.%26aulast%3DLacava%26aufirst%3DR.%26aulast%3DMarino%26aufirst%3DS.%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DZurlo%26aufirst%3DA.%26aulast%3DPutignano%26aufirst%3DS.%26atitle%3DRetrospective%2520Study%2520on%2520the%2520Benefits%2520of%2520Combined%2520Memantine%2520and%2520CholinEsterase%2520Inhibitor%2520TreatMent%2520in%2520AGEd%2520Patients%2520Affected%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520The%2520MEMAGE%2520Study%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D41%26issue%3D2%26spage%3D633%26epage%3D640%26doi%3D10.3233%2FJAD-132735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&issue=3&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-Target-Directed+Ligands+To+Combat+Neurodegenerative+Diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lgSVGxFYdn2ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-Target-Directed%2520Ligands%2520To%2520Combat%2520Neurodegenerative%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D3%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oset-Gasque, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFKis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=401-403&issue=3&author=M.+J.+Oset-Gasqueauthor=J.+Marco-Contelles&title=Alzheimer%E2%80%99s+Disease%2C+the+%E2%80%9COne-Molecule%2C+One-Target%E2%80%9D+Paradigm%2C+and+the+Multitarget+Directed+Ligand+Approach&doi=10.1021%2Facschemneuro.8b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach</span></div><div class="casAuthors">Oset-Gasque, Maria Jesus; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-403</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No selective drugs exist, and we have been designing, synthesizing, and evaluating multitarget-directed ligands since the beginning of modern medicinal chem., without knowing it, most possibly.  The challenge to discover the efficient Multi-Target Small Mols. (MTSMs) for Alzheimer's disease (AD) therapy implies to identify the key combination of biol. targets to modulate them, thus including in the design the corresponding pharmacophoric groups able to do it.  Universal and polyvalent pharmacophoric groups, able to modulate diverse receptors or enzymic systems, would simplify the drug discovery process leading to new and more efficient MTSMs for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHZZw9_3OlE7Vg90H21EOLACvtfcHk0lgSVGxFYdn2ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFKis74%253D&md5=eef2b740d6b7501d7fe58f304b7695cb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00069%26sid%3Dliteratum%253Aachs%26aulast%3DOset-Gasque%26aufirst%3DM.%2BJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%252C%2520the%2520%25E2%2580%259COne-Molecule%252C%2520One-Target%25E2%2580%259D%2520Paradigm%252C%2520and%2520the%2520Multitarget%2520Directed%2520Ligand%2520Approach%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D401%26epage%3D403%26doi%3D10.1021%2Facschemneuro.8b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dgachi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szałaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabchoub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1–42 Aggregation Inhibitors for Alzheimer’s Disease Therapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Fcmdc.201500539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26804623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1OnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1318-1327&issue=12&author=Y.+Dgachiauthor=L.+Ismailiauthor=D.+Knezauthor=M.+Benchekrounauthor=H.+Martinauthor=N.+Sza%C5%82ajauthor=S.+Wehleauthor=O.+M.+Bautista-Aguileraauthor=V.+Luzetauthor=A.+Bonnetauthor=B.+Malawskaauthor=S.+Gobecauthor=M.+Chiouaauthor=M.+Deckerauthor=F.+Chabchoubauthor=J.+Marco-Contelles&title=Synthesis+and+Biological+Assessment+of+Racemic+Benzochromenopyrimidinimines+as+Antioxidant%2C+Cholinesterase%2C+and+A%CE%B21%E2%80%9342+Aggregation+Inhibitors+for+Alzheimer%E2%80%99s+Disease+Therapy&doi=10.1002%2Fcmdc.201500539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy</span></div><div class="casAuthors">Dgachi, Youssef; Ismaili, Lhassane; Knez, Damijan; Benchekroun, Mohamed; Martin, Helene; Szalaj, Natalia; Wehle, Sarah; Bautista-Aguilera, Oscar M.; Luzet, Vincent; Bonnet, Alexandre; Malawska, Barbara; Gobec, Stanislav; Chioua, Mourad; Decker, Michael; Chabchoub, Fakher; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1318-1327</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Given the complex nature of Alzheimer's disease (AD), compds. that are able to simultaneously address two or more AD-assocd. targets show greater promise for development into drugs for AD therapy.  Herein the authors report an efficient two-step synthesis and biol. evaluation of new racemic benzochromene derivs. as antioxidants, inhibitors of cholinesterase and β-amyloid (Aβ1-42) aggregation.  Based on the results of the primary screening, the authors identified 15-(3-methoxyphenyl)-9,11,12,15-tetrahydro-10H,14H-benzo[5,6]chromeno[2,3-d]pyrido[1,2-a]pyrimidin-14-imine and 16-(3-methoxyphenyl)-9,10,11,12,13,16-hexahydro-15H-benzo[5',6']chromeno[2',3':4,5]pyrimido[1,2-a]azepin-15-imine as new potential multitarget-directed ligands for AD therapy.  Further in-depth biol. anal. showed that one compd. is a good human acetylcholinesterase inhibitor [IC50=(0.36±0.02) μmol] has strong antioxidant activity (3.61 μmol Trolox equiv.) , and moderate Aβ1-42 antiaggregation power (40.3%).  The synthesis of the target compds. was achieved by a reaction of 3-amino-1-phenyl-1H-naphtho[2,1-b]pyran-2-carbonitrile and 2-amino-4-phenyl-4H-naphtho[1,2-b]pyran-3-carbonitrile with lactams, such as 2-pyrrolidinone, 2-piperidinone, hexahydro-2H-azepin-2-one.  The title compds. thus formed included naphtho[1',2':5,6]pyrano[2,3-d]pyrimidine analogs and derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrefXSrxvP3r7Vg90H21EOLACvtfcHk0liBZcaGoCx7DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1OnsL0%253D&md5=70c884cb0a97bfe60ea833ce1073ed8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500539%26sid%3Dliteratum%253Aachs%26aulast%3DDgachi%26aufirst%3DY.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DSza%25C5%2582aj%26aufirst%3DN.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DBonnet%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DChabchoub%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Assessment%2520of%2520Racemic%2520Benzochromenopyrimidinimines%2520as%2520Antioxidant%252C%2520Cholinesterase%252C%2520and%2520A%25CE%25B21%25E2%2580%259342%2520Aggregation%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D1318%26epage%3D1327%26doi%3D10.1002%2Fcmdc.201500539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Investigation of Multi-Target-Directed Ligands (MTDLs) with Butyrylcholinesterase (BuChE) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibition: The Design, Synthesis of Miconazole Analogues Targeting Alzheimer’s Disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1674</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bmc.2018.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=29475581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFakurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1665-1674&issue=8&author=X.+Luauthor=S.+Heauthor=Q.+Liauthor=H.+Yangauthor=X.+Jiangauthor=H.+Linauthor=Y.+Chenauthor=W.+Quauthor=F.+Fengauthor=Y.+Bianauthor=Y.+Zhouauthor=H.+Sun&title=Investigation+of+Multi-Target-Directed+Ligands+%28MTDLs%29+with+Butyrylcholinesterase+%28BuChE%29+and+Indoleamine+2%2C3-Dioxygenase+1+%28IDO1%29+Inhibition%3A+The+Design%2C+Synthesis+of+Miconazole+Analogues+Targeting+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmc.2018.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease</span></div><div class="casAuthors">Lu, Xin; He, Si-yu; Li, Qi; Yang, Hongyu; Jiang, Xueyang; Lin, Hongzhi; Chen, Yao; Qu, Wei; Feng, Feng; Bian, Yaoyao; Zhou, You; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1665-1674</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our endeavor towards the development of potent multi-target ligands for the treatment of Alzheimer's disease, miconazole was identified to show BuChE-IDO1 dual-target inhibitory effects.  Morris water maze test indicated that miconazole obviously ameliorated the cognitive function impaired by scopolamine.  Furthermore, it showed good safety in primary hepatotoxicity evaluation.  Based on these results, we designed, synthesized, and evaluated a series of miconazole derivs. as BuChE-IDO1 dual-target inhibitors.  Out of the 12 compds., 5i and 5j exhibited the best potency in enzymic evaluation, thus were selected for subsequent behavioral study, in which the two compds. exerted much improved effect than tacrine.  Meanwhile, 5i and 5j displayed no apparent hepatotoxicity.  The results suggest that miconazole analog offers an attractive starting point for further development of new BuChE-IDO1 dual-target inhibitors against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFWgipL3NC8bVg90H21EOLACvtfcHk0liBZcaGoCx7DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFakurw%253D&md5=28600c6f86b9f5a30151ff0f0f9c9f58</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DInvestigation%2520of%2520Multi-Target-Directed%2520Ligands%2520%2528MTDLs%2529%2520with%2520Butyrylcholinesterase%2520%2528BuChE%2529%2520and%2520Indoleamine%25202%252C3-Dioxygenase%25201%2520%2528IDO1%2529%2520Inhibition%253A%2520The%2520Design%252C%2520Synthesis%2520of%2520Miconazole%2520Analogues%2520Targeting%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1665%26epage%3D1674%26doi%3D10.1016%2Fj.bmc.2018.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Gonzalez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaldivar-Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccheri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legname, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7640</span>– <span class="NLM_lpage">7656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7640-7656&issue=17&author=A.+Gandiniauthor=M.+Bartoliniauthor=D.+Tedescoauthor=L.+Martinez-Gonzalezauthor=C.+Rocaauthor=N.+E.+Campilloauthor=J.+Zaldivar-Diezauthor=C.+Perezauthor=G.+Zuccheriauthor=A.+Mitiauthor=A.+Feoliauthor=S.+Castellanoauthor=S.+Petrallaauthor=B.+Montiauthor=M.+Rossiauthor=F.+Modaauthor=G.+Legnameauthor=A.+Martinezauthor=M.+L.+Bolognesi&title=Tau-Centric+Multitarget+Approach+for+Alzheimer%E2%80%99s+Disease%3A+Development+of+First-in-Class+Dual+Glycogen+Synthase+Kinase+3%CE%B2+and+Tau-Aggregation+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span></div><div class="casAuthors">Gandini, Annachiara; Bartolini, Manuela; Tedesco, Daniele; Martinez-Gonzalez, Loreto; Roca, Carlos; Campillo, Nuria E.; Zaldivar-Diez, Josefa; Perez, Concepcion; Zuccheri, Giampaolo; Miti, Andrea; Feoli, Alessandra; Castellano, Sabrina; Petralla, Sabrina; Monti, Barbara; Rossi, Martina; Moda, Fabio; Legname, Giuseppe; Martinez, Ana; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7640-7656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several findings propose the altered tau protein network as an important target for Alzheimer's disease (AD).  Particularly, two points of pharmacol. intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process.  On the basis of this consideration and on the authors' interest in multitarget paradigms in AD, the authors report on the discovery of 2,4-thiazolidinedione derivs. endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, resp.  In addn., they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations.  Finally, both compds. were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model.  To the best of the authors' knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compds. hitting tau cascade at two different hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6bQV6XoAhyrVg90H21EOLACvtfcHk0lgeIHFL5W6Q1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL&md5=34b7e2f2556f3e96c768dd87fb3f0e6d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DMartinez-Gonzalez%26aufirst%3DL.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DZaldivar-Diez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DZuccheri%26aufirst%3DG.%26aulast%3DMiti%26aufirst%3DA.%26aulast%3DFeoli%26aufirst%3DA.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTau-Centric%2520Multitarget%2520Approach%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Development%2520of%2520First-in-Class%2520Dual%2520Glycogen%2520Synthase%2520Kinase%25203%25CE%25B2%2520and%2520Tau-Aggregation%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656%26doi%3D10.1021%2Facs.jmedchem.8b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Novel Multitarget-Directed Ligands Targeting Acetylcholinesterase and Σ1 Receptors as Lead Compounds for Treatment of Alzheimer’s Disease: Synthesis, Evaluation, and Structural Characterization of Their Complexes with Acetylcholinesterase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejmech.2018.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=30447434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=234-248&author=J.+Lalutauthor=G.+Santoniauthor=D.+Karilaauthor=C.+Lecouteyauthor=A.+Davisauthor=F.+Nachonauthor=I.+Silmanauthor=J.+Sussmanauthor=M.+Weikauthor=T.+Mauriceauthor=P.+Dallemagneauthor=C.+Rochais&title=Novel+Multitarget-Directed+Ligands+Targeting+Acetylcholinesterase+and+%CE%A31+Receptors+as+Lead+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Synthesis%2C+Evaluation%2C+and+Structural+Characterization+of+Their+Complexes+with+Acetylcholinesterase&doi=10.1016%2Fj.ejmech.2018.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span></div><div class="casAuthors">Lalut, Julien; Santoni, Gianluca; Karila, Delphine; Lecoutey, Cedric; Davis, Audrey; Nachon, Florian; Silman, Israel; Sussman, Joel; Weik, Martin; Maurice, Tangui; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-248</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pleiotropic intervention may be a requirement for effective limitation of the progression of multifactorial diseases such as Alzheimer's disease.  One approach to such intervention is to design a single chem. entity capable of acting on two or more targets of interest, which are accordingly known as multi-target directed ligands (MTDLs).  We recently described donecopride, the first MTDL able to simultaneously inhibit acetylcholinesterase and act as an agonist of the 5-HT4 receptor, which displays promising activities in vivo.  Pharmacomodulation of donecopride allowed us to develop a novel series of indole derivs. possessing interesting in vitro activities toward AChE and the σ1 receptor.  The crystal structures of complexes of the most promising compds. with Torpedo californica AChE were solved in order to further understand their mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp9tmUk8w_j7Vg90H21EOLACvtfcHk0lgeIHFL5W6Q1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF&md5=79dec73e1bf82d5d1b893a81366ea5ef</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DKarila%26aufirst%3DD.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DNovel%2520Multitarget-Directed%2520Ligands%2520Targeting%2520Acetylcholinesterase%2520and%2520%25CE%25A31%2520Receptors%2520as%2520Lead%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Synthesis%252C%2520Evaluation%252C%2520and%2520Structural%2520Characterization%2520of%2520Their%2520Complexes%2520with%2520Acetylcholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D234%26epage%3D248%26doi%3D10.1016%2Fj.ejmech.2018.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudlo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Donepezil-Ferulic Acid Hybrids as Anti-Alzheimer Drugs</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.4155%2Ffmc.14.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=25582330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=15-21&issue=1&author=M.+Benchekrounauthor=L.+Ismailiauthor=M.+Pudloauthor=V.+Luzetauthor=T.+Gharbiauthor=B.+Refouveletauthor=J.+Marco-Contelles&title=Donepezil-Ferulic+Acid+Hybrids+as+Anti-Alzheimer+Drugs&doi=10.4155%2Ffmc.14.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-ferulic acid hybrids as anti-Alzheimer drugs</span></div><div class="casAuthors">Benchekroun, Mohamed; Ismaili, Lhassane; Pudlo, Marc; Luzet, Vincent; Gharbi, Tijani; Refouvelet, Bernard; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: Due to the complex nature of Alzheimer's disease, there is a renewed and growing search for multitarget drugs.  Results: Donepezil-ferulic acid hybrids (DFAHs) were prepd. by the one-pot Ugi-4CR in low-to-moderate yields.  DFAHs are potent antioxidant agents, showing oxygen radical absorbance capacity values in the range 4.80-8.71 trolox equiv., quite higher compared with those recorded for ferulic acid and melatonin.  From the ChEs inhibition studies, we conclude that DFAH 8, bearing an ethylene linker, and DFAH 12, bearing a propylene linker, both substituted with a melatonin motif, are the most potent inhibitors, in the nanomolar range.  Conclusion: We have identified DFAH 8 as a very potent antioxidant, and totally selective equineButyrylCholinEsterase (eqBuChE) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3IPtYAohxbVg90H21EOLACvtfcHk0ljdOJq--um73A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1Ortw%253D%253D&md5=0917757e5b81e0e40508aa3649ffcba9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.148%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DPudlo%26aufirst%3DM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DGharbi%26aufirst%3DT.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDonepezil-Ferulic%2520Acid%2520Hybrids%2520as%2520Anti-Alzheimer%2520Drugs%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D15%26epage%3D21%26doi%3D10.4155%2Ffmc.14.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendía, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span> <span> </span><span class="NLM_article-title">The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9967</span>– <span class="NLM_lpage">9973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9967-9973&issue=21&author=M.+Benchekrounauthor=A.+Romeroauthor=J.+Egeaauthor=R.+Le%C3%B3nauthor=P.+Michalskaauthor=I.+Buend%C3%ADaauthor=M.+L.+Jimenoauthor=D.+Junauthor=J.+Janockovaauthor=V.+Sepsovaauthor=O.+Soukupauthor=O.+M.+Bautista-Aguileraauthor=B.+Refouveletauthor=O.+Ouariauthor=J.+Marco-Contellesauthor=L.+Ismaili&title=The+Antioxidant+Additive+Approach+for+Alzheimer%E2%80%99s+Disease+Therapy%3A+New+Ferulic+%28Lipoic%29+Acid+Plus+Melatonin+Modified+Tacrines+as+Cholinesterases+Inhibitors%2C+Direct+Antioxidants%2C+and+Nuclear+Factor+%28Erythroid-Derived+2%29-Like+2+Activators&doi=10.1021%2Facs.jmedchem.6b01178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators</span></div><div class="casAuthors">Benchekroun, Mohamed; Romero, Alejandro; Egea, Javier; Leon, Rafael; Michalska, Patrycja; Buendia, Izaskun; Jimeno, Maria Luisa; Jun, Daniel; Janockova, Jana; Sepsova, Vendula; Soukup, Ondrej; Bautista-Aguilera, Oscar M.; Refouvelet, Bernard; Ouari, Olivier; Marco-Contelles, Jose; Ismaili, Lhassane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9967-9973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel multifunctional tacrines for Alzheimer's disease were obtained by Ugi-reaction between ferulic (or lipoic acid), a melatonin-like isocyanide, formaldehyde, and tacrine derivs., according to the antioxidant additive approach in order to modulate the oxidative stress as therapeutic strategy.  Compd. 5c has been identified as a promising permeable agent showing excellent antioxidant properties, strong cholinesterase inhibitory activity, less hepatotoxicity than tacrine, and the best neuroprotective capacity, being able to significantly activate the Nrf2 transcriptional pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRkji0fKQbkLVg90H21EOLACvtfcHk0ljdOJq--um73A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7I&md5=45f0be476d96a6f40ccb377634ceb699</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01178%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DMichalska%26aufirst%3DP.%26aulast%3DBuend%25C3%25ADa%26aufirst%3DI.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3DOuari%26aufirst%3DO.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DThe%2520Antioxidant%2520Additive%2520Approach%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%253A%2520New%2520Ferulic%2520%2528Lipoic%2529%2520Acid%2520Plus%2520Melatonin%2520Modified%2520Tacrines%2520as%2520Cholinesterases%2520Inhibitors%252C%2520Direct%2520Antioxidants%252C%2520and%2520Nuclear%2520Factor%2520%2528Erythroid-Derived%25202%2529-Like%25202%2520Activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D21%26spage%3D9967%26epage%3D9973%26doi%3D10.1021%2Facs.jmedchem.6b01178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Carmo Carreiras, M.</span></span> <span> </span><span class="NLM_article-title">Multicomponent Reactions for Multitargeted Compounds for Alzheimer̀s Disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">3319</span>– <span class="NLM_lpage">3327</span>, <span class="refDoi"> DOI: 10.2174/1568026618666180112155424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F1568026618666180112155424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=3319-3327&issue=31&author=L.+Ismailiauthor=M.+do+Carmo+Carreiras&title=Multicomponent+Reactions+for+Multitargeted+Compounds+for+Alzheimer%CC%80s+Disease&doi=10.2174%2F1568026618666180112155424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026618666180112155424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666180112155424%26sid%3Dliteratum%253Aachs%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3Ddo%2BCarmo%2BCarreiras%26aufirst%3DM.%26atitle%3DMulticomponent%2520Reactions%2520for%2520Multitargeted%2520Compounds%2520for%2520Alzheimer%25CC%2580s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D17%26issue%3D31%26spage%3D3319%26epage%3D3327%26doi%3D10.2174%2F1568026618666180112155424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sander, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine H3 Receptor Antagonists Go to Clinics</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1248/bpb.31.2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1248%2Fbpb.31.2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19043195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=2163-2181&issue=12&author=K.+Sanderauthor=T.+Kottkeauthor=H.+Stark&title=Histamine+H3+Receptor+Antagonists+Go+to+Clinics&doi=10.1248%2Fbpb.31.2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor antagonists go to clinics</span></div><div class="casAuthors">Sander, Kerstin; Kottke, Tim; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-2181</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Within the recent years novel lead optimizations for histamine H3 receptor antagonists made their way from bench to bedside.  Structure-activity relationships, cross-affinities and side effects as well as pharmacokinetic profiling will be discussed on selected promising compd. series.  Due to diversity in potential therapeutic applications and in some cases a controversial debate, different indications will be highlighted with the potential and the problems of the test compds., e.g. sleep-wake disorders, attention-deficient hyperactivity disorder, epilepsy, cognitive impairment, schizophrenia, obesity and neuropathic pain.  First data published on clin. trials phase II (IIb) are presented showing proof of concept of H3 receptor antagonists in narcolepsy and photoinduced epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJWogrOu3mmbVg90H21EOLACvtfcHk0li-g0VZSN9PMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D&md5=b816371be0c006bef83d279a426fee45</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1248%2Fbpb.31.2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.31.2163%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DK.%26aulast%3DKottke%26aufirst%3DT.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520H3%2520Receptor%2520Antagonists%2520Go%2520to%2520Clinics%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D31%26issue%3D12%26spage%3D2163%26epage%3D2181%26doi%3D10.1248%2Fbpb.31.2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanfar, M. A.</span>; <span class="NLM_string-name">Affini, A.</span>; <span class="NLM_string-name">Lutsenko, K.</span>; <span class="NLM_string-name">Nikolic, K.</span>; <span class="NLM_string-name">Butini, S.</span>; <span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multiple Targeting Approaches on Histamine H3 Receptor Antagonists</span>.  <i>Front. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">10</span>, <span class="refDoi"> DOI: 10.3389/fnins.2016.00201</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3389%2Ffnins.2016.00201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=27303254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&author=M.+A.+Khanfar&author=A.+Affini&author=K.+Lutsenko&author=K.+Nikolic&author=S.+Butini&author=H.+Stark&title=Multiple+Targeting+Approaches+on+Histamine+H3+Receptor+Antagonists&doi=10.3389%2Ffnins.2016.00201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00201%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26atitle%3DMultiple%2520Targeting%2520Approaches%2520on%2520Histamine%2520H3%2520Receptor%2520Antagonists%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26doi%3D10.3389%2Ffnins.2016.00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farré-Alins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffrin, P.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janočková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12765</span>– <span class="NLM_lpage">12769</span>, <span class="refDoi"> DOI: 10.1002/anie.201706072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Fanie.201706072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12765-12769&issue=41&author=%C3%93.+M.+Bautista-Aguileraauthor=S.+Hagenowauthor=A.+Palomino-Antolinauthor=V.+Farr%C3%A9-Alinsauthor=L.+Ismailiauthor=P.-L.+Joffrinauthor=M.+L.+Jimenoauthor=O.+Soukupauthor=J.+Jano%C4%8Dkov%C3%A1author=L.+Kalinowskyauthor=E.+Proschakauthor=I.+Iriepaauthor=I.+Moraledaauthor=J.+S.+Schwedauthor=A.+Romero+Mart%C3%ADnezauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=M.+Chiouaauthor=J.+Egeaauthor=R.+R.+Ramsayauthor=J.+Marco-Contellesauthor=H.+Stark&title=Multitarget-Directed+Ligands+Combining+Cholinesterase+and+Monoamine+Oxidase+Inhibition+with+Histamine+H3+R+Antagonism+for+Neurodegenerative+Diseases&doi=10.1002%2Fanie.201706072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Hagenow, Stefanie; Palomino-Antolin, Alejandra; Farre-Alins, Victor; Ismaili, Lhassane; Joffrin, Pierre-Louis; Jimeno, Maria L.; Soukup, Ondrej; Janockova, Jana; Kalinowsky, Lena; Proschak, Ewgenij; Iriepa, Isabel; Moraleda, Ignacio; Schwed, Johannes S.; Romero Martinez, Alejandro; Lopez-Munoz, Francisco; Chioua, Mourad; Egea, Javier; Ramsay, Rona R.; Marco-Contelles, Jose; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12765-12769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapy of complex neurodegenerative diseases requires the development of multitarget-directed drugs (MTDs).  Novel indole derivs. with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs.  These small-mol. hits demonstrated balanced activities at the targets, mostly in the nanomolar concn. range.  Addnl. in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood-brain barrier.  With this promising in vitro profile, contilisant (at 1 mg kg-1 i.p.) also significantly improved lipopolysaccharide-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wNLAClUFULVg90H21EOLACvtfcHk0li-g0VZSN9PMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L&md5=4a962ad1ada3f5b8e8102add09cd4e60</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706072%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9-Alins%26aufirst%3DV.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DJoffrin%26aufirst%3DP.-L.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJano%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DSchwed%26aufirst%3DJ.%2BS.%26aulast%3DRomero%2BMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultitarget-Directed%2520Ligands%2520Combining%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibition%2520with%2520Histamine%2520H3%2520R%2520Antagonism%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12765%26epage%3D12769%26doi%3D10.1002%2Fanie.201706072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6937</span>– <span class="NLM_lpage">6943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6937-6943&issue=15&author=%C3%93.+M.+Bautista-Aguileraauthor=J.+Budniauthor=F.+Minaauthor=E.+B.+Medeirosauthor=W.+Deuther-Conradauthor=J.+M.+Entrenaauthor=I.+Moraledaauthor=I.+Iriepaauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=J.+Marco-Contelles&title=Contilisant%2C+a+Tetratarget+Small+Molecule+for+Alzheimer%E2%80%99s+Disease+Therapy+Combining+Cholinesterase%2C+Monoamine+Oxidase+Inhibition%2C+and+H3R+Antagonism+with+S1R+Agonism+Profile&doi=10.1021%2Facs.jmedchem.8b00848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Budni, Josiane; Mina, Francielle; Medeiros, Eduarda Behenck; Deuther-Conrad, Winnie; Entrena, Jose M.; Moraleda, Ignacio; Iriepa, Isabel; Lopez-Munoz, Francisco; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6937-6943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Contilisant, a permeable, antioxidant, and neuroprotectant agent, showing high nM affinity at H3R and excellent inhibition of the monoamine oxidases and cholinesterases, is an affine and selective S1R agonist in the nanomolar range, based on the binding affinity and functional expt., a result confirmed by mol. modeling.  In addn., contilisant significantly restores the cognitive deficit induced by Aβ1-42 in the radial maze assay in an in vivo Alzheimer's disease test, comparing very favorably with donepezil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRam68D-99zLVg90H21EOLACvtfcHk0lg2IjVB5z7BIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM&md5=526d2eedfb4f6ae6f69a4116f87a633a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DBudni%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DF.%26aulast%3DMedeiros%26aufirst%3DE.%2BB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DContilisant%252C%2520a%2520Tetratarget%2520Small%2520Molecule%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%2520Combining%2520Cholinesterase%252C%2520Monoamine%2520Oxidase%2520Inhibition%252C%2520and%2520H3R%2520Antagonism%2520with%2520S1R%2520Agonism%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943%26doi%3D10.1021%2Facs.jmedchem.8b00848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine Receptor Subtypes: A Century of Rational Drug Design</span>. <i>Front. Biosci., Scholar Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>S4</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.2741/s279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2741%2Fs279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=S4&publication_year=2012&pages=461-488&author=M.+Walterauthor=H.+Stark&title=Histamine+Receptor+Subtypes%3A+A+Century+of+Rational+Drug+Design&doi=10.2741%2Fs279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine receptor subtypes: a century of rational drug design</span></div><div class="casAuthors">Walter, Miriam; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Scholar Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">S4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-488</span>CODEN:
                <span class="NLM_cas:coden">FBSEAU</span>;
        ISSN:<span class="NLM_cas:issn">1945-0524</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Histamine plays an important role as neurotransmitter and chem. mediator in multiple physiol. and pathophysiol. processes in central and peripheral tissues.  In the last century the extensive study of its actions in the human body, resulted in the identification of four G protein-coupled receptor (GPCR) subtypes (H1R-H4R), mediating numerous effects.  The successful application of H1R and H2R antagonists/inverse agonists in the treatment of allergic conditions and gastric ulcer proved that these two receptors are excellent drug targets.  Ligands for H3R are currently in advanced stages of clin. development for a broad spectrum of mainly central diseases (e.g. narcolepsy, Alzheimer's disease, epilepsy and schizophrenia).  Meanwhile, preclin. research in the H4R field, focused on inflammatory and immunol. processes, led to the evaluation of the first H4R-targeting clin. candidates.  Drug development for each histamine receptor subtype will be discussed with a special focus on H3R and H4R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-sUaIiMMirVg90H21EOLACvtfcHk0lg2IjVB5z7BIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOiu7%252FK&md5=12b72aece130626390bf1c831d30b3a5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2741%2Fs279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fs279%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DM.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520Receptor%2520Subtypes%253A%2520A%2520Century%2520of%2520Rational%2520Drug%2520Design%26jtitle%3DFront.%2520Biosci.%252C%2520Scholar%2520Ed.%26date%3D2012%26volume%3DS4%26spage%3D461%26epage%3D488%26doi%3D10.2741%2Fs279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbroek, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiabi, B.</span></span> <span> </span><span class="NLM_article-title">The Other Side of the Histamine H3 Receptor</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2014.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.tins.2014.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24636456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkt1Sgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=191-199&issue=4&author=B.+A.+Ellenbroekauthor=B.+Ghiabi&title=The+Other+Side+of+the+Histamine+H3+Receptor&doi=10.1016%2Fj.tins.2014.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The other side of the histamine H3 receptor</span></div><div class="casAuthors">Ellenbroek, Bart A.; Ghiabi, Bibinaz</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-199</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although histamine H3 receptors are predominantly known as presynaptic receptors, regulating the release of neurotransmitters such as dopamine, acetylcholine, and histamine, in the striatal complex the vast majority of these receptors are actually located on the other side, in other words postsynaptically.  Given their strategic location, they can crucially affect signaling throughout the basal ganglia.  We describe the anatomy and function of H3 receptors within the basal ganglia with a specific focus on their colocalization with dopamine D1 and D2 receptors.  Because the basal ganglia are centrally involved in several major neurol. and psychiatric disorders, we also discuss the therapeutic potential of drugs targeting H3 receptors in the treatment of Parkinson disease (PD), schizophrenia, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCTyvYOgmdA7Vg90H21EOLACvtfcHk0ljPLBuAbNX_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkt1Sgtbk%253D&md5=a70fb6db22985403ec87e2fef7199a5b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2014.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2014.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DEllenbroek%26aufirst%3DB.%2BA.%26aulast%3DGhiabi%26aufirst%3DB.%26atitle%3DThe%2520Other%2520Side%2520of%2520the%2520Histamine%2520H3%2520Receptor%26jtitle%3DTrends%2520Neurosci.%26date%3D2014%26volume%3D37%26issue%3D4%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.tins.2014.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Łazewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Histamine H3 Receptor Antagonists/Inverse Agonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.509346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1517%2F13543776.2010.509346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20716022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1147-1169&issue=9&author=D.+%C5%81azewskaauthor=K.+Kie%C4%87-Kononowicz&title=Recent+Advances+in+Histamine+H3+Receptor+Antagonists%2FInverse+Agonists&doi=10.1517%2F13543776.2010.509346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in histamine H3 receptor antagonists/inverse agonists</span></div><div class="casAuthors">Lazewska, Dorota; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1147-1169</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Histamine H3 receptor (H3R) antagonists/inverse agonists can be therapeutically useful in the treatment of various CNS, metabolic syndrome and allergic disorders, and constitute an attractive target in the search for new drugs.  However, several drug candidates have been rejected because of unwanted effects.  There is, therefore, a strong need to develop new H3R ligands.  Areas covered in this review: A review was conducted of recent advances in the search for H3R antagonists/inverse agonists as reflected by patent applications/patents over the last 3 years.  What the reader will gain: A total of around 100 patent applications/patents along with selected peer-reviewed publications are surveyed.  These involve antagonists/inverse agonists of H3R, which the authors have divided into five groups.  The above-mentioned compds. were evaluated for their potential utility in the treatment of narcolepsy, attention deficit hyperactivity disorder, epilepsy, Alzheimer's disease, schizophrenia, obesity and neuropathic pain.  Take home message: Several H3R antagonists/inverse agonists appear to be promising drug candidates, including at least 15 compds. undergoing evaluation in clin. development.  Esp. interesting is pitolisant, which is progressing through to Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVSNfy6q5wrVg90H21EOLACvtfcHk0ljPLBuAbNX_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE&md5=033312a9f907c9b0b7d6652977b3cbc5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.509346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.509346%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581azewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DRecent%2520Advances%2520in%2520Histamine%2520H3%2520Receptor%2520Antagonists%252FInverse%2520Agonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D1147%26epage%3D1169%26doi%3D10.1517%2F13543776.2010.509346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jończyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Strategies for Alzheimer’s Disease in Clinical Trials</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2015.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.pharep.2015.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26721364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=127-138&issue=1&author=J.+Gody%C5%84author=J.+Jo%C5%84czykauthor=D.+Panekauthor=B.+Malawska&title=Therapeutic+Strategies+for+Alzheimer%E2%80%99s+Disease+in+Clinical+Trials&doi=10.1016%2Fj.pharep.2015.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies for Alzheimer's disease in clinical trials</span></div><div class="casAuthors">Godyn, Justyna; Jonczyk, Jakub; Panek, Dawid; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is considered to be the most common cause of dementia and is an incurable, progressive neurodegenerative disorder.  Current treatment of the disease, essentially symptomatic, is based on three cholinesterase inhibitors and memantine, affecting the glutamatergic system.  Since 2003, no new drugs have been approved for treatment of AD.  This article presents current directions in the search for novel, potentially effective agents for the treatment of AD, as well as selected promising treatment strategies.  These include agents acting upon the beta-amyloid, such as vaccines, antibodies and inhibitors or modulators of γ- and β-secretase; agents directed against the tau protein as well as compds. acting as antagonists of neurotransmitter systems (serotoninergic 5-HT6 and histaminergic H3).  Ongoing clin. trials with Aβ antibodies (solanezumab, gantenerumab, crenezumab) seem to be promising, while vaccines against the tau protein (AADvac1 and ACI-35) are now in early-stage trials.  Interesting results have also been achieved in trials involving small mols. such as inhibitors of β-secretase (MK-8931, E2609), a combination of 5-HT6 antagonist (idalopirdine) with donepezil, inhibition of advanced glycation end product receptors by azeliragon or modulation of the acetylcholine response of α-7 nicotinic acetylcholine receptors by encenicline.  Development of new effective drugs acting upon the central nervous system is usually a difficult and time-consuming process, and in the case of AD to-date clin. trials have had a very high failure rate.  Most phase II clin. trials ending with a pos. outcome do not succeed in phase III, often due to serious adverse effects or lack of therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2G55auOP27Vg90H21EOLACvtfcHk0ljPLBuAbNX_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslKrsb0%253D&md5=e3f4010a5408a836683024db61164ae2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2015.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2015.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DJo%25C5%2584czyk%26aufirst%3DJ.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DTherapeutic%2520Strategies%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520in%2520Clinical%2520Trials%26jtitle%3DPharmacol.%2520Rep.%26date%3D2016%26volume%3D68%26issue%3D1%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.pharep.2015.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tone, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Increased NF-ΚB Signalling up-Regulates BACE1 Expression and Its Therapeutic Potential in Alzheimer’s Disease</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1017/S1461145711000149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1017%2FS1461145711000149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=21329555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38XksValsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=77-90&issue=1&author=C.-H.+Chenauthor=W.+Zhouauthor=S.+Liuauthor=Y.+Dengauthor=F.+Caiauthor=M.+Toneauthor=Y.+Toneauthor=Y.+Tongauthor=W.+Song&title=Increased+NF-%CE%9AB+Signalling+up-Regulates+BACE1+Expression+and+Its+Therapeutic+Potential+in+Alzheimer%E2%80%99s+Disease&doi=10.1017%2FS1461145711000149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease</span></div><div class="casAuthors">Chen, Chia-Hsiung; Zhou, Weihui; Liu, Shengchun; Deng, Yu; Cai, Fang; Tone, Masahide; Tone, Yukiko; Tong, Yigang; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-90</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Elevated levels of β-site APP cleaving enzyme 1 (BACE1) were found in the brain of some sporadic Alzheimer's disease (AD) patients; however, the underlying mechanism is unknown.  BACE1 cleaves β-amyloid precursor protein (APP) to generate amyloid β protein (Aβ), a central component of neuritic plaques in AD brains.  Nuclear factor-kappa B (NF-κB) signalling plays an important role in gene regulation and is implicated in inflammation, oxidative stress and apoptosis.  In this report we found that both BACE1 and NF-κB p65 levels were significantly increased in the brains of AD patients.  Two functional NF-κB-binding elements were identified in the human BACE1 promoter region.  We found that NF-κB p65 expression resulted in increased BACE1 promoter activity and BACE1 transcription, while disruption of NF-κB p65 decreased BACE1 gene expression in p65 knockout (RelA-knockout) cells.  In addn., NF-κB p65 expression leads to up-regulated β-secretase cleavage and Aβ prodn., while non-steroidal anti-inflammatory drugs (NSAIDs) inhibited BACE1 transcriptional activation induced by strong NF-κB activator tumor necrosis factor-alpha (TNF-α).  Taken together, our results clearly demonstrate that NF-κB signalling facilitates BACE1 gene expression and APP processing, and increased BACE1 expression mediated by NF-κB signalling in the brain could be one of the novel mol. mechanisms underlying the development of AD in some sporadic cases.  Furthermore, NSAIDs could block the inflammation-induced BACE1 transcription and Aβ prodn.  Our study suggests that inhibition of NF-κB-mediated BACE1 expression may be a valuable drug target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hkA7XSgYLVg90H21EOLACvtfcHk0lht4HWOSz93xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksValsbk%253D&md5=ccbec29126abde16c207a8960edec470</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000149%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DTone%26aufirst%3DM.%26aulast%3DTone%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DIncreased%2520NF-%25CE%259AB%2520Signalling%2520up-Regulates%2520BACE1%2520Expression%2520and%2520Its%2520Therapeutic%2520Potential%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D77%26epage%3D90%26doi%3D10.1017%2FS1461145711000149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Disrupted Intracellular Calcium Regulates BACE1 Gene Expression via Nuclear Factor of Activated T Cells 1 (NFAT 1) Signaling</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1111/j.1474-9726.2007.00360.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1111%2Fj.1474-9726.2007.00360.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=18081741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFeiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=137-147&issue=2&author=H.+J.+Choauthor=S.+M.+Jinauthor=H.+D.+Younauthor=K.+Huhauthor=I.+Mook-Jung&title=Disrupted+Intracellular+Calcium+Regulates+BACE1+Gene+Expression+via+Nuclear+Factor+of+Activated+T+Cells+1+%28NFAT+1%29+Signaling&doi=10.1111%2Fj.1474-9726.2007.00360.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling</span></div><div class="casAuthors">Cho, Hyun Jin; Jin, Seok Min; Youn, Hong Deuk; Huh, Kyoon; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-147</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Beta-site APP-cleaving enzyme 1 (BACE1) expression is elevated in the brains of Alzheimer's disease (AD) patients and in aged-animal models.  Because both AD and aging are assocd. with disrupted calcium homeostasis, we investigated the role of nuclear factor of activated T cells (NFAT) - a transcription factor regulated by the calcium- and calmodulin-dependent phosphatase calcineurin - in BACE1 expression.  BACE1 expression was stimulated by a calcium ionophore in primary cortical cultures, and by SH-SY5Y neuroblastoma cells, which was both blocked by pretreatment with either cyclosporin A, an inhibitor of calcineurin, or ethyleneglycotetraacetic acid, a calcium chelator.  Gel shift assays revealed direct binding of NFAT1 to specific DNA sequences within the BACE1 gene promoter region.  Treatment with amyloid beta (Aβ), one of the major factors in AD pathogenesis, stimulated activation and nuclear translocation of NFAT1 following up-regulation of BACE1 expression.  In addn., primary cortical cultures from Tg2576 mouse brains generated more Aβ by ionophore stimulation, which was reversed by cyclosporin A treatment.  Furthermore, NFAT1 activation was obsd. in Tg2576 mouse brains.  These results suggest that calcium ionophore- or Aβ-induced increases in intracellular calcium concn. stimulate BACE1 expression, resulting in accelerated Aβ generation, and that this process is mediated through the calcineurin-NFAT1 signaling pathway.  This process may play a significant role in the pathogenesis of AD and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhztAlL7sfUbVg90H21EOLACvtfcHk0lht4HWOSz93xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFeiurk%253D&md5=df279f17e021841a3ef6705694131fb3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1474-9726.2007.00360.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1474-9726.2007.00360.x%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DJin%26aufirst%3DS.%2BM.%26aulast%3DYoun%26aufirst%3DH.%2BD.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DDisrupted%2520Intracellular%2520Calcium%2520Regulates%2520BACE1%2520Gene%2520Expression%2520via%2520Nuclear%2520Factor%2520of%2520Activated%2520T%2520Cells%25201%2520%2528NFAT%25201%2529%2520Signaling%26jtitle%3DAging%2520Cell%26date%3D2008%26volume%3D7%26issue%3D2%26spage%3D137%26epage%3D147%26doi%3D10.1111%2Fj.1474-9726.2007.00360.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perspicace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulthess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seelig, J.</span></span> <span> </span><span class="NLM_article-title">Calcium Enhances the Proteolytic Activity of BACE1: An in Vitro Biophysical and Biochemical Characterization of the BACE1-Calcium Interaction</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1788</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1933</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2009.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bbamem.2009.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19486882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVensbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1788&publication_year=2009&pages=1933-1938&issue=9&author=M.+Hayleyauthor=S.+Perspicaceauthor=T.+Schulthessauthor=J.+Seelig&title=Calcium+Enhances+the+Proteolytic+Activity+of+BACE1%3A+An+in+Vitro+Biophysical+and+Biochemical+Characterization+of+the+BACE1-Calcium+Interaction&doi=10.1016%2Fj.bbamem.2009.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium enhances the proteolytic activity of BACE1: An in vitro biophysical and biochemical characterization of the BACE1-calcium interaction</span></div><div class="casAuthors">Hayley, Michael; Perspicace, Samantha; Schulthess, Therese; Seelig, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1788</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1933-1938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a novel type I transmembrane aspartic protease that has been implicated in the pathogenesis of Alzheimer's disease.  Cleavage of the amyloid precursor protein by BACE1 is the 1st step in the prodn. of the Aβ peptide and is a prime target for therapeutic intervention.  Here, using CD, the authors reveal that the secondary structure of BACE1 in a membrane environment is significantly different from what was detd. from the previously resolved crystal structure, and, the authors provide the 1st evidence that shows differences in stability between the active (pH 4.8) and inactive (pH 7.4) forms of BACE1.  Hee, the authors also examd. Ca2+ binding to BACE1, the effect of this binding on the secondary and tertiary structural characteristics of BACE1, and the influence of this binding on the specific activity of the purified protein.  CD and endogenous Trp fluorescence measurements demonstrated that the secondary and tertiary structures, resp., were sensitive to increasing concns. of Ca2+.  Isothermal titrn. calorimetry was then used to characterize the Ca2+-BACE1 interaction in greater detail.  The results suggested that there is a high binding affinity (Kd = 2.0 μM) between Ca2+ and BACE1 and that the binding process was exothermic (ΔH = -3.5 kcal/mol).  The authors also demonstrated that low concns. of Ca2+ (micromolar range) significantly increased the proteolytic activity of BACE1.  Collectively, these results identified a direct interaction between BACE1 and Ca2+ and suggested that under physiol. conditions, the function(s) of BACE1 must also be influenced by Ca2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4kM-aQQTQbVg90H21EOLACvtfcHk0lhkniJ8Vf7wNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVensbnL&md5=41b9284b994826c5ec9196dfbe344804</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2009.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2009.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DHayley%26aufirst%3DM.%26aulast%3DPerspicace%26aufirst%3DS.%26aulast%3DSchulthess%26aufirst%3DT.%26aulast%3DSeelig%26aufirst%3DJ.%26atitle%3DCalcium%2520Enhances%2520the%2520Proteolytic%2520Activity%2520of%2520BACE1%253A%2520An%2520in%2520Vitro%2520Biophysical%2520and%2520Biochemical%2520Characterization%2520of%2520the%2520BACE1-Calcium%2520Interaction%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2009%26volume%3D1788%26issue%3D9%26spage%3D1933%26epage%3D1938%26doi%3D10.1016%2Fj.bbamem.2009.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oulès, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Prete, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevalle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterlini-Bréchot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trebak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfenati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chami, M.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">11820</span>– <span class="NLM_lpage">11834</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0875-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1523%2FJNEUROSCI.0875-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=22915123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=11820-11834&issue=34&author=B.+Oul%C3%A8sauthor=D.+Del+Preteauthor=B.+Grecoauthor=X.+Zhangauthor=I.+Lauritzenauthor=J.+Sevalleauthor=S.+Morenoauthor=P.+Paterlini-Br%C3%A9chotauthor=M.+Trebakauthor=F.+Checlerauthor=F.+Benfenatiauthor=M.+Chami&title=Ryanodine+Receptor+Blockade+Reduces+Amyloid-%CE%B2+Load+and+Memory+Impairments+in+Tg2576+Mouse+Model+of+Alzheimer+Disease&doi=10.1523%2FJNEUROSCI.0875-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease</span></div><div class="casAuthors">Oules, Benedicte; Del Prete, Dolores; Greco, Barbara; Zhang, Xuexin; Lauritzen, Inger; Sevalle, Jean; Moreno, Sebastien; Paterlini-Brechot, Patrizia; Trebak, Mohamed; Checler, Frederic; Benfenati, Fabio; Chami, Mounia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">11820-11834</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca2+) homeostasis has been linked to presenilins, the catalytic core in γ-secretase complexes cleaving the amyloid precursor protein (APP), thereby generating amyloid-β (Aβ) peptides.  Here we investigate whether APP contributes to ER Ca2+ homeostasis and whether ER Ca2+ could in turn influence Aβ prodn.  We show that overexpression of wild-type human APP (APP695), or APP harboring the Swedish double mutation (APPswe) triggers increased ryanodine receptor (RyR) expression and enhances RyR-mediated ER Ca2+ release in SH-SY5Y neuroblastoma cells and in APPswe-expressing (Tg2576) mice.  Interestingly, dantrolene-induced lowering of RyR-mediated Ca2+ release leads to the redn. of both intracellular and extracellular Aβ load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice.  This Aβ redn. can be accounted for by decreased Thr-668-dependent APP phosphorylation and β- and γ-secretases activities.  Importantly, dantrolene diminishes Aβ load, reduces Aβ-related histol. lesions, and slows down learning and memory deficits in Tg2576 mice.  Overall, our data document a key role of RyR in Aβ prodn. and learning and memory performances, and delineate RyR-mediated control of Ca2+ homeostasis as a physiol. paradigm that could be targeted for innovative therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo86SjeELAf_rVg90H21EOLACvtfcHk0lhkniJ8Vf7wNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrzN&md5=89e8e7b64e00518d8ec4bcc8189c907a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0875-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0875-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DOul%25C3%25A8s%26aufirst%3DB.%26aulast%3DDel%2BPrete%26aufirst%3DD.%26aulast%3DGreco%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLauritzen%26aufirst%3DI.%26aulast%3DSevalle%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DPaterlini-Br%25C3%25A9chot%26aufirst%3DP.%26aulast%3DTrebak%26aufirst%3DM.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DBenfenati%26aufirst%3DF.%26aulast%3DChami%26aufirst%3DM.%26atitle%3DRyanodine%2520Receptor%2520Blockade%2520Reduces%2520Amyloid-%25CE%25B2%2520Load%2520and%2520Memory%2520Impairments%2520in%2520Tg2576%2520Mouse%2520Model%2520of%2520Alzheimer%2520Disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26issue%3D34%26spage%3D11820%26epage%3D11834%26doi%3D10.1523%2FJNEUROSCI.0875-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasperini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foa, L.</span></span> <span> </span><span class="NLM_article-title">The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer’s Disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-2009-0951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19221414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=225-233&issue=2&author=D.+H.+Smallauthor=R.+Gasperiniauthor=A.+J.+Vincentauthor=A.+C.+Hungauthor=L.+Foa&title=The+Role+of+A%CE%B2-Induced+Calcium+Dysregulation+in+the+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2009-0951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease</span></div><div class="casAuthors">Small, David H.; Gasperini, Robert; Vincent, Adele J.; Hung, Amos C.; Foa, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Although many of the biochem. mechanisms which regulate prodn. or clearance of the amyloid-β protein (Aβ) of Alzheimer's disease (AD) are now well understood, the mechanism of Aβ neurotoxicity remains unclear.  A no. of studies have shown that Aβ can disrupt neuronal Ca2+ homeostasis by inducing influx of extracellular Ca2+ into the neuronal cytoplasm.  Ca2+ is known to play an important role in neuronal excitability, synaptic plasticity and neurotoxicity.  Therefore, Aβ-induced Ca2+ dysregulation may contribute to many of the cognitive and neuropathol. features of AD.  In vitro studies show that Aβ can increase ion permeability in lipid membranes.  This increased permeability is reportedly assocd. with the formation of artificial ion pores formed from Aβ oligomers.  However, a no. of other studies show that Aβ can activate endogenous ion channels on the cell surface.  There is also increasing evidence that presenilin mutations alter intracellular Ca2+ stores.  It is likely that elucidation of the mechanism by which Aβ and presenilin cause Ca2+ dysregulation in neurons will help to identify new drug targets for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ss7jA9bMJbVg90H21EOLACvtfcHk0liSphWiSNk9Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCku7g%253D&md5=62e8292884b2e7fb37ca80ac66ed2df4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0951%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DGasperini%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DA.%2BJ.%26aulast%3DHung%26aufirst%3DA.%2BC.%26aulast%3DFoa%26aufirst%3DL.%26atitle%3DThe%2520Role%2520of%2520A%25CE%25B2-Induced%2520Calcium%2520Dysregulation%2520in%2520the%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26issue%3D2%26spage%3D225%26epage%3D233%26doi%3D10.3233%2FJAD-2009-0951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. J.</span></span> <span> </span><span class="NLM_article-title">Tau in Neurodegenerative Diseases: Tau Phosphorylation and Assembly</span>. <i>Neurotoxic. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1007/BF03033284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1007%2FBF03033284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=15639780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FhsVCmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=477-482&issue=6&author=J.+Avilaauthor=M.+P%C3%A9rezauthor=F.+Limauthor=A.+G%C3%B3mez-Ramosauthor=F.+Hern%C3%A1ndezauthor=J.+J.+Lucas&title=Tau+in+Neurodegenerative+Diseases%3A+Tau+Phosphorylation+and+Assembly&doi=10.1007%2FBF03033284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in neurodegenerative diseases: tau phosphorylation and assembly</span></div><div class="casAuthors">Avila J; Perez M; Lim F; Gomez-Ramos A; Hernandez F; Lucas J J</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-82</span>
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    </div><div class="casAbstract">The possible link between tau phosphorylation and tau assembly in these neurodegenerative diseases known as tauopathies is described.  Additionally, this link is supported by an in vitro experiment showing the higher capacity of phosphotau to assemble in some specific conditions; and, by a recently reported experiment using a tau transgenic mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFoPt56svAgcKL0FlyGHDofW6udTcc2eYYjO8rJJao8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FhsVCmsQ%253D%253D&md5=504900fa227173ce8ca9c7093a3294a0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF03033284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033284%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DG%25C3%25B3mez-Ramos%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DTau%2520in%2520Neurodegenerative%2520Diseases%253A%2520Tau%2520Phosphorylation%2520and%2520Assembly%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2004%26volume%3D6%26issue%3D6%26spage%3D477%26epage%3D482%26doi%3D10.1007%2FBF03033284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakroborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzmann, G. E.</span></span> <span> </span><span class="NLM_article-title">Calcium Channelopathies and Alzheimer’s Disease: Insight into Therapeutic Success and Failures</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>739</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejphar.2013.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24316360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVShur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=739&publication_year=2014&pages=83-95&author=S.+Chakrobortyauthor=G.+E.+Stutzmann&title=Calcium+Channelopathies+and+Alzheimer%E2%80%99s+Disease%3A+Insight+into+Therapeutic+Success+and+Failures&doi=10.1016%2Fj.ejphar.2013.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures</span></div><div class="casAuthors">Chakroborty, Shreaya; Stutzmann, Grace E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">739</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-95</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Calcium ions are versatile and universal biol. signaling factors that regulate numerous cellular processes ranging from cell fertilization, to neuronal plasticity that underlies learning and memory, to cell death.  For these functions to be properly executed, calcium signaling requires precise regulation, and failure of this regulation may tip the scales from a signal for life to a signal for death.  Disruptions in calcium channel function can generate complex multi-system disorders collectively referred to as "calciumopathies" that can target essentially any cell type or organ.  In this review, we focus on the multifaceted involvement of calcium signaling in the pathophysiol. of Alzheimer's disease (AD), and summarize the various therapeutic options currently available to combat this disease.  Detailing the series of disappointing AD clin. trial results on cognitive outcomes, we emphasize the urgency to design alternative therapeutic strategies if synaptic and memory functions are to be preserved.  One such approach is to target early calcium channelopathies centrally linked to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF0bNiyBSXVLVg90H21EOLACvtfcHk0lgrHNCPl6kF2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVShur%252FM&md5=2043c1cf5c0b63d4eeb7c21995b6db88</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DChakroborty%26aufirst%3DS.%26aulast%3DStutzmann%26aufirst%3DG.%2BE.%26atitle%3DCalcium%2520Channelopathies%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Insight%2520into%2520Therapeutic%2520Success%2520and%2520Failures%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D739%26spage%3D83%26epage%3D95%26doi%3D10.1016%2Fj.ejphar.2013.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anekonda, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. F.</span></span> <span> </span><span class="NLM_article-title">Calcium Channel Blocking as a Therapeutic Strategy for Alzheimer’s Disease: The Case for Isradipine</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1812</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1590</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bbadis.2011.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=21925266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2htbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1812&publication_year=2011&pages=1584-1590&issue=12&author=T.+S.+Anekondaauthor=J.+F.+Quinn&title=Calcium+Channel+Blocking+as+a+Therapeutic+Strategy+for+Alzheimer%E2%80%99s+Disease%3A+The+Case+for+Isradipine&doi=10.1016%2Fj.bbadis.2011.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine</span></div><div class="casAuthors">Anekonda, Thimmappa S.; Quinn, Joseph F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1812</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1584-1590</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most devastating neurodegenerative disorder in the elderly, yet treatment options are severely limited.  The drug development effort to modify Alzheimer's disease pathol. by intervention at beta amyloid prodn. sites has been largely ineffective or inconclusive.  The greatest challenge has been to identify and define downstream mechanisms reliably predictive of clin. symptoms.  Beta amyloid accumulation leads to dysregulation of intracellular calcium by plasma membrane L-type calcium channels located on neuronal somatodendrites and axons in the hippocampus and cortex.  Paradoxically, L-type calcium channel subtype Cav1.2 also promotes synaptic plasticity and spatial memory.  Increased intracellular calcium modulates amyloid precursor protein processing and affects multiple downstream pathways including increased hyperphosphorylated tau and suppression of autophagy.  Isradipine is a Federal Drug Administration-approved dihydropyridine calcium channel blocker that binds selectively to Cav1.2 in the hippocampus.  Our studies have shown that isradipine in vitro attenuates beta amyloid oligomer toxicity by suppressing calcium influx into cytoplasm and by suppressing Cav1.2 expression.  We have previously shown that administration of isradipine to triple transgenic animal model for Alzheimer's disease was well-tolerated.  Our results further suggest that isradipine became bioavailable, lowered tau burden, and improved autophagy function in the brain.  A better understanding of brain pharmacokinetics of calcium channel blockers will be crit. for designing new expts. with appropriate drug doses in any future clin. trials for Alzheimer's disease.  This review highlights the importance of Cav1.2 channel overexpression, the accumulation of hyperphosphorylated tau and suppression of autophagy in Alzheimer's disease and modulation of this pathway by isradipine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3wk5eKscM47Vg90H21EOLACvtfcHk0lgrHNCPl6kF2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2htbnJ&md5=212aab116d87460754331fa496c7f63f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnekonda%26aufirst%3DT.%2BS.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26atitle%3DCalcium%2520Channel%2520Blocking%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520The%2520Case%2520for%2520Isradipine%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2011%26volume%3D1812%26issue%3D12%26spage%3D1584%26epage%3D1590%26doi%3D10.1016%2Fj.bbadis.2011.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotrane, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonawane, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhawal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharpure, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurjar, M. K.</span></span> <span> </span><span class="NLM_article-title">A Novel Method for Resolution of Amlodipine</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1021/op900283z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op900283z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=640-643&issue=3&author=D.+M.+Gotraneauthor=R.+D.+Deshmukhauthor=P.+V.+Ranadeauthor=S.+P.+Sonawaneauthor=B.+M.+Bhawalauthor=M.+M.+Gharpureauthor=M.+K.+Gurjar&title=A+Novel+Method+for+Resolution+of+Amlodipine&doi=10.1021%2Fop900283z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Method for Resolution of Amlodipine</span></div><div class="casAuthors">Gotrane, Dinkar M.; Deshmukh, Rajendra D.; Ranade, Prasad V.; Sonawane, Swapnil P.; Bhawal, Baburao M.; Gharpure, Milind M.; Gurjar, Mukund K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present invention relates to an industrially feasible and cost-efficient process for the prepn. of isomerically pure S-amlodipine besylate hemipentahydrate, a useful calcium antagonist inhibitor.  Previous workers reported that R-amlodipine-tartrate was crystd. out preferentially from the reaction mixt. when naturally occurring L-tartaric acid and racemic amlodipine base in DMSO are mixed.  In order to crystallize S-amlodipine-tartrate, the use of unnatural D-tartaric acid as a resolving agent in DMSO was required.  However, the cost of D-tartaric acid was not conducive to overall cost efficiency in the resoln. protocol.  Subsequent to the above observations, we have developed a novel resolving system in which amlodipine base with natural L-tartaric acid in DMF as a solvent gave preferentially the S-form of amlodipine tartrate directly from the reaction.  The optimization of this approach by adjusting the water percentage in DMF ensured consistent purity of S-amlodipine (+99%) and satisfactory resoln. efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ01q_9cVmg7Vg90H21EOLACvtfcHk0lhz3vlG3_UnBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFOqs7k%253D&md5=bb039f7bb006e8f51045f5cd4cbb8c9f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fop900283z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop900283z%26sid%3Dliteratum%253Aachs%26aulast%3DGotrane%26aufirst%3DD.%2BM.%26aulast%3DDeshmukh%26aufirst%3DR.%2BD.%26aulast%3DRanade%26aufirst%3DP.%2BV.%26aulast%3DSonawane%26aufirst%3DS.%2BP.%26aulast%3DBhawal%26aufirst%3DB.%2BM.%26aulast%3DGharpure%26aufirst%3DM.%2BM.%26aulast%3DGurjar%26aufirst%3DM.%2BK.%26atitle%3DA%2520Novel%2520Method%2520for%2520Resolution%2520of%2520Amlodipine%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2010%26volume%3D14%26issue%3D3%26spage%3D640%26epage%3D643%26doi%3D10.1021%2Fop900283z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navadiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris</span>. <i>Curr. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.2174/1574886310666150514114619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F1574886310666150514114619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=25973793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFyqsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=194-201&issue=3&author=K.+Navadiyaauthor=S.+Tiwari&title=Pharmacology%2C+Efficacy+and+Safety+of+Felodipine+with+a+Focus+on+Hypertension+and+Angina+Pectoris&doi=10.2174%2F1574886310666150514114619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris</span></div><div class="casAuthors">Navadiya, Kinjal; Tiwari, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Safety</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">CDSUBQ</span>;
        ISSN:<span class="NLM_cas:issn">1574-8863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Calcium channel blockers (CCBs) are a heterogeneous group of drugs often used in the therapy for hypertension and angina.  Though CCBs are generally similar in terms of their efficacy yet, they differ in their ability of causing selective inhibition in the contractility of vascular smooth muscle in comparison to cardiac muscle.  Felodipine is one of the most vascular selective of the available CCBs and it has no neg. inotropic effects at clin. administered doses.  The focus of this review is to comprehensively summarize the pharmacokinetics, efficacy, safety and tolerability of felodipine.  This review is based on evaluation of relevant literature on felodipine using meta-database PubMed and ScienceDirect and internet search engine (Google Scholar).  Clin. studies summarized in this review testify, on tech. lines, the clin. efficacy, safety and placebo- like tolerability profile of felodipine, administered alone as well as in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kr6MUnquErVg90H21EOLACvtfcHk0lhz3vlG3_UnBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFyqsbrJ&md5=96acffe3fc1c8fe282fd8235813a0bb1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1574886310666150514114619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574886310666150514114619%26sid%3Dliteratum%253Aachs%26aulast%3DNavadiya%26aufirst%3DK.%26aulast%3DTiwari%26aufirst%3DS.%26atitle%3DPharmacology%252C%2520Efficacy%2520and%2520Safety%2520of%2520Felodipine%2520with%2520a%2520Focus%2520on%2520Hypertension%2520and%2520Angina%2520Pectoris%26jtitle%3DCurr.%2520Drug%2520Saf.%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3D194%26epage%3D201%26doi%3D10.2174%2F1574886310666150514114619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&issue=2&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lhpeni3HfH3jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26issue%3D2%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampsch-Woodill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&issue=10&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+Validation+of+an+Improved+Oxygen+Radical+Absorbance+Capacity+Assay+Using+Fluorescein+as+the+Fluorescent+Probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0lhpeni3HfH3jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520an%2520Improved%2520Oxygen%2520Radical%2520Absorbance%2520Capacity%2520Assay%2520Using%2520Fluorescein%2520as%2520the%2520Fluorescent%2520Probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26issue%3D10%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dávalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Cordovés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC–Fluorescein) Assay</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&issue=1&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+Applicability+of+the+Oxygen+Radical+Absorbance+Capacity+%28ORAC%E2%80%93Fluorescein%29+Assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC-Fluorescein) Assay</span></div><div class="casAuthors">Davalos, Alberto; Gomez-Cordoves, Carmen; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORAC-fluorescein (ORAC-FL) method recently validated using automatic liq. handling systems has been adapted to manual handling and using a conventional fluorescence microplate reader.  As calcd. for Trolox, the precision of the method was <3.0, expressed as percent coeff. of variation.  The accuracy of the method was <2.3, expressed as percent variation of the mean.  The detection and quantification limits were those corresponding to 0.5- and 1-μM Trolox std. solns., resp.  The method has been applied to 10 pure compds. (benzoic and cinnamic acids and aldehydes, flavonoids, and butylated hydroxyanisole), to 30 white, rose, and bottled- and oak-aged red wines, and to 7 com. dietary antioxidant supplements.  All samples exhibited a good linear response with concn.  As seen by other methodologies, the chem. structure of a compd. dets. its antioxidant activity (ORAC-FL value).  Of particular interest were the results with oak-aged red wines from different vintages (1989-2002) that confirm influence of vintage, but not origin of the oak, in the antioxidant activity of wines from the same variety.  Dietary antioxidant supplements presented a great variability (170-fold difference) in their antioxidant potency.  This work proves applicability of the ORAC-FL assay in evaluating the antioxidant activity of diverse food samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MQ8zab9ce7Vg90H21EOLACvtfcHk0lj3-0li-nZeWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D&md5=c08c16818b9c32fc87b46570b26544f9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520Applicability%2520of%2520the%2520Oxygen%2520Radical%2520Absorbance%2520Capacity%2520%2528ORAC%25E2%2580%2593Fluorescein%2529%2520Assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26issue%3D1%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemes, L. F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade Ramos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, F. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro Couto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Boni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, M. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Nascimento Nogueira, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korábečný, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeiro, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeiro, L. A. S.</span></span> <span> </span><span class="NLM_article-title">Cardanol-Derived AChE Inhibitors: Towards the Development of Dual Binding Derivatives for Alzheimer’s Disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejmech.2015.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26735910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsV2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=687-700&author=L.+F.+N.+Lemesauthor=G.+de+Andrade+Ramosauthor=A.+S.+de+Oliveiraauthor=F.+M.+R.+da+Silvaauthor=G.+de+Castro+Coutoauthor=M.+da+Silva+Boniauthor=M.+J.+R.+Guimar%C3%A3esauthor=I.+N.+O.+Souzaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+C.+do+Nascimento+Nogueiraauthor=E.+R.+Silveiraauthor=G.+D.+Brandauthor=O.+Soukupauthor=J.+Kor%C3%A1be%C4%8Dn%C3%BDauthor=N.+C.+Romeiroauthor=N.+G.+Castroauthor=M.+L.+Bolognesiauthor=L.+A.+S.+Romeiro&title=Cardanol-Derived+AChE+Inhibitors%3A+Towards+the+Development+of+Dual+Binding+Derivatives+for+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2015.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease</span></div><div class="casAuthors">Lemes, Lais Flavia Nunes; Ramos, Giselle de Andrade; Souza de Oliveira, Andressa; da Silva, Fernanda Motta R.; Couto, Gina de Castro; Boni, Marina da Silva; Guimaraes, Marcos Jorge R.; Souza, Isis Nem O.; Bartolini, Manuela; Andrisano, Vincenza; Nogueira, Patricia Coelho do Nascimento; Silveira, Edilberto Rocha; Brand, Guilherme D.; Soukup, Ondrej; Korabecny, Jan; Romeiro, Nelilma C.; Castro, Newton G.; Bolognesi, Maria Laura; Romeiro, Luiz Antonio Soares</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cardanol is a phenolic lipid component of cashew nut shell liq. (CNSL), obtained as the byproduct of cashew nut food processing.  Being a waste product, it has attracted much attention as a precursor for the prodn. of high-value chems., including drugs.  On the basis of these findings and in connection with the authors' previous studies on cardanol derivs. as acetylcholinesterase (AChE) inhibitors, the authors designed a novel series of analogs by including a protonable amino moiety belonging to different systems.  Properly addressed docking studies suggested that the proposed structural modifications would allow the new mols. to interact with both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE, thus being able to act as dual binding inhibitors.  To disclose whether the new mols. showed the desired profile, they were first tested for their cholinesterase inhibitory activity towards EeAChE and eqBuChE.  Compd. 26 (N-ethyl-N-(2-methoxybenzyl)-8-(3-methoxyphenyl)octan-1-amine), bearing an N-ethyl-N-(2-methoxybenzyl)amine moiety, showed the highest inhibitory activity against EeAChE, with a promising IC50 of 6.6 μM, and a similar inhibition profile of the human isoform (IC50 = 5.7 μM).  As another pos. feature, most of the derivs. did not show appreciable toxicity against HT-29 cells, up to a concn. of 100 μM, which indicates drug-conform behavior.  Also, compd. 26 is capable of crossing the blood-brain barrier (BBB), as predicted by a PAMPA-BBB assay.  Collectively, the data suggest that the approach to obtain potential anti-Alzheimer drugs from CNSL is worth of further pursuit and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcgxn8kS_m7Vg90H21EOLACvtfcHk0lj3-0li-nZeWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsV2l&md5=f9ba78f805e7fa7642b3985305d52503</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DLemes%26aufirst%3DL.%2BF.%2BN.%26aulast%3Dde%2BAndrade%2BRamos%26aufirst%3DG.%26aulast%3Dde%2BOliveira%26aufirst%3DA.%2BS.%26aulast%3Dda%2BSilva%26aufirst%3DF.%2BM.%2BR.%26aulast%3Dde%2BCastro%2BCouto%26aufirst%3DG.%26aulast%3Dda%2BSilva%2BBoni%26aufirst%3DM.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DM.%2BJ.%2BR.%26aulast%3DSouza%26aufirst%3DI.%2BN.%2BO.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3Ddo%2BNascimento%2BNogueira%26aufirst%3DP.%2BC.%26aulast%3DSilveira%26aufirst%3DE.%2BR.%26aulast%3DBrand%26aufirst%3DG.%2BD.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKor%25C3%25A1be%25C4%258Dn%25C3%25BD%26aufirst%3DJ.%26aulast%3DRomeiro%26aufirst%3DN.%2BC.%26aulast%3DCastro%26aufirst%3DN.%2BG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRomeiro%26aufirst%3DL.%2BA.%2BS.%26atitle%3DCardanol-Derived%2520AChE%2520Inhibitors%253A%2520Towards%2520the%2520Development%2520of%2520Dual%2520Binding%2520Derivatives%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D687%26epage%3D700%26doi%3D10.1016%2Fj.ejmech.2015.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budriesi, R.</span></span> <span> </span><span class="NLM_article-title">Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]Thiazole-1,4-Dihydropyridines: From Heart Activity to Brain Affinity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3866</span>– <span class="NLM_lpage">3877</span>, <span class="refDoi"> DOI: 10.1021/jm301839q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301839q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3866-3877&issue=10&author=A.+Locatelliauthor=S.+Cosconatiauthor=M.+Micucciauthor=A.+Leoniauthor=L.+Marinelliauthor=A.+Bediniauthor=P.+Ioanauthor=S.+M.+Spampinatoauthor=E.+Novellinoauthor=A.+Chiariniauthor=R.+Budriesi&title=Ligand+Based+Approach+to+L-Type+Calcium+Channel+by+Imidazo%5B2%2C1-b%5DThiazole-1%2C4-Dihydropyridines%3A+From+Heart+Activity+to+Brain+Affinity&doi=10.1021%2Fjm301839q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]thiazole-1,4-Dihydropyridines: from Heart Activity to Brain Affinity</span></div><div class="casAuthors">Locatelli, Alessandra; Cosconati, Sandro; Micucci, Matteo; Leoni, Alberto; Luciana, Marinelli; Bedini, Andrea; Ioan, Pierfranco; Spampinato, Santi Mario; Novellino, Ettore; Chiarini, Alberto; Budriesi, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3866-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis, characterization, and functional in vitro assay in cardiac and smooth muscle (vascular and nonvascular) of a series of 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines I (X-Y = HC:CH, MeC:CH, etc., R = 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thienyl, 3-thienyl, 2,4-Cl2-thienyl, 2,5-(OCH3)2-C6H3,etc., R1 = Me, Et) are reported.  To define the calcium blocker nature of the imidazo[2,1-b]thiazole-1,4-DHPs and their selectivity on Cav1.2 and Cav1.3 isoforms, we performed binding studies on guinea pig atrial and ventricular membranes on intact cells expressing the cloned Cav1.2a subunit and on rat brain cortex.  To get major insights into the reasons for the affinity for Cav1.2 and/or Cav1.3, mol. modeling studies were also undertaken.  Some physicochem. and pharmacokinetic properties of selected compds. were calcd. and compared.  All the biol. data collected and reported herein allowed us to rationalize the structure-activity relationship of the 4-imidazo[2,1-b]thiazole-1,4-DHPs and to identify which of these enhanced the activity at the central level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz3k5v0tIEbVg90H21EOLACvtfcHk0lgVKUDWoPxEpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVynsLw%253D&md5=5bcf5476a37b981742307f564f9ce424</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm301839q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301839q%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DA.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMicucci%26aufirst%3DM.%26aulast%3DLeoni%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DIoan%26aufirst%3DP.%26aulast%3DSpampinato%26aufirst%3DS.%2BM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26atitle%3DLigand%2520Based%2520Approach%2520to%2520L-Type%2520Calcium%2520Channel%2520by%2520Imidazo%255B2%252C1-b%255DThiazole-1%252C4-Dihydropyridines%253A%2520From%2520Heart%2520Activity%2520to%2520Brain%2520Affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D3866%26epage%3D3877%26doi%3D10.1021%2Fjm301839q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Revelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, J. C.</span></span> <span> </span><span class="NLM_article-title">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4313</span>– <span class="NLM_lpage">4323</span>, <span class="refDoi"> DOI: 10.1021/jm500263v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500263v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4313-4323&issue=10&author=G.+Tentiauthor=E.+Paradaauthor=R.+Le%C3%B3nauthor=J.+Egeaauthor=S.+Mart%C3%ADnez-Revellesauthor=A.+M.+Brionesauthor=V.+Sridharanauthor=M.+G.+L%C3%B3pezauthor=M.+T.+Ramosauthor=J.+C.+Men%C3%A9ndez&title=New+5-Unsubstituted+Dihydropyridines+with+Improved+CaV1.3+Selectivity+as+Potential+Neuroprotective+Agents+against+Ischemic+Injury&doi=10.1021%2Fjm500263v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span></div><div class="casAuthors">Tenti, Giammarco; Parada, Esther; Leon, Rafael; Egea, Javier; Martinez-Revelles, Sonia; Briones, Ana Maria; Sridharan, Vellaisamy; Lopez, Manuela G.; Ramos, Maria Teresa; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4313-4323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C5-unsubstituted-C6-aryl-1,4-dihydropyridines were prepd. by a CAN-catalyzed multicomponent reaction from chalcones, β-dicarbonyl compds., and ammonium acetate.  These compds. were able to block Ca2+ entry after a depolarizing stimulus and showed an improved Cav1.3/Cav1.2 selectivity in comparison with nifedipine.  Furthermore, they were able to protect neuroblastoma cells against Ca2+ overload and oxidative stress models.  Their selectivity ratio makes them highly interesting for the treatment of neurol. disorders where Ca2+ dyshomeostasis and high levels of oxidative stress have been demonstrated.  Furthermore, their low potency toward the cardiovascular channel subtype makes them safer by reducing their probable side effects, in comparison to classical 1,4-dihydropyridines.  Some compds. afforded good protective profile in a postincubation model that simulates the real clin. situation of ictus patients, offering a therapeutic window of opportunity of great interest for patient recovery after a brain ischemic episode.  Good activities were also found in acute ischemia/reperfusion models of oxygen and glucose deprivation.  Compds. I and II were found to be most active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2qOTrNT3NbVg90H21EOLACvtfcHk0lgVKUDWoPxEpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D&md5=f9ed28bdea3ac4d3dda8e06159f6e4b5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500263v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500263v%26sid%3Dliteratum%253Aachs%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DParada%26aufirst%3DE.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez-Revelles%26aufirst%3DS.%26aulast%3DBriones%26aufirst%3DA.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DRamos%26aufirst%3DM.%2BT.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DJ.%2BC.%26atitle%3DNew%25205-Unsubstituted%2520Dihydropyridines%2520with%2520Improved%2520CaV1.3%2520Selectivity%2520as%2520Potential%2520Neuroprotective%2520Agents%2520against%2520Ischemic%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D10%26spage%3D4313%26epage%3D4323%26doi%3D10.1021%2Fjm500263v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Louis, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Nifedipine and Bay K 8644 on Myotropic Responses in Aortic Rings of Pregnant Rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(95)00155-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2F0014-2999%2895%2900155-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=7498248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVWgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1995&pages=1-9&issue=1&author=B.+Royauthor=B.+Sicotteauthor=M.+Brochuauthor=J.+St-Louis&title=Effects+of+Nifedipine+and+Bay+K+8644+on+Myotropic+Responses+in+Aortic+Rings+of+Pregnant+Rats&doi=10.1016%2F0014-2999%2895%2900155-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nifedipine and Bay K 8644 on myotropic responses in aortic rings of pregnant rats</span></div><div class="casAuthors">Roy, Bertrand; Sicotte, Benoit; Brochu, Michele; St-Louis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The hypothesis that Ca2+ channel function is altered during pregnancy was tested by comparing the effects of the Ca2+ antagonist nifedipine and of the Ca2+ channel activator Bay K 8644 on the contractile responses of aortic rings from virgin and term-pregnant rats to KCl and phenylephrine.  The max. response to KCl was progressively reduced by increasing nifedipine concns. (1.0-100 nM) in aortic rings from both groups of rats.  Nifedipine produced a smaller inhibition of KCl-induced contraction in aortic rings of pregnant than of virgin rats.  It exerted little inhibition on the concn.-response curve to phenylephrine.  Nifedipine (100 nM) reduced the max. response to phenylephrine in rings from virgin rats, but had no effect on those from pregnant rats.  Bay K 8644 potentiated the responses to low concns. of both phenylephrine and KCl by the tissues from both virgin and pregnant rats, but it did not affect max. responses.  It also induced concn.-dependent contractions of rings from virgin, but not pregnant, rats.  The effects of Bay K 8644 were markedly potentiated by precontracting the aorta with 10 mM KCl.  Nevertheless, tissues from pregnant rats were still less responsive to Bay K 8644 than were those from virgin rats.  However, when the strips were precontracted to the same level by different concns. of KCl, the concn.-response curves to Bay K 8644 were identical in both groups. [3H]Nitrendipine binding to membrane prepns. of the thoracic aorta was similar in virgin and pregnant rats.  These results show that the effects of both nifedipine and Bay K 8644 were decreased in aortic rings from pregnant compared to virgin rats and indicate that potential-operated Ca2+ channel function is altered in the aorta of pregnant rats.  It is suggested that modulation of membrane potential with KCl can reverse this change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0tIxG0jCirVg90H21EOLACvtfcHk0ljjUpz_sPrxFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVWgtbk%253D&md5=665e22285c10acab92a225648b8075a3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900155-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900155-E%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DB.%26aulast%3DSicotte%26aufirst%3DB.%26aulast%3DBrochu%26aufirst%3DM.%26aulast%3DSt-Louis%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Nifedipine%2520and%2520Bay%2520K%25208644%2520on%2520Myotropic%2520Responses%2520in%2520Aortic%2520Rings%2520of%2520Pregnant%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D280%26issue%3D1%26spage%3D1%26epage%3D9%26doi%3D10.1016%2F0014-2999%2895%2900155-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL Repository-New Features and Functionality</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D313</span>– <span class="NLM_lpage">D319</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1093%2Fnar%2Fgkw1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=27899672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D313-D319&issue=D1&author=S.+Bienertauthor=A.+Waterhouseauthor=T.+A.+P.+de+Beerauthor=G.+Taurielloauthor=G.+Studerauthor=L.+Bordoliauthor=T.+Schwede&title=The+SWISS-MODEL+Repository-New+Features+and+Functionality&doi=10.1093%2Fnar%2Fgkw1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL Repository--new features and functionality</span></div><div class="casAuthors">Bienert, Stefan; Waterhouse, Andrew; de Beer, Tjaart A. P.; Tauriello, Gerardo; Studer, Gabriel; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D313-D319</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">SWISS-MODEL Repository (SMR) is a database of annotated 3D protein structure models generated by the automated SWISS-MODEL homol. modeling pipeline.  It currently holds >400 000 high quality models covering almost 20% of Swiss- Prot/UniProtKB entries.  In this manuscript, we provide an update of features and functionalities which have been implemented recently.  We address improvements in target coverage, model quality ests., functional annotations and improved in-page visualization.  We also introduce a new update concept which includes regular updates of an expanded set of core organism models and UniProtKB-based targets, complemented by user-driven on-demand update of individual models.  With the new release of the modeling pipeline, SMR has implemented a REST-API and adopted an open licencing model for accessing model coordinates, thus enabling bulk download for groups of targets fostering re-use of models in other contexts.  SMR can be accessed at https://swissmodel.expasy.org/repository.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-otAf4J2uy7Vg90H21EOLACvtfcHk0ljjUpz_sPrxFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhsL0%253D&md5=bc52d569b15ca0ca6932c53dc15ecbd5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1132%26sid%3Dliteratum%253Aachs%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3Dde%2BBeer%26aufirst%3DT.%2BA.%2BP.%26aulast%3DTauriello%26aufirst%3DG.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Repository-New%2520Features%2520and%2520Functionality%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26issue%3DD1%26spage%3DD313%26epage%3DD319%26doi%3D10.1093%2Fnar%2Fgkw1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guex, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">Automated Comparative Protein Structure Modeling with SWISS-MODEL and Swiss-PdbViewer: A Historical Perspective</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S173</span>, <span class="refDoi"> DOI: 10.1002/elps.200900140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Felps.200900140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19517507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=S162-S173&issue=Suppl.+1&author=N.+Guexauthor=M.+C.+Peitschauthor=T.+Schwede&title=Automated+Comparative+Protein+Structure+Modeling+with+SWISS-MODEL+and+Swiss-PdbViewer%3A+A+Historical+Perspective&doi=10.1002%2Felps.200900140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span></div><div class="casAuthors">Guex Nicolas; Peitsch Manuel C; Schwede Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S162-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SWISS-MODEL pioneered the field of automated modeling as the first protein modeling service on the Internet.  In combination with the visualization tool Swiss-PdbViewer, the Internet-based Workspace and the SWISS-MODEL Repository, it provides a fully integrated sequence to structure analysis and modeling platform.  This computational environment is made freely available to the scientific community with the aim to hide the computational complexity of structural bioinformatics and encourage bench scientists to make use of the ever-increasing structural information available.  Indeed, over the last decade, the availability of structural information has significantly increased for many organisms as a direct consequence of the complementary nature of comparative protein modeling and experimental structure determination.  This has a very positive and enabling impact on many different applications in biomedical research as described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUn40ZFOULN-cVm4E2RlLfW6udTcc2eaxoYIQHbOtLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D&md5=e74c27636b8f333cd344bedff31c97fa</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Felps.200900140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200900140%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DAutomated%2520Comparative%2520Protein%2520Structure%2520Modeling%2520with%2520SWISS-MODEL%2520and%2520Swiss-PdbViewer%253A%2520A%2520Historical%2520Perspective%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26issue%3DSuppl.%25201%26spage%3DS162%26epage%3DS173%26doi%3D10.1002%2Felps.200900140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lj2vCEnmdjgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doman, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4477</span>– <span class="NLM_lpage">4486</span>, <span class="refDoi"> DOI: 10.1021/jm030191r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030191r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Kkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4477-4486&issue=21&author=J.+Seidlerauthor=S.+L.+McGovernauthor=T.+N.+Domanauthor=B.+K.+Shoichet&title=Identification+and+Prediction+of+Promiscuous+Aggregating+Inhibitors+among+Known+Drugs&doi=10.1021%2Fjm030191r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and prediction of promiscuous aggregating inhibitors among known drugs</span></div><div class="casAuthors">Seidler, James; McGovern, Susan L.; Doman, Thompson N.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4477-4486</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some small mols., often hits from screening, form aggregates in soln. that inhibit many enzymes.  In contrast, drugs are thought to act specifically.  To investigate this assumption, 50 unrelated drugs were tested for promiscuous inhibition via aggregation.  Each drug was tested against three unrelated model enzymes: β-lactamase, chymotrypsin, and malate dehydrogenase, none of which are considered targets of these drugs.  To be judged promiscuous, the drugs had to inhibit all three enzymes, do so in a time-dependent manner, be sensitive to detergent and to enzyme concn., and form particles detectable by light scattering.  Of the 50 drugs tested, 43 were nonpromiscuous by these criteria.  Surprisingly, four of the drugs showed promiscuous, aggregation-based inhibition at concns. below 100 μM: clotrimazole, benzyl benzoate, nicardipine, and delavirdine.  Three other drugs also behaved as aggregation-based inhibitors, but only at high concns. (about 400 μM).  To investigate possible structure-activity relationships among promiscuous drugs, five analogs of the antifungal clotrimazole were studied.  Three of these, miconazole, econazole, and sulconazole, were promiscuous but the other two, fluconazole and ketoconazole, were not.  Using recursive partitioning, these exptl. results were used to develop a model for predicting aggregate-based promiscuity.  This model correctly classified 94% of 111 compds.-- 47 aggregators and 64 nonaggregators-- that have been studied for this effect.  To evaluate the model, it was used to predict the behavior of 75 drugs not previously investigated for aggregation.  Several preliminary points emerge.  Most drugs are not promiscuous, even at high concns.  Nevertheless, at high enough concns. (20-400 μM), some drugs can aggregate and act promiscuously, suggesting that aggregation may be common among small mols. at micromolar concns., at least in biochem. buffers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6rct1y8KO7Vg90H21EOLACvtfcHk0lj2vCEnmdjgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Kkt74%253D&md5=4bc47e2d426be688a79aa077ce6f9c3b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm030191r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030191r%26sid%3Dliteratum%253Aachs%26aulast%3DSeidler%26aufirst%3DJ.%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DDoman%26aufirst%3DT.%2BN.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DIdentification%2520and%2520Prediction%2520of%2520Promiscuous%2520Aggregating%2520Inhibitors%2520among%2520Known%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D21%26spage%3D4477%26epage%3D4486%26doi%3D10.1021%2Fjm030191r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzouz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gembus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ţînţaş, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopková-de Oliveira
Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papamicaël, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levacher, V.</span></span> <span> </span><span class="NLM_article-title">Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5909</span>– <span class="NLM_lpage">5926</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00702</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00702" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpvFeju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5909-5926&issue=13&author=L.+Peaugerauthor=R.+Azzouzauthor=V.+Gembusauthor=M.-L.+%C5%A2%C3%AEn%C5%A3a%C5%9Fauthor=J.+Sopkov%C3%A1-de+Oliveira%0ASantosauthor=P.+Bohnauthor=C.+Papamica%C3%ABlauthor=V.+Levacher&title=Donepezil-Based+Central+Acetylcholinesterase+Inhibitors+by+Means+of+a+%E2%80%9CBio-Oxidizable%E2%80%9D+Prodrug+Strategy%3A+Design%2C+Synthesis%2C+and+in+Vitro+Biological+Evaluation&doi=10.1021%2Facs.jmedchem.7b00702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation</span></div><div class="casAuthors">Peauger, Ludovic; Azzouz, Rabah; Gembus, Vincent; Tintas, Mihaela-Liliana; Sopkova-de Oliveira Santos, Jana; Bohn, Pierre; Papamicael, Cyril; Levacher, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5909-5926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim of reducing side effects of acetylcholinesterase inhibitors (AChEIs) during symptomatic treatment of Alzheimer's disease, we report herein a new class of donepezil-based "bio-oxidizable" prodrugs 1 designed to be converted into dual binding site AChEIs 2.  While most of indanone-derived N-benzylpyridinium salts 2 revealed to be highly potent dual binding site hAChEIs (IC50 up to 3 nM), outperforming the std. drug donepezil (IC50 = 11 nM), most of the corresponding 1,4-dihydropyridines 1 were found to be inactive.  Promisingly, whereas the selected prodrug 1r showed good permeability in the PAMPA-BBB model and high in vitro antioxidant activity, its conversion to AChEI 2r could be easily achieved under mild conditions when incubated in various oxidizing media.  Lastly, both compds. 1r and 2r did not show genotoxicity in vitro and displayed high LD50 values in mice, making this prodrug 1r/drug 2r couple a good candidate for further in vivo biol. expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOI51deRlDLVg90H21EOLACvtfcHk0lhbIJAzvpjlIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpvFeju74%253D&md5=bd539cf43f39c5058b243fb1bbdb4da4</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00702%26sid%3Dliteratum%253Aachs%26aulast%3DPeauger%26aufirst%3DL.%26aulast%3DAzzouz%26aufirst%3DR.%26aulast%3DGembus%26aufirst%3DV.%26aulast%3D%25C5%25A2%25C3%25AEn%25C5%25A3a%25C5%259F%26aufirst%3DM.-L.%26aulast%3DSopkov%25C3%25A1-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DPapamica%25C3%25ABl%26aufirst%3DC.%26aulast%3DLevacher%26aufirst%3DV.%26atitle%3DDonepezil-Based%2520Central%2520Acetylcholinesterase%2520Inhibitors%2520by%2520Means%2520of%2520a%2520%25E2%2580%259CBio-Oxidizable%25E2%2580%259D%2520Prodrug%2520Strategy%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Biological%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5909%26epage%3D5926%26doi%3D10.1021%2Facs.jmedchem.7b00702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lhassane Ismaili, Julie Monnin, Adeline Etievant, Raquel L. Arribas, Lucía Viejo, Bernard Refouvelet, Ondrej Soukup, Jana Janockova, Vendula Hepnarova, Jan Korabecny, Tomas Kucera, Daniel Jun, Rudolf Andrys, Kamil Musilek, Aurelie Baguet, Eva M. García-Frutos, Angela De Simone, Vincenza Andrisano, Manuela Bartolini, Cristóbal de los Ríos, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel Haffen</span>. </span><span class="cited-content_cbyCitation_article-title">(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (8)
                                     , 1328-1342. <a href="https://doi.org/10.1021/acschemneuro.0c00803" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00803%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D%252528%2525C2%2525B1%252529-BIGI-3h%25253A%252BPentatarget-Directed%252BLigand%252Bcombining%252BCholinesterase%25252C%252BMonoamine%252BOxidase%25252C%252Band%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252BInhibition%252Bwith%252BCalcium%252BChannel%252BAntagonism%252Band%252BAntiaggregating%252BProperties%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DIsmaili%26aufirst%3DLhassane%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19122020%26date%3D22032021%26date%3D02042021%26volume%3D12%26issue%3D8%26spage%3D1328%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Pedro Cisternas, Carolina A. Oliva, Elena Sánchez-López, Miren Ettcheto, Manuela Bartolini, Angela De Simone, Mattia Ricchini, Marisa Rendina, Mégane Pons, Omidreza Firuzi, Belén Pérez, Luciano Saso, Vincenza Andrisano, Florian Nachon, Xavier Brazzolotto, Maria Luisa García, Antoni Camins, Israel Silman, Ludovic Jean, Nibaldo C. Inestrosa, Jacques-Philippe Colletier, Pierre-Yves Renard, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 812-839. <a href="https://doi.org/10.1021/acs.jmedchem.0c01775" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDual%252BInhibitor%252Bof%252BAcetylcholinesterase%252Band%252BButyrylcholinesterase%252Bwith%252BAntioxidant%252BActivity%252Bthat%252BAlleviates%252BAlzheimer-like%252BPathology%252Bin%252BOld%252BAPP%25252FPS1%252BMice%26aulast%3DViayna%26aufirst%3DElisabet%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D09102020%26date%3D28122020%26volume%3D64%26issue%3D1%26spage%3D812%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter A.  Sidhom</span>, <span class="hlFld-ContribAuthor ">Eman  El-Bastawissy</span>, <span class="hlFld-ContribAuthor ">Abeer A.  Salama</span>, <span class="hlFld-ContribAuthor ">Tarek F.  El-Moselhy</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105054. <a href="https://doi.org/10.1016/j.bioorg.2021.105054" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DRevisiting%252Bageless%252Bantiques%25253B%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bdocking%252Bsimulation%252Band%252Bmechanistic%252Binsights%252Bof%252B1%25252C4-Dihydropyridines%252Bas%252Banticancer%252Bagents%26aulast%3DSidhom%26aufirst%3DPeter%2BA.%26date%3D2021%26volume%3D114%26spage%3D105054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flávia B.  Lopes</span>, <span class="hlFld-ContribAuthor ">Cecília M. S. Q.  Aranha</span>, <span class="hlFld-ContribAuthor ">João Paulo S.  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H
              3
              receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>98 </em>
                                    (2)
                                     , 212-225. <a href="https://doi.org/10.1111/cbdd.13866" title="DOI URL">https://doi.org/10.1111/cbdd.13866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13866%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DHistamine%252BH%252B3%252Breceptor%252Band%252Bcholinesterases%252Bas%252Bsynergistic%252Btargets%252Bfor%252Bcognitive%252Bdecline%25253A%252BStrategies%252Bto%252Bthe%252Brational%252Bdesign%252Bof%252Bmultitarget%252Bligands%26aulast%3DLopes%26aufirst%3DFl%25C3%25A1via%2BB.%26date%3D2021%26date%3D2021%26volume%3D98%26issue%3D2%26spage%3D212%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Julia  Tabor</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Fabien  Chantegreil</span>, <span class="hlFld-ContribAuthor ">José  Dias</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Junfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Georg  Höfner</span>, <span class="hlFld-ContribAuthor ">Klaus  Wanner</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113397. <a href="https://doi.org/10.1016/j.ejmech.2021.113397" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113397%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmultifunctional%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%252Bwith%252Ba%252Bunique%252Bmechanism%252Bof%252Baction%252Bincluding%252Binhibition%252Bof%252Bthe%252Benzyme%252Bbutyrylcholinesterase%252Band%252B%2525CE%2525B3-aminobutyric%252Bacid%252Btransporters%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2021%26volume%3D218%26spage%3D113397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinming  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Yin</span>, <span class="hlFld-ContribAuthor ">Huixian  Ye</span>, <span class="hlFld-ContribAuthor ">Zhonghong  Gao</span>, <span class="hlFld-ContribAuthor ">Hailing  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure relationship of metalloporphyrins in inhibiting the aggregation of hIAPP. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>167 </em>, 141-150. <a href="https://doi.org/10.1016/j.ijbiomac.2020.11.161" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.11.161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.11.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.11.161%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DStructure%252Brelationship%252Bof%252Bmetalloporphyrins%252Bin%252Binhibiting%252Bthe%252Baggregation%252Bof%252BhIAPP%26aulast%3DWu%26aufirst%3DJinming%26date%3D2021%26volume%3D167%26spage%3D141%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, , <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, , <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Ligand Approach: Search for Effective Therapy Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-203. <a href="https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11" title="DOI URL">https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.36255/exonpublications.alzheimersdisease.2020.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.36255%2Fexonpublications.alzheimersdisease.2020.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DMultifunctional%252BLigand%252BApproach%25253A%252BSearch%252Bfor%252BEffective%252BTherapy%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26spage%3D181%26epage%3D203%26pub%3DExon%2520Publications%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDrug%252BDiscovery%26aulast%3DHuang%26aufirst%3DXudong%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Pachón Angona</span>, <span class="hlFld-ContribAuthor ">Helene  Martin</span>, <span class="hlFld-ContribAuthor ">Solene  Daniel</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bonet</span>, <span class="hlFld-ContribAuthor ">Artur  Wnorowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Maj</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jozwiak</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7652. <a href="https://doi.org/10.3390/ijms21207652" title="DOI URL">https://doi.org/10.3390/ijms21207652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207652%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%252Bof%252BHantzsch%252BAdducts%252Bas%252BCholinesterases%252Band%252BCalcium%252BFlux%252Binhibitors%25252C%252BAntioxidants%252Band%252BNeuroprotectives%26aulast%3DPach%25C3%25B3n%2BAngona%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongguang  Ma</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 1682-1692. <a href="https://doi.org/10.1016/j.drudis.2020.07.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRecent%252Badvances%252Bin%252Bmultitarget-directed%252Bligands%252Btargeting%252BG-protein-coupled%252Breceptors%26aulast%3DMa%26aufirst%3DHongguang%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D1682%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay  Kumar</span>, <span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashish  Ranjan Dwivedi</span>, <span class="hlFld-ContribAuthor ">Devashish  Mehta</span>, <span class="hlFld-ContribAuthor ">Naveen  Kumar</span>, <span class="hlFld-ContribAuthor ">Beenu  Bajaj</span>, <span class="hlFld-ContribAuthor ">Tania  Arora</span>, <span class="hlFld-ContribAuthor ">Vikash  Prashar</span>, <span class="hlFld-ContribAuthor ">Jyoti  Parkash</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of
              O
              ‐Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (27)
                                     , 8021-8032. <a href="https://doi.org/10.1002/slct.202002425" title="DOI URL">https://doi.org/10.1002/slct.202002425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BO%252B%2525E2%252580%252590Pentyne%252BSubstituted%252BDiphenylpyrimidines%252Bas%252BMonoamine%252BOxidase%252Band%252BAcetylcholinesterase%252BInhibitors%26aulast%3DKumar%26aufirst%3DVijay%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D27%26spage%3D8021%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lazhar  Zribi</span>, <span class="hlFld-ContribAuthor ">Irene  Pachòn-Angona</span>, <span class="hlFld-ContribAuthor ">Òscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Daniel  Diez-Iriepa</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Fakher  Chabchoub</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (14)
                                     , 3190. <a href="https://doi.org/10.3390/molecules25143190" title="DOI URL">https://doi.org/10.3390/molecules25143190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25143190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25143190%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTriazolopyridopyrimidine%25253A%252BA%252BNew%252BScaffold%252Bfor%252BDual-Target%252BSmall%252BMolecules%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DZribi%26aufirst%3DLazhar%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D14%26spage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Salerno</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.1002/med.21699" title="DOI URL">https://doi.org/10.1002/med.21699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21699%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFrom%252Bcombinations%252Bto%252Bmultitarget%2525E2%252580%252590directed%252Bligands%25253A%252BA%252Bcontinuum%252Bin%252BAlzheimer%252527s%252Bdisease%252Bpolypharmacology%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Adel  Youssef</span>, <span class="hlFld-ContribAuthor ">Siva S.  Panda</span>, <span class="hlFld-ContribAuthor ">Riham A.  El-Shiekh</span>, <span class="hlFld-ContribAuthor ">ElSayed M.  Shalaby</span>, <span class="hlFld-ContribAuthor ">Dalia R.  Aboshouk</span>, <span class="hlFld-ContribAuthor ">Walid  Fayad</span>, <span class="hlFld-ContribAuthor ">Nehmedo G.  Fawzy</span>, <span class="hlFld-ContribAuthor ">Adel S.  Girgis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines]. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (37)
                                     , 21830-21838. <a href="https://doi.org/10.1039/D0RA03064C" title="DOI URL">https://doi.org/10.1039/D0RA03064C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03064C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03064C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bcholinesterase%252Binhibitor%252Bdispiro%25255Bindoline-3%25252C2%2525E2%252580%2525B2-pyrrolidine-3%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%2525E2%252580%2525B2-pyrrolidines%25255D%26aulast%3DYoussef%26aufirst%3DM.%2BAdel%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D37%26spage%3D21830%26epage%3D21838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Pachòn Angona</span>, <span class="hlFld-ContribAuthor ">Solene  Daniel</span>, <span class="hlFld-ContribAuthor ">Helene  Martin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bonet</span>, <span class="hlFld-ContribAuthor ">Artur  Wnorowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Maj</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jóźwiak</span>, <span class="hlFld-ContribAuthor ">Tiago Barros  Silva</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1329. <a href="https://doi.org/10.3390/molecules25061329" title="DOI URL">https://doi.org/10.3390/molecules25061329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061329%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BAntioxidant%252Band%252BNeuroprotective%252BMultitarget%252BDirected%252BLigands%252BAble%252Bto%252BBlock%252BCalcium%252BChannels%26aulast%3DPach%25C3%25B2n%2BAngona%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Paula  Zaręba</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Anja  Pislar</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>. </span><span class="cited-content_cbyCitation_article-title">Multidirectional
              in vitro
              and
              in cellulo
              studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1944-1952. <a href="https://doi.org/10.1080/14756366.2020.1835882" title="DOI URL">https://doi.org/10.1080/14756366.2020.1835882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1835882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1835882%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DMultidirectional%252Bin%2525C2%2525A0vitro%252Band%252Bin%252Bcellulo%252Bstudies%252Bas%252Ba%252Btool%252Bfor%252Bidentification%252Bof%252Bmulti-target-directed%252Bligands%252Baiming%252Bat%252Bsymptoms%252Band%252Bcauses%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSza%25C5%2582aj%26aufirst%3DNatalia%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1944%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of 1,4-DHPs <b>3a</b>–<b>p</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) Br-(CH<sub>2</sub>)<sub><i>n</i></sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 24 h; (2) corresponding cycloalkylamine, KI, reflux, 24 h; (ii) ethyl 3-oxobutanoate, ammonium carbonate, EtOH–H<sub>2</sub>O (1:1), MWI, 120 °C, 4 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of ip compounds <b>3o</b>,<b>p</b> and donepezil on LPS (250 μg/kg) induced memory impairment in the novel recognition test in mice: ***<i>p</i> ≤ 0.001 with respect to control; <sup>##</sup><i>p</i> ≤ 0.01 with respect to LPS-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the vasorelaxant effects of <b>3p</b> and nifedipine. The vasorelaxant responses of <b>3p</b> and nifedipine at 0.1, 1, and 10 nM were assessed on endothelium-denuded aortic rings preconstricted with 100 mM KCl. Data are expressed as the mean ± SEM (<i>n</i> = 6 aortic rings): **<i>p</i> < 0.01; n.s., not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3p</b> in the binding site of hH3R homology built 3D-model based on human M1 muscarinic acetylcholine receptor (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CXV">5CXV</a>). Compound <b>3p</b> is rendered as balls and sticks and illustrated in orange. The side chain conformations of the mobile residues are illustrated in blue sticks. Asp114 is colored in yellow. Hydrogen bond is represented as green dashed line, and π–cation and salt bridge interactions are represented as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/medium/jm9b00937_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Binding of <b>3o</b> (blue) and <b>3p</b> (yellow) in the hH1R (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>). (b) Binding of <b>3o</b> (yellow) and <b>3p</b> (pink) in the homology model of hH4R based on hH1R (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>). The key binding site amino acids are shown in orange sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b00937/20191219/images/large/jm9b00937_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00937&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i15">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Querfurth, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFerla, F. M.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>362</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1056/NEJMra0909142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&issue=4&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease&doi=10.1056%2FNEJMra0909142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lhR87XNGgFDYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26issue%3D4%26spage%3D329%26epage%3D344%26doi%3D10.1056%2FNEJMra0909142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frölich, L.</span></span> <span> </span><span class="NLM_article-title">The Cholinergic Pathology in Alzheimer’s Disease--Discrepancies between Clinical Experience and Pathophysiological Findings</span>. <i>J. Neural Transm. Vienna Austria 1996</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1007/s007020200083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1007%2Fs007020200083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD38zms1yisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1003-1013&issue=7%E2%80%938&author=L.+Fr%C3%B6lich&title=The+Cholinergic+Pathology+in+Alzheimer%E2%80%99s+Disease%2D%2DDiscrepancies+between+Clinical+Experience+and+Pathophysiological+Findings&doi=10.1007%2Fs007020200083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings</span></div><div class="casAuthors">Frolich L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1003-13</span>
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    </div><div class="casAbstract">The cholinergic hypothesis of Alzheimer's disease (AD) states 1. that cholinergic neurons in the basal forebrain are severely affected in the course of disease, detectable both histopathologically by a loss of neurons and neurochemically, by a loss of marker enzymes for acetylcholine synthesis and degradation, and 2. that the resulting cerebral cholinergic deficit leads to memory loss and other cognitive and non-cognitive symptoms, which are characteristic for the illness.  This hypothesis was mainly based on studies, which had been conducted on brains of patients with advanced dementia.  Nevertheless, it has served as the rationale for the development of drugs, i.e. acetylcholine-esterase inhibitors (AChE-I), which have shown consistent, but modest clinical efficacy against cognitive decline and behavioural symptoms of dementia for a limited period of time.  These drugs are presently regarded the standard treatment of dementia in Alzheimer's disease.  Now, due to a more sensitive and reliable clinical diagnosis, neurobiological investigations can be performed on early stages of disease, when the changes detected presumably are more relevant for the pathogenesis.  New studies on the pathophysiology of the cholinergic system in AD suggest 1. that the cholinergic deficit occurs only late in the disease, 2. that at the earliest stages there even is an upregulation of cholinergic activity in the brain, and 3. that an increased activity of AChE may develop under therapy with AChE-I's.  These data show that there is a plasticity of the central cholinergic system in AD and that the positive clinical effects of AChE-I are to be weighted against possible detrimental effects on a pathophysiological level.  These data challenge the cholinergic hypothesis in its present form, e.g. should stimulate studies on the underlying process, which leads the cholinergic system to increase its activity in patients in the early stage of AD and may have clinical consequences regarding cholinergic drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2xbVApEVCbVf1XRtfYM0dfW6udTcc2eYvkQvm6ECv4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zms1yisw%253D%253D&md5=93c09f085d14268752bf80ef16264145</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs007020200083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs007020200083%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6lich%26aufirst%3DL.%26atitle%3DThe%2520Cholinergic%2520Pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease--Discrepancies%2520between%2520Clinical%2520Experience%2520and%2520Pathophysiological%2520Findings%26jtitle%3DJ.%2520Neural%2520Transm.%2520Vienna%2520Austria%25201996%26date%3D2002%26volume%3D109%26issue%3D7%25E2%2580%25938%26spage%3D1003%26epage%3D1013%26doi%3D10.1007%2Fs007020200083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Tacrine Derivatives and Alzheimer’s Disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1838</span>, <span class="refDoi"> DOI: 10.2174/092986710791111206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F092986710791111206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20345341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1825-1838&issue=17&author=V.+Tumiattiauthor=A.+Minariniauthor=M.+L.+Bolognesiauthor=A.+Milelliauthor=M.+Rosiniauthor=C.+Melchiorre&title=Tacrine+Derivatives+and+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F092986710791111206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine derivatives and Alzheimer's disease</span></div><div class="casAuthors">Tumiatti, V.; Minarini, A.; Bolognesi, M. L.; Milelli, A.; Rosini, M.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) inhibitors (AChEIs) and, more recently, an N-methyl-D-aspartate receptor (NMDAR) antagonist.  AD is a multifactorial syndrome with several target proteins contributing to its etiol.  "Multi-target-directed ligands" (MTDLs) have great potential for treating complex diseases such as AD because they can interact with multiple targets.  The design of compds. that can hit more than one specific AD target thus represents an innovative strategy for AD treatment.  Tacrine was the first AChEI introduced in therapy.  Recent studies have demonstrated its ability to interact with different AD targets.  Furthermore, numerous tacrine homo- and heterodimers were developed with the aim of improving and enlarging its biol. profile beyond its ability to act as an AChEI.  Several tacrine hybrid derivs. were designed and synthesized with the same goal.  This review will focus on and summarize the last 2 years of research into the development of tacrine derivs. able to hit AD targets beyond simple AChE inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAUhZIxP33LVg90H21EOLACvtfcHk0lhR87XNGgFDYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D&md5=0506197d9fdaa47d5a76bdf2099cf483</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986710791111206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791111206%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DTacrine%2520Derivatives%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26issue%3D17%26spage%3D1825%26epage%3D1838%26doi%3D10.2174%2F092986710791111206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&issue=7&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+Stress+in+Alzheimer%E2%80%99s+Disease%3A+Are+We+Connecting+the+Dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0lgjO1hhC3B7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520Stress%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Are%2520We%2520Connecting%2520the%2520Dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D7%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Drug Development Based on the Metals Hypothesis of Alzheimer’s Disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.3233/JAD-2008-15208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-2008-15208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=18953111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cmtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=223-240&issue=2&author=A.+I.+Bush&title=Drug+Development+Based+on+the+Metals+Hypothesis+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2008-15208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Development Based on the Metals Hypothesis of Alzheimer's Disease</span></div><div class="casAuthors">Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-240</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The recent report of pos. results from a Phase IIa clin. trial of PBT2, a novel drug that targets amyloid-β-metal interactions, underscores the value of abnormal transition metal metab. as a potential therapeutic target in Alzheimer's disease.  The Metals Hypothesis of Alzheimer's disease is based upon observations of the pptn. of amyloid-β by zinc and its radicalization by copper.  Both metals are markedly enriched in plaques.  The Hypothesis involves the perturbance of these endogenous brain metals, and it does not consider toxicol. exposure part of pathogenesis.  Recent descriptions of the release of ionic zinc and copper in the cortical glutamatergic synapse, modulating the response of the NMDA receptor, may explain the vulnerability of amyloid-β to abnormal interaction with these metal ions in the synaptic region leading to aggregation and fostering toxicity.  Increasingly sophisticated medicinal chem. approaches are being tested which correct the abnormalities without causing systemic disturbance of these essential minerals.  PBT2, clioquinol and related compds. are ionophores rather than chelators.  PBT2 is a once per day, orally bioavailable, second generation 8-OH quinoline deriv. of clioquinol.  It has performed very satisfactorily in toxicol. and Phase I clin. trials and is advancing as a disease-modifying candidate drug for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhLYKZxz7C7Vg90H21EOLACvtfcHk0lgjO1hhC3B7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cmtr3J&md5=e69992b89e2c5294552ada499b3afa1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3233%2FJAD-2008-15208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2008-15208%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DDrug%2520Development%2520Based%2520on%2520the%2520Metals%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2008%26volume%3D15%26issue%3D2%26spage%3D223%26epage%3D240%26doi%3D10.3233%2FJAD-2008-15208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilukuri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase and the Cholinergic System</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2012.12.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.neuroscience.2012.12.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=23305761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2013&pages=53-68&author=G.+A.+Reidauthor=N.+Chilukuriauthor=S.+Darvesh&title=Butyrylcholinesterase+and+the+Cholinergic+System&doi=10.1016%2Fj.neuroscience.2012.12.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase and the cholinergic system</span></div><div class="casAuthors">Reid, G. A.; Chilukuri, N.; Darvesh, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-68</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cholinergic system plays important roles in neurotransmission in both the peripheral and central nervous systems.  The cholinergic neurotransmitter acetylcholine is synthesized by choline acetyltransferase (ChAT) and its action terminated by acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).  The predominance of AChE has focused much attention on understanding the relationship of this enzyme to ChAT-pos. cholinergic neurons.  However, there is ample evidence that BuChE also plays an important role in cholinergic regulation.  To elucidate the relationship of BuChE to neural elements that are producing acetylcholine, the distribution of this enzyme was compared to that of ChAT in the mouse CNS.  Brain tissues from 129S1/SvImJ mice were stained for BuChE and ChAT using histochem., immunohistochem. and immunofluorescent techniques.  Both BuChE and ChAT were found in neural elements throughout the CNS.  BuChE staining with histochem. and immunohistochem. produced the same distribution of labeling throughout the brain and spinal cord.  Immunofluorescent double labeling demonstrated that many nuclei in the medulla oblongata, as well as regions of the spinal cord, had neurons that contained both BuChE and ChAT.  BuChE-pos. neurons without ChAT were found in close proximity with ChAT-pos. neuropil in areas such as the thalamus and amygdala.  BuChE-pos. neuropil was also found closely assocd. with ChAT-pos. neurons, particularly in tegmental nuclei of the pons.  These observations provide further neuroanatomical evidence of a role for BuChE in the regulation of acetylcholine levels in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryfLt0nfCszLVg90H21EOLACvtfcHk0lgjO1hhC3B7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWgtL4%253D&md5=0e70a02526df9cb9f925e1367b610681</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2012.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2012.12.054%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DG.%2BA.%26aulast%3DChilukuri%26aufirst%3DN.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DButyrylcholinesterase%2520and%2520the%2520Cholinergic%2520System%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D234%26spage%3D53%26epage%3D68%26doi%3D10.1016%2Fj.neuroscience.2012.12.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bond, M.</span>; <span class="NLM_string-name">Rogers, G.</span>; <span class="NLM_string-name">Peters, J.</span>; <span class="NLM_string-name">Anderson, R.</span>; <span class="NLM_string-name">Hoyle, M.</span>; <span class="NLM_string-name">Miners, A.</span>; <span class="NLM_string-name">Moxham, T.</span>; <span class="NLM_string-name">Davis, S.</span>; <span class="NLM_string-name">Thokala, P.</span>; <span class="NLM_string-name">Wailoo, A.</span>; <span class="NLM_string-name">Jeffreys, M.</span>; <span class="NLM_string-name">Hyde, C.</span></span> <span> </span><span class="NLM_article-title">The Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Review of Technology Appraisal No. 111): A Systematic Review and Economic Model</span>.  <i>Health Technol. Assess.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume">16</span> (<span class="NLM_issue">21</span>), <span class="refDoi"> DOI: 10.3310/hta16210</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3310%2Fhta16210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=22541366" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&issue=21&author=M.+Bond&author=G.+Rogers&author=J.+Peters&author=R.+Anderson&author=M.+Hoyle&author=A.+Miners&author=T.+Moxham&author=S.+Davis&author=P.+Thokala&author=A.+Wailoo&author=M.+Jeffreys&author=C.+Hyde&title=The+Effectiveness+and+Cost-Effectiveness+of+Donepezil%2C+Galantamine%2C+Rivastigmine+and+Memantine+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease+%28Review+of+Technology+Appraisal+No.+111%29%3A+A+Systematic+Review+and+Economic+Model&doi=10.3310%2Fhta16210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3310%2Fhta16210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3310%252Fhta16210%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DM.%26atitle%3DThe%2520Effectiveness%2520and%2520Cost-Effectiveness%2520of%2520Donepezil%252C%2520Galantamine%252C%2520Rivastigmine%2520and%2520Memantine%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520%2528Review%2520of%2520Technology%2520Appraisal%2520No.%2520111%2529%253A%2520A%2520Systematic%2520Review%2520and%2520Economic%2520Model%26jtitle%3DHealth%2520Technol.%2520Assess.%26date%3D2012%26volume%3D16%26issue%3D21%26doi%3D10.3310%2Fhta16210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, C.</span></span> <span> </span><span class="NLM_article-title">Memantine in Patients with Moderate to Severe Alzheimer’s Disease: Meta-Analyses Using Realistic Definitions of Response</span>. <i>Dementia Geriatr. Cognit. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1159/000353801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1159%2F000353801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24107324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVCls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=71-85&issue=1%E2%80%932&author=D.+Wilkinsonauthor=Y.+Wirthauthor=C.+Goebel&title=Memantine+in+Patients+with+Moderate+to+Severe+Alzheimer%E2%80%99s+Disease%3A+Meta-Analyses+Using+Realistic+Definitions+of+Response&doi=10.1159%2F000353801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in Patients with Moderate to Severe Alzheimer's Disease: Meta-Analyses Using Realistic Definitions of Response</span></div><div class="casAuthors">Wilkinson, David; Wirth, Yvonne; Goebel, Claus</div><div class="citationInfo"><span class="NLM_cas:title">Dementia and Geriatric Cognitive Disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">DGCDFX</span>;
        ISSN:<span class="NLM_cas:issn">1420-8008</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: We aimed to develop realistic definitions of clin. worsening in advanced Alzheimer's disease (AD) and to use them in a post hoc responder anal. of memantine.  Methods: 2,340 patients with moderate to severe AD (Mini-Mental State Examn. <20) were included from 9 multicentre, 16- to 28-wk, randomized, double-blind, placebo-controlled studies of memantine 20 mg/day vs. placebo.  Responder meta-analyses were performed, with definitions of response based on minimally important differences (MIDs) on cognitive, functional, and global assessment scales.  Validated or established MIDs were used where available; otherwise, MIDs were estd. by a data-driven approach, using data from our moderate to severe AD population.  Results: Patients with moderate to severe AD treated with memantine had a lower incidence of worsening from baseline to endpoint than patients treated with placebo, in cognition [24.4 vs. 35.0%; odds ratio (OR) = 0.60; p < 0.001], function (38.1 vs. 43.4%; OR = 0.81; p = 0.01), global status (39.8 vs. 48.6%; OR = 0.70; p < 0.001), and in a combined 'triple' worsening measure (9.4 vs. 16.1%; OR = 0.54; p < 0.001).  Conclusions: New definitions of clin. worsening based on MIDs represent a more realistic functional decline in advanced stages of AD.  Results of this new anal. show that memantine reduces the incidence of clin. worsening in key symptomatic domains in moderate to severe AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU9KiS3U7Bm7Vg90H21EOLACvtfcHk0ljNc_cjkrQcMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVCls7s%253D&md5=37b5803823d4cacc3fba5a8d12805a34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1159%2F000353801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353801%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DWirth%26aufirst%3DY.%26aulast%3DGoebel%26aufirst%3DC.%26atitle%3DMemantine%2520in%2520Patients%2520with%2520Moderate%2520to%2520Severe%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Meta-Analyses%2520Using%2520Realistic%2520Definitions%2520of%2520Response%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2014%26volume%3D37%26issue%3D1%25E2%2580%25932%26spage%3D71%26epage%3D85%26doi%3D10.1159%2F000353801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gareri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putignano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotroneo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Palo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacummo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurlo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putignano, S.</span></span> <span> </span><span class="NLM_article-title">Retrospective Study on the Benefits of Combined Memantine and CholinEsterase Inhibitor TreatMent in AGEd Patients Affected with Alzheimer’s Disease: The MEMAGE Study</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.3233/JAD-132735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-132735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24643135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKhsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=633-640&issue=2&author=P.+Gareriauthor=D.+Putignanoauthor=A.+Castagnaauthor=A.+M.+Cotroneoauthor=G.+De+Paloauthor=A.+Fabboauthor=L.+Forgioneauthor=A.+Giacummoauthor=R.+Lacavaauthor=S.+Marinoauthor=M.+Simoneauthor=A.+Zurloauthor=S.+Putignano&title=Retrospective+Study+on+the+Benefits+of+Combined+Memantine+and+CholinEsterase+Inhibitor+TreatMent+in+AGEd+Patients+Affected+with+Alzheimer%E2%80%99s+Disease%3A+The+MEMAGE+Study&doi=10.3233%2FJAD-132735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study</span></div><div class="casAuthors">Gareri, Pietro; Putignano, Daria; Castagna, Alberto; Cotroneo, Antonino Maria; De Palo, Grazia; Fabbo, Andrea; Forgione, Luigi; Giacummo, Attilio; Lacava, Roberto; Marino, Saverio; Simone, Maurizio; Zurlo, Amedeo; Putignano, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">633-640</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Combined therapy of memantine and acetylcholinesterase inhibitors (AChEIs) in patients with Alzheimer's disease (AD) may be assocd. with higher benefits than either monotherapy.  This retrospective multicentric study conducted in 7 Italian Ambulatory Centers for Dementia assessed the efficacy and safety of memantine 20 mg/day administered for 6 mo in addn. to an AChEI in AD patients with worsened cognitive functions and behavioral disorders.  A total no. of 240 patients (61.7% of women, 38.3% men, mean age 77.9 years old) who had started treatment with the combination therapy were recruited.  At baseline (T0), Month 3 (T1), and Month 6 (T2), cognitive functions were assessed by Mini-Mental State Examn. (MMSE), functional dependence by activities of daily living (ADL) and instrumental ADL, behavioral disturbances by the Neuropsychiatric Inventory (NPI), and comorbidities by Cumulative Illness Rating Scale.  Adverse events were reported during the study.  MMSE total score significantly increased at Month 6 and IADL total score significantly decreased from baseline to endpoint.  There were no significant changes from baseline in mean ADL, despite significant improvements in NPI total score.  The mean MMSE total score significantly increased with the combination donepezil + memantine compared to rivastigmine + memantine.  The adverse events profile was in line with the expected range of the drugs studied and concomitant therapies.  Overall, 17 patients discontinued treatment in the observation time.  Combined treatment with memantine and AChEIs was effective in patients with AD, particularly in slowing cognitive impairment and preventing the onset of agitation and aggression in elderly AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGX2p5bzUUmLVg90H21EOLACvtfcHk0ljNc_cjkrQcMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKhsrbF&md5=4f4d9a1efcdb0e02ba95f4f5ba256fc2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3233%2FJAD-132735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-132735%26sid%3Dliteratum%253Aachs%26aulast%3DGareri%26aufirst%3DP.%26aulast%3DPutignano%26aufirst%3DD.%26aulast%3DCastagna%26aufirst%3DA.%26aulast%3DCotroneo%26aufirst%3DA.%2BM.%26aulast%3DDe%2BPalo%26aufirst%3DG.%26aulast%3DFabbo%26aufirst%3DA.%26aulast%3DForgione%26aufirst%3DL.%26aulast%3DGiacummo%26aufirst%3DA.%26aulast%3DLacava%26aufirst%3DR.%26aulast%3DMarino%26aufirst%3DS.%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DZurlo%26aufirst%3DA.%26aulast%3DPutignano%26aufirst%3DS.%26atitle%3DRetrospective%2520Study%2520on%2520the%2520Benefits%2520of%2520Combined%2520Memantine%2520and%2520CholinEsterase%2520Inhibitor%2520TreatMent%2520in%2520AGEd%2520Patients%2520Affected%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520The%2520MEMAGE%2520Study%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D41%26issue%3D2%26spage%3D633%26epage%3D640%26doi%3D10.3233%2FJAD-132735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&issue=3&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-Target-Directed+Ligands+To+Combat+Neurodegenerative+Diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljNc_cjkrQcMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-Target-Directed%2520Ligands%2520To%2520Combat%2520Neurodegenerative%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D3%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oset-Gasque, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFKis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=401-403&issue=3&author=M.+J.+Oset-Gasqueauthor=J.+Marco-Contelles&title=Alzheimer%E2%80%99s+Disease%2C+the+%E2%80%9COne-Molecule%2C+One-Target%E2%80%9D+Paradigm%2C+and+the+Multitarget+Directed+Ligand+Approach&doi=10.1021%2Facschemneuro.8b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach</span></div><div class="casAuthors">Oset-Gasque, Maria Jesus; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-403</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No selective drugs exist, and we have been designing, synthesizing, and evaluating multitarget-directed ligands since the beginning of modern medicinal chem., without knowing it, most possibly.  The challenge to discover the efficient Multi-Target Small Mols. (MTSMs) for Alzheimer's disease (AD) therapy implies to identify the key combination of biol. targets to modulate them, thus including in the design the corresponding pharmacophoric groups able to do it.  Universal and polyvalent pharmacophoric groups, able to modulate diverse receptors or enzymic systems, would simplify the drug discovery process leading to new and more efficient MTSMs for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHZZw9_3OlE7Vg90H21EOLACvtfcHk0lhgybveKWpItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFKis74%253D&md5=eef2b740d6b7501d7fe58f304b7695cb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00069%26sid%3Dliteratum%253Aachs%26aulast%3DOset-Gasque%26aufirst%3DM.%2BJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%252C%2520the%2520%25E2%2580%259COne-Molecule%252C%2520One-Target%25E2%2580%259D%2520Paradigm%252C%2520and%2520the%2520Multitarget%2520Directed%2520Ligand%2520Approach%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D401%26epage%3D403%26doi%3D10.1021%2Facschemneuro.8b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dgachi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szałaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabchoub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1–42 Aggregation Inhibitors for Alzheimer’s Disease Therapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Fcmdc.201500539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26804623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1OnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1318-1327&issue=12&author=Y.+Dgachiauthor=L.+Ismailiauthor=D.+Knezauthor=M.+Benchekrounauthor=H.+Martinauthor=N.+Sza%C5%82ajauthor=S.+Wehleauthor=O.+M.+Bautista-Aguileraauthor=V.+Luzetauthor=A.+Bonnetauthor=B.+Malawskaauthor=S.+Gobecauthor=M.+Chiouaauthor=M.+Deckerauthor=F.+Chabchoubauthor=J.+Marco-Contelles&title=Synthesis+and+Biological+Assessment+of+Racemic+Benzochromenopyrimidinimines+as+Antioxidant%2C+Cholinesterase%2C+and+A%CE%B21%E2%80%9342+Aggregation+Inhibitors+for+Alzheimer%E2%80%99s+Disease+Therapy&doi=10.1002%2Fcmdc.201500539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy</span></div><div class="casAuthors">Dgachi, Youssef; Ismaili, Lhassane; Knez, Damijan; Benchekroun, Mohamed; Martin, Helene; Szalaj, Natalia; Wehle, Sarah; Bautista-Aguilera, Oscar M.; Luzet, Vincent; Bonnet, Alexandre; Malawska, Barbara; Gobec, Stanislav; Chioua, Mourad; Decker, Michael; Chabchoub, Fakher; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1318-1327</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Given the complex nature of Alzheimer's disease (AD), compds. that are able to simultaneously address two or more AD-assocd. targets show greater promise for development into drugs for AD therapy.  Herein the authors report an efficient two-step synthesis and biol. evaluation of new racemic benzochromene derivs. as antioxidants, inhibitors of cholinesterase and β-amyloid (Aβ1-42) aggregation.  Based on the results of the primary screening, the authors identified 15-(3-methoxyphenyl)-9,11,12,15-tetrahydro-10H,14H-benzo[5,6]chromeno[2,3-d]pyrido[1,2-a]pyrimidin-14-imine and 16-(3-methoxyphenyl)-9,10,11,12,13,16-hexahydro-15H-benzo[5',6']chromeno[2',3':4,5]pyrimido[1,2-a]azepin-15-imine as new potential multitarget-directed ligands for AD therapy.  Further in-depth biol. anal. showed that one compd. is a good human acetylcholinesterase inhibitor [IC50=(0.36±0.02) μmol] has strong antioxidant activity (3.61 μmol Trolox equiv.) , and moderate Aβ1-42 antiaggregation power (40.3%).  The synthesis of the target compds. was achieved by a reaction of 3-amino-1-phenyl-1H-naphtho[2,1-b]pyran-2-carbonitrile and 2-amino-4-phenyl-4H-naphtho[1,2-b]pyran-3-carbonitrile with lactams, such as 2-pyrrolidinone, 2-piperidinone, hexahydro-2H-azepin-2-one.  The title compds. thus formed included naphtho[1',2':5,6]pyrano[2,3-d]pyrimidine analogs and derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrefXSrxvP3r7Vg90H21EOLACvtfcHk0lhgybveKWpItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1OnsL0%253D&md5=70c884cb0a97bfe60ea833ce1073ed8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500539%26sid%3Dliteratum%253Aachs%26aulast%3DDgachi%26aufirst%3DY.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DH.%26aulast%3DSza%25C5%2582aj%26aufirst%3DN.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DBonnet%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DChabchoub%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Assessment%2520of%2520Racemic%2520Benzochromenopyrimidinimines%2520as%2520Antioxidant%252C%2520Cholinesterase%252C%2520and%2520A%25CE%25B21%25E2%2580%259342%2520Aggregation%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D1318%26epage%3D1327%26doi%3D10.1002%2Fcmdc.201500539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Investigation of Multi-Target-Directed Ligands (MTDLs) with Butyrylcholinesterase (BuChE) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibition: The Design, Synthesis of Miconazole Analogues Targeting Alzheimer’s Disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1674</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bmc.2018.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=29475581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFakurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1665-1674&issue=8&author=X.+Luauthor=S.+Heauthor=Q.+Liauthor=H.+Yangauthor=X.+Jiangauthor=H.+Linauthor=Y.+Chenauthor=W.+Quauthor=F.+Fengauthor=Y.+Bianauthor=Y.+Zhouauthor=H.+Sun&title=Investigation+of+Multi-Target-Directed+Ligands+%28MTDLs%29+with+Butyrylcholinesterase+%28BuChE%29+and+Indoleamine+2%2C3-Dioxygenase+1+%28IDO1%29+Inhibition%3A+The+Design%2C+Synthesis+of+Miconazole+Analogues+Targeting+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmc.2018.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease</span></div><div class="casAuthors">Lu, Xin; He, Si-yu; Li, Qi; Yang, Hongyu; Jiang, Xueyang; Lin, Hongzhi; Chen, Yao; Qu, Wei; Feng, Feng; Bian, Yaoyao; Zhou, You; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1665-1674</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our endeavor towards the development of potent multi-target ligands for the treatment of Alzheimer's disease, miconazole was identified to show BuChE-IDO1 dual-target inhibitory effects.  Morris water maze test indicated that miconazole obviously ameliorated the cognitive function impaired by scopolamine.  Furthermore, it showed good safety in primary hepatotoxicity evaluation.  Based on these results, we designed, synthesized, and evaluated a series of miconazole derivs. as BuChE-IDO1 dual-target inhibitors.  Out of the 12 compds., 5i and 5j exhibited the best potency in enzymic evaluation, thus were selected for subsequent behavioral study, in which the two compds. exerted much improved effect than tacrine.  Meanwhile, 5i and 5j displayed no apparent hepatotoxicity.  The results suggest that miconazole analog offers an attractive starting point for further development of new BuChE-IDO1 dual-target inhibitors against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFWgipL3NC8bVg90H21EOLACvtfcHk0ljw53EU9w3a0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFakurw%253D&md5=28600c6f86b9f5a30151ff0f0f9c9f58</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DInvestigation%2520of%2520Multi-Target-Directed%2520Ligands%2520%2528MTDLs%2529%2520with%2520Butyrylcholinesterase%2520%2528BuChE%2529%2520and%2520Indoleamine%25202%252C3-Dioxygenase%25201%2520%2528IDO1%2529%2520Inhibition%253A%2520The%2520Design%252C%2520Synthesis%2520of%2520Miconazole%2520Analogues%2520Targeting%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1665%26epage%3D1674%26doi%3D10.1016%2Fj.bmc.2018.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Gonzalez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaldivar-Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccheri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legname, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7640</span>– <span class="NLM_lpage">7656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7640-7656&issue=17&author=A.+Gandiniauthor=M.+Bartoliniauthor=D.+Tedescoauthor=L.+Martinez-Gonzalezauthor=C.+Rocaauthor=N.+E.+Campilloauthor=J.+Zaldivar-Diezauthor=C.+Perezauthor=G.+Zuccheriauthor=A.+Mitiauthor=A.+Feoliauthor=S.+Castellanoauthor=S.+Petrallaauthor=B.+Montiauthor=M.+Rossiauthor=F.+Modaauthor=G.+Legnameauthor=A.+Martinezauthor=M.+L.+Bolognesi&title=Tau-Centric+Multitarget+Approach+for+Alzheimer%E2%80%99s+Disease%3A+Development+of+First-in-Class+Dual+Glycogen+Synthase+Kinase+3%CE%B2+and+Tau-Aggregation+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span></div><div class="casAuthors">Gandini, Annachiara; Bartolini, Manuela; Tedesco, Daniele; Martinez-Gonzalez, Loreto; Roca, Carlos; Campillo, Nuria E.; Zaldivar-Diez, Josefa; Perez, Concepcion; Zuccheri, Giampaolo; Miti, Andrea; Feoli, Alessandra; Castellano, Sabrina; Petralla, Sabrina; Monti, Barbara; Rossi, Martina; Moda, Fabio; Legname, Giuseppe; Martinez, Ana; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7640-7656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several findings propose the altered tau protein network as an important target for Alzheimer's disease (AD).  Particularly, two points of pharmacol. intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process.  On the basis of this consideration and on the authors' interest in multitarget paradigms in AD, the authors report on the discovery of 2,4-thiazolidinedione derivs. endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, resp.  In addn., they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations.  Finally, both compds. were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model.  To the best of the authors' knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compds. hitting tau cascade at two different hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6bQV6XoAhyrVg90H21EOLACvtfcHk0ljw53EU9w3a0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL&md5=34b7e2f2556f3e96c768dd87fb3f0e6d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DMartinez-Gonzalez%26aufirst%3DL.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DZaldivar-Diez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DZuccheri%26aufirst%3DG.%26aulast%3DMiti%26aufirst%3DA.%26aulast%3DFeoli%26aufirst%3DA.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTau-Centric%2520Multitarget%2520Approach%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Development%2520of%2520First-in-Class%2520Dual%2520Glycogen%2520Synthase%2520Kinase%25203%25CE%25B2%2520and%2520Tau-Aggregation%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656%26doi%3D10.1021%2Facs.jmedchem.8b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Novel Multitarget-Directed Ligands Targeting Acetylcholinesterase and Σ1 Receptors as Lead Compounds for Treatment of Alzheimer’s Disease: Synthesis, Evaluation, and Structural Characterization of Their Complexes with Acetylcholinesterase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejmech.2018.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=30447434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=234-248&author=J.+Lalutauthor=G.+Santoniauthor=D.+Karilaauthor=C.+Lecouteyauthor=A.+Davisauthor=F.+Nachonauthor=I.+Silmanauthor=J.+Sussmanauthor=M.+Weikauthor=T.+Mauriceauthor=P.+Dallemagneauthor=C.+Rochais&title=Novel+Multitarget-Directed+Ligands+Targeting+Acetylcholinesterase+and+%CE%A31+Receptors+as+Lead+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Synthesis%2C+Evaluation%2C+and+Structural+Characterization+of+Their+Complexes+with+Acetylcholinesterase&doi=10.1016%2Fj.ejmech.2018.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span></div><div class="casAuthors">Lalut, Julien; Santoni, Gianluca; Karila, Delphine; Lecoutey, Cedric; Davis, Audrey; Nachon, Florian; Silman, Israel; Sussman, Joel; Weik, Martin; Maurice, Tangui; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-248</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pleiotropic intervention may be a requirement for effective limitation of the progression of multifactorial diseases such as Alzheimer's disease.  One approach to such intervention is to design a single chem. entity capable of acting on two or more targets of interest, which are accordingly known as multi-target directed ligands (MTDLs).  We recently described donecopride, the first MTDL able to simultaneously inhibit acetylcholinesterase and act as an agonist of the 5-HT4 receptor, which displays promising activities in vivo.  Pharmacomodulation of donecopride allowed us to develop a novel series of indole derivs. possessing interesting in vitro activities toward AChE and the σ1 receptor.  The crystal structures of complexes of the most promising compds. with Torpedo californica AChE were solved in order to further understand their mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp9tmUk8w_j7Vg90H21EOLACvtfcHk0lgpIX4hmKkSmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF&md5=79dec73e1bf82d5d1b893a81366ea5ef</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DKarila%26aufirst%3DD.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DNovel%2520Multitarget-Directed%2520Ligands%2520Targeting%2520Acetylcholinesterase%2520and%2520%25CE%25A31%2520Receptors%2520as%2520Lead%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Synthesis%252C%2520Evaluation%252C%2520and%2520Structural%2520Characterization%2520of%2520Their%2520Complexes%2520with%2520Acetylcholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D234%26epage%3D248%26doi%3D10.1016%2Fj.ejmech.2018.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudlo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Donepezil-Ferulic Acid Hybrids as Anti-Alzheimer Drugs</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.4155%2Ffmc.14.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=25582330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=15-21&issue=1&author=M.+Benchekrounauthor=L.+Ismailiauthor=M.+Pudloauthor=V.+Luzetauthor=T.+Gharbiauthor=B.+Refouveletauthor=J.+Marco-Contelles&title=Donepezil-Ferulic+Acid+Hybrids+as+Anti-Alzheimer+Drugs&doi=10.4155%2Ffmc.14.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-ferulic acid hybrids as anti-Alzheimer drugs</span></div><div class="casAuthors">Benchekroun, Mohamed; Ismaili, Lhassane; Pudlo, Marc; Luzet, Vincent; Gharbi, Tijani; Refouvelet, Bernard; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: Due to the complex nature of Alzheimer's disease, there is a renewed and growing search for multitarget drugs.  Results: Donepezil-ferulic acid hybrids (DFAHs) were prepd. by the one-pot Ugi-4CR in low-to-moderate yields.  DFAHs are potent antioxidant agents, showing oxygen radical absorbance capacity values in the range 4.80-8.71 trolox equiv., quite higher compared with those recorded for ferulic acid and melatonin.  From the ChEs inhibition studies, we conclude that DFAH 8, bearing an ethylene linker, and DFAH 12, bearing a propylene linker, both substituted with a melatonin motif, are the most potent inhibitors, in the nanomolar range.  Conclusion: We have identified DFAH 8 as a very potent antioxidant, and totally selective equineButyrylCholinEsterase (eqBuChE) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3IPtYAohxbVg90H21EOLACvtfcHk0lgpIX4hmKkSmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1Ortw%253D%253D&md5=0917757e5b81e0e40508aa3649ffcba9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.148%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DPudlo%26aufirst%3DM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DGharbi%26aufirst%3DT.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDonepezil-Ferulic%2520Acid%2520Hybrids%2520as%2520Anti-Alzheimer%2520Drugs%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D15%26epage%3D21%26doi%3D10.4155%2Ffmc.14.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendía, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refouvelet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span> <span> </span><span class="NLM_article-title">The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9967</span>– <span class="NLM_lpage">9973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9967-9973&issue=21&author=M.+Benchekrounauthor=A.+Romeroauthor=J.+Egeaauthor=R.+Le%C3%B3nauthor=P.+Michalskaauthor=I.+Buend%C3%ADaauthor=M.+L.+Jimenoauthor=D.+Junauthor=J.+Janockovaauthor=V.+Sepsovaauthor=O.+Soukupauthor=O.+M.+Bautista-Aguileraauthor=B.+Refouveletauthor=O.+Ouariauthor=J.+Marco-Contellesauthor=L.+Ismaili&title=The+Antioxidant+Additive+Approach+for+Alzheimer%E2%80%99s+Disease+Therapy%3A+New+Ferulic+%28Lipoic%29+Acid+Plus+Melatonin+Modified+Tacrines+as+Cholinesterases+Inhibitors%2C+Direct+Antioxidants%2C+and+Nuclear+Factor+%28Erythroid-Derived+2%29-Like+2+Activators&doi=10.1021%2Facs.jmedchem.6b01178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators</span></div><div class="casAuthors">Benchekroun, Mohamed; Romero, Alejandro; Egea, Javier; Leon, Rafael; Michalska, Patrycja; Buendia, Izaskun; Jimeno, Maria Luisa; Jun, Daniel; Janockova, Jana; Sepsova, Vendula; Soukup, Ondrej; Bautista-Aguilera, Oscar M.; Refouvelet, Bernard; Ouari, Olivier; Marco-Contelles, Jose; Ismaili, Lhassane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9967-9973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel multifunctional tacrines for Alzheimer's disease were obtained by Ugi-reaction between ferulic (or lipoic acid), a melatonin-like isocyanide, formaldehyde, and tacrine derivs., according to the antioxidant additive approach in order to modulate the oxidative stress as therapeutic strategy.  Compd. 5c has been identified as a promising permeable agent showing excellent antioxidant properties, strong cholinesterase inhibitory activity, less hepatotoxicity than tacrine, and the best neuroprotective capacity, being able to significantly activate the Nrf2 transcriptional pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRkji0fKQbkLVg90H21EOLACvtfcHk0li6FU4GqIAiXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7I&md5=45f0be476d96a6f40ccb377634ceb699</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01178%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DMichalska%26aufirst%3DP.%26aulast%3DBuend%25C3%25ADa%26aufirst%3DI.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3DOuari%26aufirst%3DO.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DThe%2520Antioxidant%2520Additive%2520Approach%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%253A%2520New%2520Ferulic%2520%2528Lipoic%2529%2520Acid%2520Plus%2520Melatonin%2520Modified%2520Tacrines%2520as%2520Cholinesterases%2520Inhibitors%252C%2520Direct%2520Antioxidants%252C%2520and%2520Nuclear%2520Factor%2520%2528Erythroid-Derived%25202%2529-Like%25202%2520Activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D21%26spage%3D9967%26epage%3D9973%26doi%3D10.1021%2Facs.jmedchem.6b01178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Carmo Carreiras, M.</span></span> <span> </span><span class="NLM_article-title">Multicomponent Reactions for Multitargeted Compounds for Alzheimer̀s Disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">3319</span>– <span class="NLM_lpage">3327</span>, <span class="refDoi"> DOI: 10.2174/1568026618666180112155424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F1568026618666180112155424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=3319-3327&issue=31&author=L.+Ismailiauthor=M.+do+Carmo+Carreiras&title=Multicomponent+Reactions+for+Multitargeted+Compounds+for+Alzheimer%CC%80s+Disease&doi=10.2174%2F1568026618666180112155424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026618666180112155424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666180112155424%26sid%3Dliteratum%253Aachs%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3Ddo%2BCarmo%2BCarreiras%26aufirst%3DM.%26atitle%3DMulticomponent%2520Reactions%2520for%2520Multitargeted%2520Compounds%2520for%2520Alzheimer%25CC%2580s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D17%26issue%3D31%26spage%3D3319%26epage%3D3327%26doi%3D10.2174%2F1568026618666180112155424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sander, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine H3 Receptor Antagonists Go to Clinics</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1248/bpb.31.2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1248%2Fbpb.31.2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19043195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=2163-2181&issue=12&author=K.+Sanderauthor=T.+Kottkeauthor=H.+Stark&title=Histamine+H3+Receptor+Antagonists+Go+to+Clinics&doi=10.1248%2Fbpb.31.2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor antagonists go to clinics</span></div><div class="casAuthors">Sander, Kerstin; Kottke, Tim; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-2181</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Within the recent years novel lead optimizations for histamine H3 receptor antagonists made their way from bench to bedside.  Structure-activity relationships, cross-affinities and side effects as well as pharmacokinetic profiling will be discussed on selected promising compd. series.  Due to diversity in potential therapeutic applications and in some cases a controversial debate, different indications will be highlighted with the potential and the problems of the test compds., e.g. sleep-wake disorders, attention-deficient hyperactivity disorder, epilepsy, cognitive impairment, schizophrenia, obesity and neuropathic pain.  First data published on clin. trials phase II (IIb) are presented showing proof of concept of H3 receptor antagonists in narcolepsy and photoinduced epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJWogrOu3mmbVg90H21EOLACvtfcHk0li6FU4GqIAiXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D&md5=b816371be0c006bef83d279a426fee45</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1248%2Fbpb.31.2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.31.2163%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DK.%26aulast%3DKottke%26aufirst%3DT.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520H3%2520Receptor%2520Antagonists%2520Go%2520to%2520Clinics%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D31%26issue%3D12%26spage%3D2163%26epage%3D2181%26doi%3D10.1248%2Fbpb.31.2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanfar, M. A.</span>; <span class="NLM_string-name">Affini, A.</span>; <span class="NLM_string-name">Lutsenko, K.</span>; <span class="NLM_string-name">Nikolic, K.</span>; <span class="NLM_string-name">Butini, S.</span>; <span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multiple Targeting Approaches on Histamine H3 Receptor Antagonists</span>.  <i>Front. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">10</span>, <span class="refDoi"> DOI: 10.3389/fnins.2016.00201</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3389%2Ffnins.2016.00201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=27303254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&author=M.+A.+Khanfar&author=A.+Affini&author=K.+Lutsenko&author=K.+Nikolic&author=S.+Butini&author=H.+Stark&title=Multiple+Targeting+Approaches+on+Histamine+H3+Receptor+Antagonists&doi=10.3389%2Ffnins.2016.00201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00201%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26atitle%3DMultiple%2520Targeting%2520Approaches%2520on%2520Histamine%2520H3%2520Receptor%2520Antagonists%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26doi%3D10.3389%2Ffnins.2016.00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farré-Alins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffrin, P.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janočková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwed, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12765</span>– <span class="NLM_lpage">12769</span>, <span class="refDoi"> DOI: 10.1002/anie.201706072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Fanie.201706072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12765-12769&issue=41&author=%C3%93.+M.+Bautista-Aguileraauthor=S.+Hagenowauthor=A.+Palomino-Antolinauthor=V.+Farr%C3%A9-Alinsauthor=L.+Ismailiauthor=P.-L.+Joffrinauthor=M.+L.+Jimenoauthor=O.+Soukupauthor=J.+Jano%C4%8Dkov%C3%A1author=L.+Kalinowskyauthor=E.+Proschakauthor=I.+Iriepaauthor=I.+Moraledaauthor=J.+S.+Schwedauthor=A.+Romero+Mart%C3%ADnezauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=M.+Chiouaauthor=J.+Egeaauthor=R.+R.+Ramsayauthor=J.+Marco-Contellesauthor=H.+Stark&title=Multitarget-Directed+Ligands+Combining+Cholinesterase+and+Monoamine+Oxidase+Inhibition+with+Histamine+H3+R+Antagonism+for+Neurodegenerative+Diseases&doi=10.1002%2Fanie.201706072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Hagenow, Stefanie; Palomino-Antolin, Alejandra; Farre-Alins, Victor; Ismaili, Lhassane; Joffrin, Pierre-Louis; Jimeno, Maria L.; Soukup, Ondrej; Janockova, Jana; Kalinowsky, Lena; Proschak, Ewgenij; Iriepa, Isabel; Moraleda, Ignacio; Schwed, Johannes S.; Romero Martinez, Alejandro; Lopez-Munoz, Francisco; Chioua, Mourad; Egea, Javier; Ramsay, Rona R.; Marco-Contelles, Jose; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12765-12769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapy of complex neurodegenerative diseases requires the development of multitarget-directed drugs (MTDs).  Novel indole derivs. with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs.  These small-mol. hits demonstrated balanced activities at the targets, mostly in the nanomolar concn. range.  Addnl. in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood-brain barrier.  With this promising in vitro profile, contilisant (at 1 mg kg-1 i.p.) also significantly improved lipopolysaccharide-induced cognitive deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2wNLAClUFULVg90H21EOLACvtfcHk0li4TF15SXPT3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekt73L&md5=4a962ad1ada3f5b8e8102add09cd4e60</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706072%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9-Alins%26aufirst%3DV.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DJoffrin%26aufirst%3DP.-L.%26aulast%3DJimeno%26aufirst%3DM.%2BL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJano%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DSchwed%26aufirst%3DJ.%2BS.%26aulast%3DRomero%2BMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultitarget-Directed%2520Ligands%2520Combining%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibition%2520with%2520Histamine%2520H3%2520R%2520Antagonism%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12765%26epage%3D12769%26doi%3D10.1002%2Fanie.201706072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista-Aguilera, Ó. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Contilisant, a Tetratarget Small Molecule for Alzheimer’s Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6937</span>– <span class="NLM_lpage">6943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6937-6943&issue=15&author=%C3%93.+M.+Bautista-Aguileraauthor=J.+Budniauthor=F.+Minaauthor=E.+B.+Medeirosauthor=W.+Deuther-Conradauthor=J.+M.+Entrenaauthor=I.+Moraledaauthor=I.+Iriepaauthor=F.+L%C3%B3pez-Mu%C3%B1ozauthor=J.+Marco-Contelles&title=Contilisant%2C+a+Tetratarget+Small+Molecule+for+Alzheimer%E2%80%99s+Disease+Therapy+Combining+Cholinesterase%2C+Monoamine+Oxidase+Inhibition%2C+and+H3R+Antagonism+with+S1R+Agonism+Profile&doi=10.1021%2Facs.jmedchem.8b00848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile</span></div><div class="casAuthors">Bautista-Aguilera, Oscar M.; Budni, Josiane; Mina, Francielle; Medeiros, Eduarda Behenck; Deuther-Conrad, Winnie; Entrena, Jose M.; Moraleda, Ignacio; Iriepa, Isabel; Lopez-Munoz, Francisco; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6937-6943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Contilisant, a permeable, antioxidant, and neuroprotectant agent, showing high nM affinity at H3R and excellent inhibition of the monoamine oxidases and cholinesterases, is an affine and selective S1R agonist in the nanomolar range, based on the binding affinity and functional expt., a result confirmed by mol. modeling.  In addn., contilisant significantly restores the cognitive deficit induced by Aβ1-42 in the radial maze assay in an in vivo Alzheimer's disease test, comparing very favorably with donepezil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRam68D-99zLVg90H21EOLACvtfcHk0ljigmA9XakPkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Cqu7nM&md5=526d2eedfb4f6ae6f69a4116f87a633a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00848%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3D%25C3%2593.%2BM.%26aulast%3DBudni%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DF.%26aulast%3DMedeiros%26aufirst%3DE.%2BB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DContilisant%252C%2520a%2520Tetratarget%2520Small%2520Molecule%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapy%2520Combining%2520Cholinesterase%252C%2520Monoamine%2520Oxidase%2520Inhibition%252C%2520and%2520H3R%2520Antagonism%2520with%2520S1R%2520Agonism%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6937%26epage%3D6943%26doi%3D10.1021%2Facs.jmedchem.8b00848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine Receptor Subtypes: A Century of Rational Drug Design</span>. <i>Front. Biosci., Scholar Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>S4</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.2741/s279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2741%2Fs279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=S4&publication_year=2012&pages=461-488&author=M.+Walterauthor=H.+Stark&title=Histamine+Receptor+Subtypes%3A+A+Century+of+Rational+Drug+Design&doi=10.2741%2Fs279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine receptor subtypes: a century of rational drug design</span></div><div class="casAuthors">Walter, Miriam; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Scholar Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">S4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-488</span>CODEN:
                <span class="NLM_cas:coden">FBSEAU</span>;
        ISSN:<span class="NLM_cas:issn">1945-0524</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Histamine plays an important role as neurotransmitter and chem. mediator in multiple physiol. and pathophysiol. processes in central and peripheral tissues.  In the last century the extensive study of its actions in the human body, resulted in the identification of four G protein-coupled receptor (GPCR) subtypes (H1R-H4R), mediating numerous effects.  The successful application of H1R and H2R antagonists/inverse agonists in the treatment of allergic conditions and gastric ulcer proved that these two receptors are excellent drug targets.  Ligands for H3R are currently in advanced stages of clin. development for a broad spectrum of mainly central diseases (e.g. narcolepsy, Alzheimer's disease, epilepsy and schizophrenia).  Meanwhile, preclin. research in the H4R field, focused on inflammatory and immunol. processes, led to the evaluation of the first H4R-targeting clin. candidates.  Drug development for each histamine receptor subtype will be discussed with a special focus on H3R and H4R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-sUaIiMMirVg90H21EOLACvtfcHk0ljigmA9XakPkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOiu7%252FK&md5=12b72aece130626390bf1c831d30b3a5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2741%2Fs279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fs279%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DM.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520Receptor%2520Subtypes%253A%2520A%2520Century%2520of%2520Rational%2520Drug%2520Design%26jtitle%3DFront.%2520Biosci.%252C%2520Scholar%2520Ed.%26date%3D2012%26volume%3DS4%26spage%3D461%26epage%3D488%26doi%3D10.2741%2Fs279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbroek, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiabi, B.</span></span> <span> </span><span class="NLM_article-title">The Other Side of the Histamine H3 Receptor</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2014.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.tins.2014.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24636456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkt1Sgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=191-199&issue=4&author=B.+A.+Ellenbroekauthor=B.+Ghiabi&title=The+Other+Side+of+the+Histamine+H3+Receptor&doi=10.1016%2Fj.tins.2014.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The other side of the histamine H3 receptor</span></div><div class="casAuthors">Ellenbroek, Bart A.; Ghiabi, Bibinaz</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-199</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although histamine H3 receptors are predominantly known as presynaptic receptors, regulating the release of neurotransmitters such as dopamine, acetylcholine, and histamine, in the striatal complex the vast majority of these receptors are actually located on the other side, in other words postsynaptically.  Given their strategic location, they can crucially affect signaling throughout the basal ganglia.  We describe the anatomy and function of H3 receptors within the basal ganglia with a specific focus on their colocalization with dopamine D1 and D2 receptors.  Because the basal ganglia are centrally involved in several major neurol. and psychiatric disorders, we also discuss the therapeutic potential of drugs targeting H3 receptors in the treatment of Parkinson disease (PD), schizophrenia, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCTyvYOgmdA7Vg90H21EOLACvtfcHk0lhBOJntgYTs4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkt1Sgtbk%253D&md5=a70fb6db22985403ec87e2fef7199a5b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2014.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2014.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DEllenbroek%26aufirst%3DB.%2BA.%26aulast%3DGhiabi%26aufirst%3DB.%26atitle%3DThe%2520Other%2520Side%2520of%2520the%2520Histamine%2520H3%2520Receptor%26jtitle%3DTrends%2520Neurosci.%26date%3D2014%26volume%3D37%26issue%3D4%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.tins.2014.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Łazewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Histamine H3 Receptor Antagonists/Inverse Agonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.509346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1517%2F13543776.2010.509346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=20716022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1147-1169&issue=9&author=D.+%C5%81azewskaauthor=K.+Kie%C4%87-Kononowicz&title=Recent+Advances+in+Histamine+H3+Receptor+Antagonists%2FInverse+Agonists&doi=10.1517%2F13543776.2010.509346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in histamine H3 receptor antagonists/inverse agonists</span></div><div class="casAuthors">Lazewska, Dorota; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1147-1169</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Histamine H3 receptor (H3R) antagonists/inverse agonists can be therapeutically useful in the treatment of various CNS, metabolic syndrome and allergic disorders, and constitute an attractive target in the search for new drugs.  However, several drug candidates have been rejected because of unwanted effects.  There is, therefore, a strong need to develop new H3R ligands.  Areas covered in this review: A review was conducted of recent advances in the search for H3R antagonists/inverse agonists as reflected by patent applications/patents over the last 3 years.  What the reader will gain: A total of around 100 patent applications/patents along with selected peer-reviewed publications are surveyed.  These involve antagonists/inverse agonists of H3R, which the authors have divided into five groups.  The above-mentioned compds. were evaluated for their potential utility in the treatment of narcolepsy, attention deficit hyperactivity disorder, epilepsy, Alzheimer's disease, schizophrenia, obesity and neuropathic pain.  Take home message: Several H3R antagonists/inverse agonists appear to be promising drug candidates, including at least 15 compds. undergoing evaluation in clin. development.  Esp. interesting is pitolisant, which is progressing through to Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVSNfy6q5wrVg90H21EOLACvtfcHk0lhBOJntgYTs4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCntLnE&md5=033312a9f907c9b0b7d6652977b3cbc5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.509346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.509346%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581azewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DRecent%2520Advances%2520in%2520Histamine%2520H3%2520Receptor%2520Antagonists%252FInverse%2520Agonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D1147%26epage%3D1169%26doi%3D10.1517%2F13543776.2010.509346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jończyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Strategies for Alzheimer’s Disease in Clinical Trials</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2015.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.pharep.2015.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26721364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=127-138&issue=1&author=J.+Gody%C5%84author=J.+Jo%C5%84czykauthor=D.+Panekauthor=B.+Malawska&title=Therapeutic+Strategies+for+Alzheimer%E2%80%99s+Disease+in+Clinical+Trials&doi=10.1016%2Fj.pharep.2015.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies for Alzheimer's disease in clinical trials</span></div><div class="casAuthors">Godyn, Justyna; Jonczyk, Jakub; Panek, Dawid; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is considered to be the most common cause of dementia and is an incurable, progressive neurodegenerative disorder.  Current treatment of the disease, essentially symptomatic, is based on three cholinesterase inhibitors and memantine, affecting the glutamatergic system.  Since 2003, no new drugs have been approved for treatment of AD.  This article presents current directions in the search for novel, potentially effective agents for the treatment of AD, as well as selected promising treatment strategies.  These include agents acting upon the beta-amyloid, such as vaccines, antibodies and inhibitors or modulators of γ- and β-secretase; agents directed against the tau protein as well as compds. acting as antagonists of neurotransmitter systems (serotoninergic 5-HT6 and histaminergic H3).  Ongoing clin. trials with Aβ antibodies (solanezumab, gantenerumab, crenezumab) seem to be promising, while vaccines against the tau protein (AADvac1 and ACI-35) are now in early-stage trials.  Interesting results have also been achieved in trials involving small mols. such as inhibitors of β-secretase (MK-8931, E2609), a combination of 5-HT6 antagonist (idalopirdine) with donepezil, inhibition of advanced glycation end product receptors by azeliragon or modulation of the acetylcholine response of α-7 nicotinic acetylcholine receptors by encenicline.  Development of new effective drugs acting upon the central nervous system is usually a difficult and time-consuming process, and in the case of AD to-date clin. trials have had a very high failure rate.  Most phase II clin. trials ending with a pos. outcome do not succeed in phase III, often due to serious adverse effects or lack of therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC2G55auOP27Vg90H21EOLACvtfcHk0lhBOJntgYTs4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslKrsb0%253D&md5=e3f4010a5408a836683024db61164ae2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2015.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2015.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DJo%25C5%2584czyk%26aufirst%3DJ.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DTherapeutic%2520Strategies%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520in%2520Clinical%2520Trials%26jtitle%3DPharmacol.%2520Rep.%26date%3D2016%26volume%3D68%26issue%3D1%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.pharep.2015.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tone, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Increased NF-ΚB Signalling up-Regulates BACE1 Expression and Its Therapeutic Potential in Alzheimer’s Disease</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1017/S1461145711000149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1017%2FS1461145711000149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=21329555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38XksValsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=77-90&issue=1&author=C.-H.+Chenauthor=W.+Zhouauthor=S.+Liuauthor=Y.+Dengauthor=F.+Caiauthor=M.+Toneauthor=Y.+Toneauthor=Y.+Tongauthor=W.+Song&title=Increased+NF-%CE%9AB+Signalling+up-Regulates+BACE1+Expression+and+Its+Therapeutic+Potential+in+Alzheimer%E2%80%99s+Disease&doi=10.1017%2FS1461145711000149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease</span></div><div class="casAuthors">Chen, Chia-Hsiung; Zhou, Weihui; Liu, Shengchun; Deng, Yu; Cai, Fang; Tone, Masahide; Tone, Yukiko; Tong, Yigang; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-90</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Elevated levels of β-site APP cleaving enzyme 1 (BACE1) were found in the brain of some sporadic Alzheimer's disease (AD) patients; however, the underlying mechanism is unknown.  BACE1 cleaves β-amyloid precursor protein (APP) to generate amyloid β protein (Aβ), a central component of neuritic plaques in AD brains.  Nuclear factor-kappa B (NF-κB) signalling plays an important role in gene regulation and is implicated in inflammation, oxidative stress and apoptosis.  In this report we found that both BACE1 and NF-κB p65 levels were significantly increased in the brains of AD patients.  Two functional NF-κB-binding elements were identified in the human BACE1 promoter region.  We found that NF-κB p65 expression resulted in increased BACE1 promoter activity and BACE1 transcription, while disruption of NF-κB p65 decreased BACE1 gene expression in p65 knockout (RelA-knockout) cells.  In addn., NF-κB p65 expression leads to up-regulated β-secretase cleavage and Aβ prodn., while non-steroidal anti-inflammatory drugs (NSAIDs) inhibited BACE1 transcriptional activation induced by strong NF-κB activator tumor necrosis factor-alpha (TNF-α).  Taken together, our results clearly demonstrate that NF-κB signalling facilitates BACE1 gene expression and APP processing, and increased BACE1 expression mediated by NF-κB signalling in the brain could be one of the novel mol. mechanisms underlying the development of AD in some sporadic cases.  Furthermore, NSAIDs could block the inflammation-induced BACE1 transcription and Aβ prodn.  Our study suggests that inhibition of NF-κB-mediated BACE1 expression may be a valuable drug target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hkA7XSgYLVg90H21EOLACvtfcHk0lhdTk-DddptQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksValsbk%253D&md5=ccbec29126abde16c207a8960edec470</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000149%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DTone%26aufirst%3DM.%26aulast%3DTone%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DIncreased%2520NF-%25CE%259AB%2520Signalling%2520up-Regulates%2520BACE1%2520Expression%2520and%2520Its%2520Therapeutic%2520Potential%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D77%26epage%3D90%26doi%3D10.1017%2FS1461145711000149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Disrupted Intracellular Calcium Regulates BACE1 Gene Expression via Nuclear Factor of Activated T Cells 1 (NFAT 1) Signaling</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1111/j.1474-9726.2007.00360.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1111%2Fj.1474-9726.2007.00360.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=18081741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFeiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=137-147&issue=2&author=H.+J.+Choauthor=S.+M.+Jinauthor=H.+D.+Younauthor=K.+Huhauthor=I.+Mook-Jung&title=Disrupted+Intracellular+Calcium+Regulates+BACE1+Gene+Expression+via+Nuclear+Factor+of+Activated+T+Cells+1+%28NFAT+1%29+Signaling&doi=10.1111%2Fj.1474-9726.2007.00360.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling</span></div><div class="casAuthors">Cho, Hyun Jin; Jin, Seok Min; Youn, Hong Deuk; Huh, Kyoon; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-147</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Beta-site APP-cleaving enzyme 1 (BACE1) expression is elevated in the brains of Alzheimer's disease (AD) patients and in aged-animal models.  Because both AD and aging are assocd. with disrupted calcium homeostasis, we investigated the role of nuclear factor of activated T cells (NFAT) - a transcription factor regulated by the calcium- and calmodulin-dependent phosphatase calcineurin - in BACE1 expression.  BACE1 expression was stimulated by a calcium ionophore in primary cortical cultures, and by SH-SY5Y neuroblastoma cells, which was both blocked by pretreatment with either cyclosporin A, an inhibitor of calcineurin, or ethyleneglycotetraacetic acid, a calcium chelator.  Gel shift assays revealed direct binding of NFAT1 to specific DNA sequences within the BACE1 gene promoter region.  Treatment with amyloid beta (Aβ), one of the major factors in AD pathogenesis, stimulated activation and nuclear translocation of NFAT1 following up-regulation of BACE1 expression.  In addn., primary cortical cultures from Tg2576 mouse brains generated more Aβ by ionophore stimulation, which was reversed by cyclosporin A treatment.  Furthermore, NFAT1 activation was obsd. in Tg2576 mouse brains.  These results suggest that calcium ionophore- or Aβ-induced increases in intracellular calcium concn. stimulate BACE1 expression, resulting in accelerated Aβ generation, and that this process is mediated through the calcineurin-NFAT1 signaling pathway.  This process may play a significant role in the pathogenesis of AD and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhztAlL7sfUbVg90H21EOLACvtfcHk0lhdTk-DddptQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFeiurk%253D&md5=df279f17e021841a3ef6705694131fb3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1474-9726.2007.00360.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1474-9726.2007.00360.x%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DJin%26aufirst%3DS.%2BM.%26aulast%3DYoun%26aufirst%3DH.%2BD.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DDisrupted%2520Intracellular%2520Calcium%2520Regulates%2520BACE1%2520Gene%2520Expression%2520via%2520Nuclear%2520Factor%2520of%2520Activated%2520T%2520Cells%25201%2520%2528NFAT%25201%2529%2520Signaling%26jtitle%3DAging%2520Cell%26date%3D2008%26volume%3D7%26issue%3D2%26spage%3D137%26epage%3D147%26doi%3D10.1111%2Fj.1474-9726.2007.00360.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perspicace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulthess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seelig, J.</span></span> <span> </span><span class="NLM_article-title">Calcium Enhances the Proteolytic Activity of BACE1: An in Vitro Biophysical and Biochemical Characterization of the BACE1-Calcium Interaction</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1788</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1933</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2009.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bbamem.2009.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19486882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVensbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1788&publication_year=2009&pages=1933-1938&issue=9&author=M.+Hayleyauthor=S.+Perspicaceauthor=T.+Schulthessauthor=J.+Seelig&title=Calcium+Enhances+the+Proteolytic+Activity+of+BACE1%3A+An+in+Vitro+Biophysical+and+Biochemical+Characterization+of+the+BACE1-Calcium+Interaction&doi=10.1016%2Fj.bbamem.2009.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium enhances the proteolytic activity of BACE1: An in vitro biophysical and biochemical characterization of the BACE1-calcium interaction</span></div><div class="casAuthors">Hayley, Michael; Perspicace, Samantha; Schulthess, Therese; Seelig, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1788</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1933-1938</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a novel type I transmembrane aspartic protease that has been implicated in the pathogenesis of Alzheimer's disease.  Cleavage of the amyloid precursor protein by BACE1 is the 1st step in the prodn. of the Aβ peptide and is a prime target for therapeutic intervention.  Here, using CD, the authors reveal that the secondary structure of BACE1 in a membrane environment is significantly different from what was detd. from the previously resolved crystal structure, and, the authors provide the 1st evidence that shows differences in stability between the active (pH 4.8) and inactive (pH 7.4) forms of BACE1.  Hee, the authors also examd. Ca2+ binding to BACE1, the effect of this binding on the secondary and tertiary structural characteristics of BACE1, and the influence of this binding on the specific activity of the purified protein.  CD and endogenous Trp fluorescence measurements demonstrated that the secondary and tertiary structures, resp., were sensitive to increasing concns. of Ca2+.  Isothermal titrn. calorimetry was then used to characterize the Ca2+-BACE1 interaction in greater detail.  The results suggested that there is a high binding affinity (Kd = 2.0 μM) between Ca2+ and BACE1 and that the binding process was exothermic (ΔH = -3.5 kcal/mol).  The authors also demonstrated that low concns. of Ca2+ (micromolar range) significantly increased the proteolytic activity of BACE1.  Collectively, these results identified a direct interaction between BACE1 and Ca2+ and suggested that under physiol. conditions, the function(s) of BACE1 must also be influenced by Ca2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4kM-aQQTQbVg90H21EOLACvtfcHk0lhRlgDct0vOnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVensbnL&md5=41b9284b994826c5ec9196dfbe344804</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2009.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2009.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DHayley%26aufirst%3DM.%26aulast%3DPerspicace%26aufirst%3DS.%26aulast%3DSchulthess%26aufirst%3DT.%26aulast%3DSeelig%26aufirst%3DJ.%26atitle%3DCalcium%2520Enhances%2520the%2520Proteolytic%2520Activity%2520of%2520BACE1%253A%2520An%2520in%2520Vitro%2520Biophysical%2520and%2520Biochemical%2520Characterization%2520of%2520the%2520BACE1-Calcium%2520Interaction%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2009%26volume%3D1788%26issue%3D9%26spage%3D1933%26epage%3D1938%26doi%3D10.1016%2Fj.bbamem.2009.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oulès, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Prete, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevalle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterlini-Bréchot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trebak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfenati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chami, M.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">11820</span>– <span class="NLM_lpage">11834</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0875-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1523%2FJNEUROSCI.0875-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=22915123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=11820-11834&issue=34&author=B.+Oul%C3%A8sauthor=D.+Del+Preteauthor=B.+Grecoauthor=X.+Zhangauthor=I.+Lauritzenauthor=J.+Sevalleauthor=S.+Morenoauthor=P.+Paterlini-Br%C3%A9chotauthor=M.+Trebakauthor=F.+Checlerauthor=F.+Benfenatiauthor=M.+Chami&title=Ryanodine+Receptor+Blockade+Reduces+Amyloid-%CE%B2+Load+and+Memory+Impairments+in+Tg2576+Mouse+Model+of+Alzheimer+Disease&doi=10.1523%2FJNEUROSCI.0875-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease</span></div><div class="casAuthors">Oules, Benedicte; Del Prete, Dolores; Greco, Barbara; Zhang, Xuexin; Lauritzen, Inger; Sevalle, Jean; Moreno, Sebastien; Paterlini-Brechot, Patrizia; Trebak, Mohamed; Checler, Frederic; Benfenati, Fabio; Chami, Mounia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">11820-11834</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca2+) homeostasis has been linked to presenilins, the catalytic core in γ-secretase complexes cleaving the amyloid precursor protein (APP), thereby generating amyloid-β (Aβ) peptides.  Here we investigate whether APP contributes to ER Ca2+ homeostasis and whether ER Ca2+ could in turn influence Aβ prodn.  We show that overexpression of wild-type human APP (APP695), or APP harboring the Swedish double mutation (APPswe) triggers increased ryanodine receptor (RyR) expression and enhances RyR-mediated ER Ca2+ release in SH-SY5Y neuroblastoma cells and in APPswe-expressing (Tg2576) mice.  Interestingly, dantrolene-induced lowering of RyR-mediated Ca2+ release leads to the redn. of both intracellular and extracellular Aβ load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice.  This Aβ redn. can be accounted for by decreased Thr-668-dependent APP phosphorylation and β- and γ-secretases activities.  Importantly, dantrolene diminishes Aβ load, reduces Aβ-related histol. lesions, and slows down learning and memory deficits in Tg2576 mice.  Overall, our data document a key role of RyR in Aβ prodn. and learning and memory performances, and delineate RyR-mediated control of Ca2+ homeostasis as a physiol. paradigm that could be targeted for innovative therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo86SjeELAf_rVg90H21EOLACvtfcHk0lhRlgDct0vOnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrzN&md5=89e8e7b64e00518d8ec4bcc8189c907a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0875-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0875-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DOul%25C3%25A8s%26aufirst%3DB.%26aulast%3DDel%2BPrete%26aufirst%3DD.%26aulast%3DGreco%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLauritzen%26aufirst%3DI.%26aulast%3DSevalle%26aufirst%3DJ.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DPaterlini-Br%25C3%25A9chot%26aufirst%3DP.%26aulast%3DTrebak%26aufirst%3DM.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DBenfenati%26aufirst%3DF.%26aulast%3DChami%26aufirst%3DM.%26atitle%3DRyanodine%2520Receptor%2520Blockade%2520Reduces%2520Amyloid-%25CE%25B2%2520Load%2520and%2520Memory%2520Impairments%2520in%2520Tg2576%2520Mouse%2520Model%2520of%2520Alzheimer%2520Disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26issue%3D34%26spage%3D11820%26epage%3D11834%26doi%3D10.1523%2FJNEUROSCI.0875-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasperini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foa, L.</span></span> <span> </span><span class="NLM_article-title">The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer’s Disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.3233%2FJAD-2009-0951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19221414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=225-233&issue=2&author=D.+H.+Smallauthor=R.+Gasperiniauthor=A.+J.+Vincentauthor=A.+C.+Hungauthor=L.+Foa&title=The+Role+of+A%CE%B2-Induced+Calcium+Dysregulation+in+the+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2009-0951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease</span></div><div class="casAuthors">Small, David H.; Gasperini, Robert; Vincent, Adele J.; Hung, Amos C.; Foa, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Although many of the biochem. mechanisms which regulate prodn. or clearance of the amyloid-β protein (Aβ) of Alzheimer's disease (AD) are now well understood, the mechanism of Aβ neurotoxicity remains unclear.  A no. of studies have shown that Aβ can disrupt neuronal Ca2+ homeostasis by inducing influx of extracellular Ca2+ into the neuronal cytoplasm.  Ca2+ is known to play an important role in neuronal excitability, synaptic plasticity and neurotoxicity.  Therefore, Aβ-induced Ca2+ dysregulation may contribute to many of the cognitive and neuropathol. features of AD.  In vitro studies show that Aβ can increase ion permeability in lipid membranes.  This increased permeability is reportedly assocd. with the formation of artificial ion pores formed from Aβ oligomers.  However, a no. of other studies show that Aβ can activate endogenous ion channels on the cell surface.  There is also increasing evidence that presenilin mutations alter intracellular Ca2+ stores.  It is likely that elucidation of the mechanism by which Aβ and presenilin cause Ca2+ dysregulation in neurons will help to identify new drug targets for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ss7jA9bMJbVg90H21EOLACvtfcHk0lhRlgDct0vOnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCku7g%253D&md5=62e8292884b2e7fb37ca80ac66ed2df4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0951%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DGasperini%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DA.%2BJ.%26aulast%3DHung%26aufirst%3DA.%2BC.%26aulast%3DFoa%26aufirst%3DL.%26atitle%3DThe%2520Role%2520of%2520A%25CE%25B2-Induced%2520Calcium%2520Dysregulation%2520in%2520the%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26issue%3D2%26spage%3D225%26epage%3D233%26doi%3D10.3233%2FJAD-2009-0951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. J.</span></span> <span> </span><span class="NLM_article-title">Tau in Neurodegenerative Diseases: Tau Phosphorylation and Assembly</span>. <i>Neurotoxic. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1007/BF03033284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1007%2FBF03033284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=15639780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FhsVCmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=477-482&issue=6&author=J.+Avilaauthor=M.+P%C3%A9rezauthor=F.+Limauthor=A.+G%C3%B3mez-Ramosauthor=F.+Hern%C3%A1ndezauthor=J.+J.+Lucas&title=Tau+in+Neurodegenerative+Diseases%3A+Tau+Phosphorylation+and+Assembly&doi=10.1007%2FBF03033284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in neurodegenerative diseases: tau phosphorylation and assembly</span></div><div class="casAuthors">Avila J; Perez M; Lim F; Gomez-Ramos A; Hernandez F; Lucas J J</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">477-82</span>
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    </div><div class="casAbstract">The possible link between tau phosphorylation and tau assembly in these neurodegenerative diseases known as tauopathies is described.  Additionally, this link is supported by an in vitro experiment showing the higher capacity of phosphotau to assemble in some specific conditions; and, by a recently reported experiment using a tau transgenic mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFoPt56svAgcKL0FlyGHDofW6udTcc2eaYTZXidNudE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FhsVCmsQ%253D%253D&md5=504900fa227173ce8ca9c7093a3294a0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF03033284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033284%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DG%25C3%25B3mez-Ramos%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DTau%2520in%2520Neurodegenerative%2520Diseases%253A%2520Tau%2520Phosphorylation%2520and%2520Assembly%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2004%26volume%3D6%26issue%3D6%26spage%3D477%26epage%3D482%26doi%3D10.1007%2FBF03033284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakroborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzmann, G. E.</span></span> <span> </span><span class="NLM_article-title">Calcium Channelopathies and Alzheimer’s Disease: Insight into Therapeutic Success and Failures</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>739</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejphar.2013.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=24316360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVShur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=739&publication_year=2014&pages=83-95&author=S.+Chakrobortyauthor=G.+E.+Stutzmann&title=Calcium+Channelopathies+and+Alzheimer%E2%80%99s+Disease%3A+Insight+into+Therapeutic+Success+and+Failures&doi=10.1016%2Fj.ejphar.2013.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures</span></div><div class="casAuthors">Chakroborty, Shreaya; Stutzmann, Grace E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">739</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-95</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Calcium ions are versatile and universal biol. signaling factors that regulate numerous cellular processes ranging from cell fertilization, to neuronal plasticity that underlies learning and memory, to cell death.  For these functions to be properly executed, calcium signaling requires precise regulation, and failure of this regulation may tip the scales from a signal for life to a signal for death.  Disruptions in calcium channel function can generate complex multi-system disorders collectively referred to as "calciumopathies" that can target essentially any cell type or organ.  In this review, we focus on the multifaceted involvement of calcium signaling in the pathophysiol. of Alzheimer's disease (AD), and summarize the various therapeutic options currently available to combat this disease.  Detailing the series of disappointing AD clin. trial results on cognitive outcomes, we emphasize the urgency to design alternative therapeutic strategies if synaptic and memory functions are to be preserved.  One such approach is to target early calcium channelopathies centrally linked to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF0bNiyBSXVLVg90H21EOLACvtfcHk0ljAUiSQOivIiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVShur%252FM&md5=2043c1cf5c0b63d4eeb7c21995b6db88</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DChakroborty%26aufirst%3DS.%26aulast%3DStutzmann%26aufirst%3DG.%2BE.%26atitle%3DCalcium%2520Channelopathies%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Insight%2520into%2520Therapeutic%2520Success%2520and%2520Failures%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D739%26spage%3D83%26epage%3D95%26doi%3D10.1016%2Fj.ejphar.2013.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anekonda, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. F.</span></span> <span> </span><span class="NLM_article-title">Calcium Channel Blocking as a Therapeutic Strategy for Alzheimer’s Disease: The Case for Isradipine</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1812</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1590</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.bbadis.2011.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=21925266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2htbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1812&publication_year=2011&pages=1584-1590&issue=12&author=T.+S.+Anekondaauthor=J.+F.+Quinn&title=Calcium+Channel+Blocking+as+a+Therapeutic+Strategy+for+Alzheimer%E2%80%99s+Disease%3A+The+Case+for+Isradipine&doi=10.1016%2Fj.bbadis.2011.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine</span></div><div class="casAuthors">Anekonda, Thimmappa S.; Quinn, Joseph F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1812</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1584-1590</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most devastating neurodegenerative disorder in the elderly, yet treatment options are severely limited.  The drug development effort to modify Alzheimer's disease pathol. by intervention at beta amyloid prodn. sites has been largely ineffective or inconclusive.  The greatest challenge has been to identify and define downstream mechanisms reliably predictive of clin. symptoms.  Beta amyloid accumulation leads to dysregulation of intracellular calcium by plasma membrane L-type calcium channels located on neuronal somatodendrites and axons in the hippocampus and cortex.  Paradoxically, L-type calcium channel subtype Cav1.2 also promotes synaptic plasticity and spatial memory.  Increased intracellular calcium modulates amyloid precursor protein processing and affects multiple downstream pathways including increased hyperphosphorylated tau and suppression of autophagy.  Isradipine is a Federal Drug Administration-approved dihydropyridine calcium channel blocker that binds selectively to Cav1.2 in the hippocampus.  Our studies have shown that isradipine in vitro attenuates beta amyloid oligomer toxicity by suppressing calcium influx into cytoplasm and by suppressing Cav1.2 expression.  We have previously shown that administration of isradipine to triple transgenic animal model for Alzheimer's disease was well-tolerated.  Our results further suggest that isradipine became bioavailable, lowered tau burden, and improved autophagy function in the brain.  A better understanding of brain pharmacokinetics of calcium channel blockers will be crit. for designing new expts. with appropriate drug doses in any future clin. trials for Alzheimer's disease.  This review highlights the importance of Cav1.2 channel overexpression, the accumulation of hyperphosphorylated tau and suppression of autophagy in Alzheimer's disease and modulation of this pathway by isradipine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3wk5eKscM47Vg90H21EOLACvtfcHk0ljAUiSQOivIiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2htbnJ&md5=212aab116d87460754331fa496c7f63f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnekonda%26aufirst%3DT.%2BS.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26atitle%3DCalcium%2520Channel%2520Blocking%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520The%2520Case%2520for%2520Isradipine%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2011%26volume%3D1812%26issue%3D12%26spage%3D1584%26epage%3D1590%26doi%3D10.1016%2Fj.bbadis.2011.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotrane, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonawane, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhawal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharpure, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurjar, M. K.</span></span> <span> </span><span class="NLM_article-title">A Novel Method for Resolution of Amlodipine</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1021/op900283z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op900283z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=640-643&issue=3&author=D.+M.+Gotraneauthor=R.+D.+Deshmukhauthor=P.+V.+Ranadeauthor=S.+P.+Sonawaneauthor=B.+M.+Bhawalauthor=M.+M.+Gharpureauthor=M.+K.+Gurjar&title=A+Novel+Method+for+Resolution+of+Amlodipine&doi=10.1021%2Fop900283z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Method for Resolution of Amlodipine</span></div><div class="casAuthors">Gotrane, Dinkar M.; Deshmukh, Rajendra D.; Ranade, Prasad V.; Sonawane, Swapnil P.; Bhawal, Baburao M.; Gharpure, Milind M.; Gurjar, Mukund K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present invention relates to an industrially feasible and cost-efficient process for the prepn. of isomerically pure S-amlodipine besylate hemipentahydrate, a useful calcium antagonist inhibitor.  Previous workers reported that R-amlodipine-tartrate was crystd. out preferentially from the reaction mixt. when naturally occurring L-tartaric acid and racemic amlodipine base in DMSO are mixed.  In order to crystallize S-amlodipine-tartrate, the use of unnatural D-tartaric acid as a resolving agent in DMSO was required.  However, the cost of D-tartaric acid was not conducive to overall cost efficiency in the resoln. protocol.  Subsequent to the above observations, we have developed a novel resolving system in which amlodipine base with natural L-tartaric acid in DMF as a solvent gave preferentially the S-form of amlodipine tartrate directly from the reaction.  The optimization of this approach by adjusting the water percentage in DMF ensured consistent purity of S-amlodipine (+99%) and satisfactory resoln. efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ01q_9cVmg7Vg90H21EOLACvtfcHk0ljAUiSQOivIiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFOqs7k%253D&md5=bb039f7bb006e8f51045f5cd4cbb8c9f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fop900283z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop900283z%26sid%3Dliteratum%253Aachs%26aulast%3DGotrane%26aufirst%3DD.%2BM.%26aulast%3DDeshmukh%26aufirst%3DR.%2BD.%26aulast%3DRanade%26aufirst%3DP.%2BV.%26aulast%3DSonawane%26aufirst%3DS.%2BP.%26aulast%3DBhawal%26aufirst%3DB.%2BM.%26aulast%3DGharpure%26aufirst%3DM.%2BM.%26aulast%3DGurjar%26aufirst%3DM.%2BK.%26atitle%3DA%2520Novel%2520Method%2520for%2520Resolution%2520of%2520Amlodipine%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2010%26volume%3D14%26issue%3D3%26spage%3D640%26epage%3D643%26doi%3D10.1021%2Fop900283z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navadiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris</span>. <i>Curr. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.2174/1574886310666150514114619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.2174%2F1574886310666150514114619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=25973793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFyqsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=194-201&issue=3&author=K.+Navadiyaauthor=S.+Tiwari&title=Pharmacology%2C+Efficacy+and+Safety+of+Felodipine+with+a+Focus+on+Hypertension+and+Angina+Pectoris&doi=10.2174%2F1574886310666150514114619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris</span></div><div class="casAuthors">Navadiya, Kinjal; Tiwari, Sanjay</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Safety</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">CDSUBQ</span>;
        ISSN:<span class="NLM_cas:issn">1574-8863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Calcium channel blockers (CCBs) are a heterogeneous group of drugs often used in the therapy for hypertension and angina.  Though CCBs are generally similar in terms of their efficacy yet, they differ in their ability of causing selective inhibition in the contractility of vascular smooth muscle in comparison to cardiac muscle.  Felodipine is one of the most vascular selective of the available CCBs and it has no neg. inotropic effects at clin. administered doses.  The focus of this review is to comprehensively summarize the pharmacokinetics, efficacy, safety and tolerability of felodipine.  This review is based on evaluation of relevant literature on felodipine using meta-database PubMed and ScienceDirect and internet search engine (Google Scholar).  Clin. studies summarized in this review testify, on tech. lines, the clin. efficacy, safety and placebo- like tolerability profile of felodipine, administered alone as well as in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kr6MUnquErVg90H21EOLACvtfcHk0liOhTNVcxwCtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFyqsbrJ&md5=96acffe3fc1c8fe282fd8235813a0bb1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1574886310666150514114619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574886310666150514114619%26sid%3Dliteratum%253Aachs%26aulast%3DNavadiya%26aufirst%3DK.%26aulast%3DTiwari%26aufirst%3DS.%26atitle%3DPharmacology%252C%2520Efficacy%2520and%2520Safety%2520of%2520Felodipine%2520with%2520a%2520Focus%2520on%2520Hypertension%2520and%2520Angina%2520Pectoris%26jtitle%3DCurr.%2520Drug%2520Saf.%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3D194%26epage%3D201%26doi%3D10.2174%2F1574886310666150514114619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&issue=2&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0liOhTNVcxwCtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26issue%3D2%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampsch-Woodill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&issue=10&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+Validation+of+an+Improved+Oxygen+Radical+Absorbance+Capacity+Assay+Using+Fluorescein+as+the+Fluorescent+Probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0liOhTNVcxwCtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520an%2520Improved%2520Oxygen%2520Radical%2520Absorbance%2520Capacity%2520Assay%2520Using%2520Fluorescein%2520as%2520the%2520Fluorescent%2520Probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26issue%3D10%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dávalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Cordovés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC–Fluorescein) Assay</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&issue=1&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+Applicability+of+the+Oxygen+Radical+Absorbance+Capacity+%28ORAC%E2%80%93Fluorescein%29+Assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC-Fluorescein) Assay</span></div><div class="casAuthors">Davalos, Alberto; Gomez-Cordoves, Carmen; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORAC-fluorescein (ORAC-FL) method recently validated using automatic liq. handling systems has been adapted to manual handling and using a conventional fluorescence microplate reader.  As calcd. for Trolox, the precision of the method was <3.0, expressed as percent coeff. of variation.  The accuracy of the method was <2.3, expressed as percent variation of the mean.  The detection and quantification limits were those corresponding to 0.5- and 1-μM Trolox std. solns., resp.  The method has been applied to 10 pure compds. (benzoic and cinnamic acids and aldehydes, flavonoids, and butylated hydroxyanisole), to 30 white, rose, and bottled- and oak-aged red wines, and to 7 com. dietary antioxidant supplements.  All samples exhibited a good linear response with concn.  As seen by other methodologies, the chem. structure of a compd. dets. its antioxidant activity (ORAC-FL value).  Of particular interest were the results with oak-aged red wines from different vintages (1989-2002) that confirm influence of vintage, but not origin of the oak, in the antioxidant activity of wines from the same variety.  Dietary antioxidant supplements presented a great variability (170-fold difference) in their antioxidant potency.  This work proves applicability of the ORAC-FL assay in evaluating the antioxidant activity of diverse food samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MQ8zab9ce7Vg90H21EOLACvtfcHk0lgmQHxQFlOLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D&md5=c08c16818b9c32fc87b46570b26544f9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520Applicability%2520of%2520the%2520Oxygen%2520Radical%2520Absorbance%2520Capacity%2520%2528ORAC%25E2%2580%2593Fluorescein%2529%2520Assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26issue%3D1%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemes, L. F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade Ramos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, F. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro Couto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Boni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, M. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Nascimento Nogueira, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korábečný, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeiro, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeiro, L. A. S.</span></span> <span> </span><span class="NLM_article-title">Cardanol-Derived AChE Inhibitors: Towards the Development of Dual Binding Derivatives for Alzheimer’s Disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2Fj.ejmech.2015.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=26735910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsV2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=687-700&author=L.+F.+N.+Lemesauthor=G.+de+Andrade+Ramosauthor=A.+S.+de+Oliveiraauthor=F.+M.+R.+da+Silvaauthor=G.+de+Castro+Coutoauthor=M.+da+Silva+Boniauthor=M.+J.+R.+Guimar%C3%A3esauthor=I.+N.+O.+Souzaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+C.+do+Nascimento+Nogueiraauthor=E.+R.+Silveiraauthor=G.+D.+Brandauthor=O.+Soukupauthor=J.+Kor%C3%A1be%C4%8Dn%C3%BDauthor=N.+C.+Romeiroauthor=N.+G.+Castroauthor=M.+L.+Bolognesiauthor=L.+A.+S.+Romeiro&title=Cardanol-Derived+AChE+Inhibitors%3A+Towards+the+Development+of+Dual+Binding+Derivatives+for+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2015.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease</span></div><div class="casAuthors">Lemes, Lais Flavia Nunes; Ramos, Giselle de Andrade; Souza de Oliveira, Andressa; da Silva, Fernanda Motta R.; Couto, Gina de Castro; Boni, Marina da Silva; Guimaraes, Marcos Jorge R.; Souza, Isis Nem O.; Bartolini, Manuela; Andrisano, Vincenza; Nogueira, Patricia Coelho do Nascimento; Silveira, Edilberto Rocha; Brand, Guilherme D.; Soukup, Ondrej; Korabecny, Jan; Romeiro, Nelilma C.; Castro, Newton G.; Bolognesi, Maria Laura; Romeiro, Luiz Antonio Soares</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cardanol is a phenolic lipid component of cashew nut shell liq. (CNSL), obtained as the byproduct of cashew nut food processing.  Being a waste product, it has attracted much attention as a precursor for the prodn. of high-value chems., including drugs.  On the basis of these findings and in connection with the authors' previous studies on cardanol derivs. as acetylcholinesterase (AChE) inhibitors, the authors designed a novel series of analogs by including a protonable amino moiety belonging to different systems.  Properly addressed docking studies suggested that the proposed structural modifications would allow the new mols. to interact with both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE, thus being able to act as dual binding inhibitors.  To disclose whether the new mols. showed the desired profile, they were first tested for their cholinesterase inhibitory activity towards EeAChE and eqBuChE.  Compd. 26 (N-ethyl-N-(2-methoxybenzyl)-8-(3-methoxyphenyl)octan-1-amine), bearing an N-ethyl-N-(2-methoxybenzyl)amine moiety, showed the highest inhibitory activity against EeAChE, with a promising IC50 of 6.6 μM, and a similar inhibition profile of the human isoform (IC50 = 5.7 μM).  As another pos. feature, most of the derivs. did not show appreciable toxicity against HT-29 cells, up to a concn. of 100 μM, which indicates drug-conform behavior.  Also, compd. 26 is capable of crossing the blood-brain barrier (BBB), as predicted by a PAMPA-BBB assay.  Collectively, the data suggest that the approach to obtain potential anti-Alzheimer drugs from CNSL is worth of further pursuit and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcgxn8kS_m7Vg90H21EOLACvtfcHk0lgmQHxQFlOLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsV2l&md5=f9ba78f805e7fa7642b3985305d52503</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DLemes%26aufirst%3DL.%2BF.%2BN.%26aulast%3Dde%2BAndrade%2BRamos%26aufirst%3DG.%26aulast%3Dde%2BOliveira%26aufirst%3DA.%2BS.%26aulast%3Dda%2BSilva%26aufirst%3DF.%2BM.%2BR.%26aulast%3Dde%2BCastro%2BCouto%26aufirst%3DG.%26aulast%3Dda%2BSilva%2BBoni%26aufirst%3DM.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DM.%2BJ.%2BR.%26aulast%3DSouza%26aufirst%3DI.%2BN.%2BO.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3Ddo%2BNascimento%2BNogueira%26aufirst%3DP.%2BC.%26aulast%3DSilveira%26aufirst%3DE.%2BR.%26aulast%3DBrand%26aufirst%3DG.%2BD.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKor%25C3%25A1be%25C4%258Dn%25C3%25BD%26aufirst%3DJ.%26aulast%3DRomeiro%26aufirst%3DN.%2BC.%26aulast%3DCastro%26aufirst%3DN.%2BG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRomeiro%26aufirst%3DL.%2BA.%2BS.%26atitle%3DCardanol-Derived%2520AChE%2520Inhibitors%253A%2520Towards%2520the%2520Development%2520of%2520Dual%2520Binding%2520Derivatives%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D687%26epage%3D700%26doi%3D10.1016%2Fj.ejmech.2015.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budriesi, R.</span></span> <span> </span><span class="NLM_article-title">Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]Thiazole-1,4-Dihydropyridines: From Heart Activity to Brain Affinity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3866</span>– <span class="NLM_lpage">3877</span>, <span class="refDoi"> DOI: 10.1021/jm301839q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301839q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3866-3877&issue=10&author=A.+Locatelliauthor=S.+Cosconatiauthor=M.+Micucciauthor=A.+Leoniauthor=L.+Marinelliauthor=A.+Bediniauthor=P.+Ioanauthor=S.+M.+Spampinatoauthor=E.+Novellinoauthor=A.+Chiariniauthor=R.+Budriesi&title=Ligand+Based+Approach+to+L-Type+Calcium+Channel+by+Imidazo%5B2%2C1-b%5DThiazole-1%2C4-Dihydropyridines%3A+From+Heart+Activity+to+Brain+Affinity&doi=10.1021%2Fjm301839q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]thiazole-1,4-Dihydropyridines: from Heart Activity to Brain Affinity</span></div><div class="casAuthors">Locatelli, Alessandra; Cosconati, Sandro; Micucci, Matteo; Leoni, Alberto; Luciana, Marinelli; Bedini, Andrea; Ioan, Pierfranco; Spampinato, Santi Mario; Novellino, Ettore; Chiarini, Alberto; Budriesi, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3866-3877</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis, characterization, and functional in vitro assay in cardiac and smooth muscle (vascular and nonvascular) of a series of 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines I (X-Y = HC:CH, MeC:CH, etc., R = 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thienyl, 3-thienyl, 2,4-Cl2-thienyl, 2,5-(OCH3)2-C6H3,etc., R1 = Me, Et) are reported.  To define the calcium blocker nature of the imidazo[2,1-b]thiazole-1,4-DHPs and their selectivity on Cav1.2 and Cav1.3 isoforms, we performed binding studies on guinea pig atrial and ventricular membranes on intact cells expressing the cloned Cav1.2a subunit and on rat brain cortex.  To get major insights into the reasons for the affinity for Cav1.2 and/or Cav1.3, mol. modeling studies were also undertaken.  Some physicochem. and pharmacokinetic properties of selected compds. were calcd. and compared.  All the biol. data collected and reported herein allowed us to rationalize the structure-activity relationship of the 4-imidazo[2,1-b]thiazole-1,4-DHPs and to identify which of these enhanced the activity at the central level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz3k5v0tIEbVg90H21EOLACvtfcHk0lgmQHxQFlOLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVynsLw%253D&md5=5bcf5476a37b981742307f564f9ce424</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm301839q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301839q%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DA.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMicucci%26aufirst%3DM.%26aulast%3DLeoni%26aufirst%3DA.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DIoan%26aufirst%3DP.%26aulast%3DSpampinato%26aufirst%3DS.%2BM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26atitle%3DLigand%2520Based%2520Approach%2520to%2520L-Type%2520Calcium%2520Channel%2520by%2520Imidazo%255B2%252C1-b%255DThiazole-1%252C4-Dihydropyridines%253A%2520From%2520Heart%2520Activity%2520to%2520Brain%2520Affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D3866%26epage%3D3877%26doi%3D10.1021%2Fjm301839q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Revelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, J. C.</span></span> <span> </span><span class="NLM_article-title">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4313</span>– <span class="NLM_lpage">4323</span>, <span class="refDoi"> DOI: 10.1021/jm500263v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500263v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4313-4323&issue=10&author=G.+Tentiauthor=E.+Paradaauthor=R.+Le%C3%B3nauthor=J.+Egeaauthor=S.+Mart%C3%ADnez-Revellesauthor=A.+M.+Brionesauthor=V.+Sridharanauthor=M.+G.+L%C3%B3pezauthor=M.+T.+Ramosauthor=J.+C.+Men%C3%A9ndez&title=New+5-Unsubstituted+Dihydropyridines+with+Improved+CaV1.3+Selectivity+as+Potential+Neuroprotective+Agents+against+Ischemic+Injury&doi=10.1021%2Fjm500263v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span></div><div class="casAuthors">Tenti, Giammarco; Parada, Esther; Leon, Rafael; Egea, Javier; Martinez-Revelles, Sonia; Briones, Ana Maria; Sridharan, Vellaisamy; Lopez, Manuela G.; Ramos, Maria Teresa; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4313-4323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C5-unsubstituted-C6-aryl-1,4-dihydropyridines were prepd. by a CAN-catalyzed multicomponent reaction from chalcones, β-dicarbonyl compds., and ammonium acetate.  These compds. were able to block Ca2+ entry after a depolarizing stimulus and showed an improved Cav1.3/Cav1.2 selectivity in comparison with nifedipine.  Furthermore, they were able to protect neuroblastoma cells against Ca2+ overload and oxidative stress models.  Their selectivity ratio makes them highly interesting for the treatment of neurol. disorders where Ca2+ dyshomeostasis and high levels of oxidative stress have been demonstrated.  Furthermore, their low potency toward the cardiovascular channel subtype makes them safer by reducing their probable side effects, in comparison to classical 1,4-dihydropyridines.  Some compds. afforded good protective profile in a postincubation model that simulates the real clin. situation of ictus patients, offering a therapeutic window of opportunity of great interest for patient recovery after a brain ischemic episode.  Good activities were also found in acute ischemia/reperfusion models of oxygen and glucose deprivation.  Compds. I and II were found to be most active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2qOTrNT3NbVg90H21EOLACvtfcHk0liG45o-jNM1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D&md5=f9ed28bdea3ac4d3dda8e06159f6e4b5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500263v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500263v%26sid%3Dliteratum%253Aachs%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DParada%26aufirst%3DE.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez-Revelles%26aufirst%3DS.%26aulast%3DBriones%26aufirst%3DA.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DRamos%26aufirst%3DM.%2BT.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DJ.%2BC.%26atitle%3DNew%25205-Unsubstituted%2520Dihydropyridines%2520with%2520Improved%2520CaV1.3%2520Selectivity%2520as%2520Potential%2520Neuroprotective%2520Agents%2520against%2520Ischemic%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D10%26spage%3D4313%26epage%3D4323%26doi%3D10.1021%2Fjm500263v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Louis, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Nifedipine and Bay K 8644 on Myotropic Responses in Aortic Rings of Pregnant Rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(95)00155-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1016%2F0014-2999%2895%2900155-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=7498248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVWgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1995&pages=1-9&issue=1&author=B.+Royauthor=B.+Sicotteauthor=M.+Brochuauthor=J.+St-Louis&title=Effects+of+Nifedipine+and+Bay+K+8644+on+Myotropic+Responses+in+Aortic+Rings+of+Pregnant+Rats&doi=10.1016%2F0014-2999%2895%2900155-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nifedipine and Bay K 8644 on myotropic responses in aortic rings of pregnant rats</span></div><div class="casAuthors">Roy, Bertrand; Sicotte, Benoit; Brochu, Michele; St-Louis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The hypothesis that Ca2+ channel function is altered during pregnancy was tested by comparing the effects of the Ca2+ antagonist nifedipine and of the Ca2+ channel activator Bay K 8644 on the contractile responses of aortic rings from virgin and term-pregnant rats to KCl and phenylephrine.  The max. response to KCl was progressively reduced by increasing nifedipine concns. (1.0-100 nM) in aortic rings from both groups of rats.  Nifedipine produced a smaller inhibition of KCl-induced contraction in aortic rings of pregnant than of virgin rats.  It exerted little inhibition on the concn.-response curve to phenylephrine.  Nifedipine (100 nM) reduced the max. response to phenylephrine in rings from virgin rats, but had no effect on those from pregnant rats.  Bay K 8644 potentiated the responses to low concns. of both phenylephrine and KCl by the tissues from both virgin and pregnant rats, but it did not affect max. responses.  It also induced concn.-dependent contractions of rings from virgin, but not pregnant, rats.  The effects of Bay K 8644 were markedly potentiated by precontracting the aorta with 10 mM KCl.  Nevertheless, tissues from pregnant rats were still less responsive to Bay K 8644 than were those from virgin rats.  However, when the strips were precontracted to the same level by different concns. of KCl, the concn.-response curves to Bay K 8644 were identical in both groups. [3H]Nitrendipine binding to membrane prepns. of the thoracic aorta was similar in virgin and pregnant rats.  These results show that the effects of both nifedipine and Bay K 8644 were decreased in aortic rings from pregnant compared to virgin rats and indicate that potential-operated Ca2+ channel function is altered in the aorta of pregnant rats.  It is suggested that modulation of membrane potential with KCl can reverse this change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0tIxG0jCirVg90H21EOLACvtfcHk0liG45o-jNM1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVWgtbk%253D&md5=665e22285c10acab92a225648b8075a3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900155-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900155-E%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DB.%26aulast%3DSicotte%26aufirst%3DB.%26aulast%3DBrochu%26aufirst%3DM.%26aulast%3DSt-Louis%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Nifedipine%2520and%2520Bay%2520K%25208644%2520on%2520Myotropic%2520Responses%2520in%2520Aortic%2520Rings%2520of%2520Pregnant%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D280%26issue%3D1%26spage%3D1%26epage%3D9%26doi%3D10.1016%2F0014-2999%2895%2900155-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL Repository-New Features and Functionality</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D313</span>– <span class="NLM_lpage">D319</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1093%2Fnar%2Fgkw1132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=27899672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D313-D319&issue=D1&author=S.+Bienertauthor=A.+Waterhouseauthor=T.+A.+P.+de+Beerauthor=G.+Taurielloauthor=G.+Studerauthor=L.+Bordoliauthor=T.+Schwede&title=The+SWISS-MODEL+Repository-New+Features+and+Functionality&doi=10.1093%2Fnar%2Fgkw1132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL Repository--new features and functionality</span></div><div class="casAuthors">Bienert, Stefan; Waterhouse, Andrew; de Beer, Tjaart A. P.; Tauriello, Gerardo; Studer, Gabriel; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D313-D319</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">SWISS-MODEL Repository (SMR) is a database of annotated 3D protein structure models generated by the automated SWISS-MODEL homol. modeling pipeline.  It currently holds >400 000 high quality models covering almost 20% of Swiss- Prot/UniProtKB entries.  In this manuscript, we provide an update of features and functionalities which have been implemented recently.  We address improvements in target coverage, model quality ests., functional annotations and improved in-page visualization.  We also introduce a new update concept which includes regular updates of an expanded set of core organism models and UniProtKB-based targets, complemented by user-driven on-demand update of individual models.  With the new release of the modeling pipeline, SMR has implemented a REST-API and adopted an open licencing model for accessing model coordinates, thus enabling bulk download for groups of targets fostering re-use of models in other contexts.  SMR can be accessed at https://swissmodel.expasy.org/repository.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-otAf4J2uy7Vg90H21EOLACvtfcHk0liG45o-jNM1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhsL0%253D&md5=bc52d569b15ca0ca6932c53dc15ecbd5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1132%26sid%3Dliteratum%253Aachs%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3Dde%2BBeer%26aufirst%3DT.%2BA.%2BP.%26aulast%3DTauriello%26aufirst%3DG.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Repository-New%2520Features%2520and%2520Functionality%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26issue%3DD1%26spage%3DD313%26epage%3DD319%26doi%3D10.1093%2Fnar%2Fgkw1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guex, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">Automated Comparative Protein Structure Modeling with SWISS-MODEL and Swiss-PdbViewer: A Historical Perspective</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S173</span>, <span class="refDoi"> DOI: 10.1002/elps.200900140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=10.1002%2Felps.200900140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=19517507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=S162-S173&issue=Suppl.+1&author=N.+Guexauthor=M.+C.+Peitschauthor=T.+Schwede&title=Automated+Comparative+Protein+Structure+Modeling+with+SWISS-MODEL+and+Swiss-PdbViewer%3A+A+Historical+Perspective&doi=10.1002%2Felps.200900140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span></div><div class="casAuthors">Guex Nicolas; Peitsch Manuel C; Schwede Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S162-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SWISS-MODEL pioneered the field of automated modeling as the first protein modeling service on the Internet.  In combination with the visualization tool Swiss-PdbViewer, the Internet-based Workspace and the SWISS-MODEL Repository, it provides a fully integrated sequence to structure analysis and modeling platform.  This computational environment is made freely available to the scientific community with the aim to hide the computational complexity of structural bioinformatics and encourage bench scientists to make use of the ever-increasing structural information available.  Indeed, over the last decade, the availability of structural information has significantly increased for many organisms as a direct consequence of the complementary nature of comparative protein modeling and experimental structure determination.  This has a very positive and enabling impact on many different applications in biomedical research as described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUn40ZFOULN-cVm4E2RlLfW6udTcc2eZjjgf9SaC2Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D&md5=e74c27636b8f333cd344bedff31c97fa</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Felps.200900140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200900140%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DAutomated%2520Comparative%2520Protein%2520Structure%2520Modeling%2520with%2520SWISS-MODEL%2520and%2520Swiss-PdbViewer%253A%2520A%2520Historical%2520Perspective%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26issue%3DSuppl.%25201%26spage%3DS162%26epage%3DS173%26doi%3D10.1002%2Felps.200900140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&issue=7&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liU40TbpDNdwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doman, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4477</span>– <span class="NLM_lpage">4486</span>, <span class="refDoi"> DOI: 10.1021/jm030191r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030191r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Kkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4477-4486&issue=21&author=J.+Seidlerauthor=S.+L.+McGovernauthor=T.+N.+Domanauthor=B.+K.+Shoichet&title=Identification+and+Prediction+of+Promiscuous+Aggregating+Inhibitors+among+Known+Drugs&doi=10.1021%2Fjm030191r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and prediction of promiscuous aggregating inhibitors among known drugs</span></div><div class="casAuthors">Seidler, James; McGovern, Susan L.; Doman, Thompson N.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4477-4486</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some small mols., often hits from screening, form aggregates in soln. that inhibit many enzymes.  In contrast, drugs are thought to act specifically.  To investigate this assumption, 50 unrelated drugs were tested for promiscuous inhibition via aggregation.  Each drug was tested against three unrelated model enzymes: β-lactamase, chymotrypsin, and malate dehydrogenase, none of which are considered targets of these drugs.  To be judged promiscuous, the drugs had to inhibit all three enzymes, do so in a time-dependent manner, be sensitive to detergent and to enzyme concn., and form particles detectable by light scattering.  Of the 50 drugs tested, 43 were nonpromiscuous by these criteria.  Surprisingly, four of the drugs showed promiscuous, aggregation-based inhibition at concns. below 100 μM: clotrimazole, benzyl benzoate, nicardipine, and delavirdine.  Three other drugs also behaved as aggregation-based inhibitors, but only at high concns. (about 400 μM).  To investigate possible structure-activity relationships among promiscuous drugs, five analogs of the antifungal clotrimazole were studied.  Three of these, miconazole, econazole, and sulconazole, were promiscuous but the other two, fluconazole and ketoconazole, were not.  Using recursive partitioning, these exptl. results were used to develop a model for predicting aggregate-based promiscuity.  This model correctly classified 94% of 111 compds.-- 47 aggregators and 64 nonaggregators-- that have been studied for this effect.  To evaluate the model, it was used to predict the behavior of 75 drugs not previously investigated for aggregation.  Several preliminary points emerge.  Most drugs are not promiscuous, even at high concns.  Nevertheless, at high enough concns. (20-400 μM), some drugs can aggregate and act promiscuously, suggesting that aggregation may be common among small mols. at micromolar concns., at least in biochem. buffers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6rct1y8KO7Vg90H21EOLACvtfcHk0lh1N6F8VJ53Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Kkt74%253D&md5=4bc47e2d426be688a79aa077ce6f9c3b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm030191r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030191r%26sid%3Dliteratum%253Aachs%26aulast%3DSeidler%26aufirst%3DJ.%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DDoman%26aufirst%3DT.%2BN.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DIdentification%2520and%2520Prediction%2520of%2520Promiscuous%2520Aggregating%2520Inhibitors%2520among%2520Known%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D21%26spage%3D4477%26epage%3D4486%26doi%3D10.1021%2Fjm030191r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzouz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gembus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ţînţaş, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopková-de Oliveira
Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papamicaël, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levacher, V.</span></span> <span> </span><span class="NLM_article-title">Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5909</span>– <span class="NLM_lpage">5926</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00702</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00702" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpvFeju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5909-5926&issue=13&author=L.+Peaugerauthor=R.+Azzouzauthor=V.+Gembusauthor=M.-L.+%C5%A2%C3%AEn%C5%A3a%C5%9Fauthor=J.+Sopkov%C3%A1-de+Oliveira%0ASantosauthor=P.+Bohnauthor=C.+Papamica%C3%ABlauthor=V.+Levacher&title=Donepezil-Based+Central+Acetylcholinesterase+Inhibitors+by+Means+of+a+%E2%80%9CBio-Oxidizable%E2%80%9D+Prodrug+Strategy%3A+Design%2C+Synthesis%2C+and+in+Vitro+Biological+Evaluation&doi=10.1021%2Facs.jmedchem.7b00702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation</span></div><div class="casAuthors">Peauger, Ludovic; Azzouz, Rabah; Gembus, Vincent; Tintas, Mihaela-Liliana; Sopkova-de Oliveira Santos, Jana; Bohn, Pierre; Papamicael, Cyril; Levacher, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5909-5926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim of reducing side effects of acetylcholinesterase inhibitors (AChEIs) during symptomatic treatment of Alzheimer's disease, we report herein a new class of donepezil-based "bio-oxidizable" prodrugs 1 designed to be converted into dual binding site AChEIs 2.  While most of indanone-derived N-benzylpyridinium salts 2 revealed to be highly potent dual binding site hAChEIs (IC50 up to 3 nM), outperforming the std. drug donepezil (IC50 = 11 nM), most of the corresponding 1,4-dihydropyridines 1 were found to be inactive.  Promisingly, whereas the selected prodrug 1r showed good permeability in the PAMPA-BBB model and high in vitro antioxidant activity, its conversion to AChEI 2r could be easily achieved under mild conditions when incubated in various oxidizing media.  Lastly, both compds. 1r and 2r did not show genotoxicity in vitro and displayed high LD50 values in mice, making this prodrug 1r/drug 2r couple a good candidate for further in vivo biol. expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOI51deRlDLVg90H21EOLACvtfcHk0lh1N6F8VJ53Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpvFeju74%253D&md5=bd539cf43f39c5058b243fb1bbdb4da4</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00702%26sid%3Dliteratum%253Aachs%26aulast%3DPeauger%26aufirst%3DL.%26aulast%3DAzzouz%26aufirst%3DR.%26aulast%3DGembus%26aufirst%3DV.%26aulast%3D%25C5%25A2%25C3%25AEn%25C5%25A3a%25C5%259F%26aufirst%3DM.-L.%26aulast%3DSopkov%25C3%25A1-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DPapamica%25C3%25ABl%26aufirst%3DC.%26aulast%3DLevacher%26aufirst%3DV.%26atitle%3DDonepezil-Based%2520Central%2520Acetylcholinesterase%2520Inhibitors%2520by%2520Means%2520of%2520a%2520%25E2%2580%259CBio-Oxidizable%25E2%2580%259D%2520Prodrug%2520Strategy%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Biological%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5909%26epage%3D5926%26doi%3D10.1021%2Facs.jmedchem.7b00702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE','PDB','3RZE'); return false;">PDB: 3RZE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CXV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CXV','PDB','5CXV'); return false;">PDB: 5CXV</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i11"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00937">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18017"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b00937?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00937</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures covering the synthesis, spectral characterization of compounds <b>2a</b>–<b>p</b> and hybrids <b>3a</b>–<b>p</b>, pharmacological methods, and docking studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf">PDF</a>)</p></li><li><p class="inline">PDB files (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_002.zip">ZIP</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_001.pdf">jm9b00937_si_001.pdf (3.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_002.zip">jm9b00937_si_002.zip (822.74 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00937/suppl_file/jm9b00937_si_003.csv">jm9b00937_si_003.csv (2.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00937%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00937" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997f712b473cd0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
